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Novel approaches to the control of cyathostomins in equids 
Laura Elizabeth Peachey 
Cyathostomins, are clade 5 gastrointestinal (GI) nematodes infecting equids. They are 
associated with a range of pathologies, the most serious of which is larval cyathostominosis, a 
protein losing enteropathy with a 50 % mortality rate. Importantly, they are the most abundant 
GI nematode of equids in the developed world and, as they do not induce protective immunity, 
equids remain at risk of infection throughout their lives. The effective control of cyathostomins 
is currently threatened by the development of anthelmintic resistance (AR) to all three major 
classes of anthelmintic licenced for use in equids. Of primary concern is the emerging 
resistance to the macrocyclic lactones (MLs), which are the mainstay of cyathostomin control. 
It is therefore important that novel options for controlling cyathostomins are explored. In this 
study in vitro tests were used to explore a range of options for developing novel treatments 
against AR cyathostomins and improving the efficacy of the widely used ML, ivermectin 
(IVM).  
First the potential use of ethnoveterinary medicines for treatment of cyathostomins in equids 
in Ethiopia and the UK was explored (Chapters 3, 4 and 5). A participatory rural appraisal was 
performed in the Oromia region of Ethiopia to identify plants currently used as anthelmintics 
in equids and other livestock. A total of 37 species of plant were identified, data on dosing and 
side effects were also recorded. These data were triangulated with a literature review to identify 
five plants for in vitro screening for anthelmintic activity against cyathostomins. A literature 
review was used to identify plants for in vitro screening in the UK. A total of 138 publications, 
reporting the anthelmintic activity of plant extracts against nematodes, were found. The data 
collected was used to design a ranking system to provide a shortlist of five plant candidates. 
Shortlisted plants were collected, dried and chemically extracted to give crude extracts, which 
were screened against cyathostomins in the egg hatch test (EHT) and larval migration inhibition 
test (LMIT). A total of 7/9 plants screened in this way showed anthelmintic activity in either 
the EHT and/or the LMIT with median effective concentrations (EC-50s) in the range 0.18-
8.90 mg/ml. For some of the most efficacious extracts there were reports of in vivo efficacy 
against GI nematodes of other veterinary parasitic nematodes, making these good candidates 
for future in vivo trials. One of the plants shortlisted for the UK, for which there was extensive 
evidence of anthelmintic activity in the literature, was the cysteine proteinase (CP) containing 
Carica papaya. Extract from this species, papaya latex supernatant (PLS), could not be 
processed and tested using the same protocols as the other plant species, as the active compound 
is an enzyme. The EHT and LMIT were optimised for use with PLS and its efficacy evaluated 
in chapter 5. It was found that PLS had a potent anthelmintic effect against cyathostomins in 
the EHT, which was attributable to the action of CPs, with EC-50 values in repeats ranging 
between 0.12-0.22 µM. PLS also showed efficacy in the LMIT, although this appeared due to 
another active compound. To the authors knowledge this is the first report of efficacy of PLS 
against the free living stages of any parasitic nematode, which may indicate that cyathostomins 
are particularly susceptible to CPs. 
In chapter 6 the role of P-glycoproteins (P-gps) in IVM resistance in cyathostomins was 
investigated, with the more specific aim of assessing whether P-gp inhibitors could potentially 
be used in combination with IVM to improve its efficacy against AR parasites. The 
transcription of pgp-9, which is putatively associated with IVM resistance in Teladorsagia 
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circumcincta and Haemonchus contortus, was measured after exposure to IVM in in ML 
resistant (AR) versus anthelmintic naïve (AN) cyathostomin third stage larvae (L3). Pgp-9 
expression was significantly increased after incubation with IVM in the AR, but not the AN, 
parasite population. Two in vitro tests, the LMIT and the larval development test (LDT), were 
used to assess the effect of a range of P-gp inhibitors (ketoconazole, pluronic 85 and ivermectin 
aglycone) on IVM efficacy in ML resistant (AR) versus anthelmintic naïve (AN) 
cyathostomins. In the LMIT ketoconazole and ivermectin aglycone conferred a significant 
increase in IVM efficacy in the AR parasites, but had less effect on the AN parasites. Pluronic 
85 also had a profound effect on IVM efficacy which depended on IVM concentration, however 
there was no differential effect dependent on parasite population. In the LDT, ketoconazole 
and pluronic 85 both significantly increased IVM efficacy in both AR and AN parasites. These 
results suggest that there is a lifecycle stage-specific association of P-gps with AR 
cyathostomins, and that P-gp inhibitors could potentially be used to improve IVM efficacy in 
AR cyathostomin populations.  
In summary in this study has identified a range of potential novel treatments for cyathostomins. 
The data also suggest a role for P-gps in the emerging resistance to MLs, which could 
potentially be exploited to improve ML efficacy in AR cyathostomin populations. Importantly, 
this work will underpin the financial and ethical justification for future in vivo trials on the 
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Globally equids are susceptible to a range of gastrointestinal (GI) helminths, these include the 
ascarid Parascaris equorum, tapeworms such as Anoplocephola perfoliata, the stomach worms 
Habronema spp. and Trichostrongylus axei, the threadworm Strongloides westeri and the 
strongyles (Bucknell et al., 1995; Cirak et al., 1996; Gawor, 1995; Krecek et al., 1989; 
Ogbourne, 1976; Reinemeyer et al., 1984; Torbert et al., 1986). The strongyles are the most 
prevalent and represent a complex group which are highly significant to the health and welfare 
of equids; they are nematodes of the order Strongylida, belonging to the Strongylidae family. 
They are subdivided into Strongylinea, comprising Strongylus vulgaris, Strongylus edentatus, 
Strongylus equinus and Strongylus asinsi, (collectively known as the large strongyles) and 
cyathostominae (known as the small strongyles or cyathostomins).  
 
Naturally infected, untreated equids are usually co-infected with multiple species of strongyle 
nematode, although in populations receiving regular anthelmintic treatments the large 
strongyles are rare (Boxell et al., 2004; Herd and Coles, 1995; Kaplan, 2002). In many 
developed countries cyathostomins are the most prevalent, at almost 100 %, and are the focus 
of control regimens (Lyons et al., 1999). Cyathostomins themselves are a complex group, 
comprised of 52 different species belonging to 13 genera (Lichtenfels et al., 2002; Lichtenfels 
et al., 1998; Matthee et al., 2002a). Infections are complex mixes of species and may differ 
geographically, however in horses 90-99 % of infections usually consist of 5-10 common 
species: Cylicostephanus longibursatus, Cyathostomum catinatum, Cylicostephanus goldi, 
Cylicocyclus nassatus, Cyclicocyclus brevicapsulatis, Cyathostomum coronatum, 
Cylicostephanus calicatus, Cyclicostephanus, minutus, Cyclicocyclus leptostomus, 
Cyathostomum pateratum, Cylicocyclus insigne, Cylicocyclus radiatus and Cylicocyclus 
3 
 
ashworthi (Bucknell et al., 1995; Gawor, 1995; Love and Duncan, 1992; Ogbourne, 1976; 
Reinemeyer et al., 1984; Traversa et al., 2010). Only a few studies have determined species 
mix in donkeys and zebras, but the evidence suggests that there are some differences in relative 
abundance to those found infecting horses, in particular Cyathostomum tetracanthum is 
commonly found in donkeys (Eysker and Pandey, 1989; Getachew et al., 2010; Kharchenko et 
al., 2009; Krecek et al., 1994). In terms of species, the composition of co-infections has been 
shown to be relatively stable over decades within equid populations (Chapman et al., 2002a). 
There is some evidence of infection site specificity for cyathostomins; it has been reported that 
C. longibursatus, C. goldi and C. insigne are more prevalent in the dorsal colon, with C. 
catinatum, C. nassatus and C. minutus most abundant in the ventral colon and C. calicatus and 
C. coronatum showing a predilection for the caecum (Bucknell et al., 1995; Collobert-Laugier 
et al., 2002b; Gawor, 1995; Ogbourne, 1976). The large number of cyathostomin species 
present in an infected host or population of equids is an important consideration when studying 
their biology and epidemiology; much of what is currently known is based on mixed co-
infections, rather than on an individual species basis. Historically the only way of accurately 
differentiating between species infecting a host was to identify adults at post-mortem 
(Lichtenfels et al., 2002; Lichtenfels et al., 2008), improvement to these methods has since 
allowed the culture of eggs from faeces to larval stages, followed by morphological 
identification (Kornas et al., 2009), however these methods are laborious and this has largely 
prohibited studies on the effect of different species in co-infections. Over the last 15 years 
molecular tools have been developed which can quickly differentiate between a range of 
cyathostomins species within samples of eggs collected from faeces. These developments 
include a PCR-enzyme-linked immunosorbent assay (PCR-ELISA) (Hodgkinson et al., 2005; 
Hodgkinson et al., 2003; Hodgkinson et al., 2001) and a reverse line blot assay (Traversa et al., 
4 
 
2007a) both of which apply species specific probes to intergenic spacer DNA fragments and 
can identify a range of six and 13 species, respectively.  
 











Figure 1.1. Diagrammatic representation of the direct life-cycle of cyathostomins. The life cycle can 
be halted for up to three years at the encysted L3 stage. 
 
 
Cyathostomins have a direct life cycle, see Figure 1.1. Eggs laid by adult females in the large 
intestine are passed out in faeces, in which they hatch to first stage larvae (L1). Hatching 
requires moisture and a minimum temperature of 7.2 ºC (Ogbourne, 1972). The L1 feed on 
bacteria in the faecal pat and develop into second stage larvae (L2), which then moult to the 
infective third stage larvae (IL3). The L2 and L3 have a cuticle to help protect them against 
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desiccation or freezing. The time for development of IL3 from eggs depends on climatic 
conditions; the optimum temperatures for maturation have been shown to range from 20-33 ºC 
(Mfitilodze and Hutchinson, 1987). Development can take between 3-24 days at these 
temperatures, but can be considerably affected by desiccation (Mfitilodze and Hutchinson, 
1987, 1988; Ogbourne, 1972). The L3 are not thought to move more than 15 cm horizontally, 
or climb higher than 10 cm from the ground on herbage (English, 1979), and hence the main 
mechanism of dispersal over the pasture is through rainfall (Hutchinson et al., 1989; Ogbourne, 
1972). The IL3 are then ingested by the host where they are immediately ex-sheathed in the 
stomach and small intestine (Poynter, 1954), before passing to the caecum and large colon 
where they encyst in the large intestinal mucosa or sub-mucosa (Urquhart et al., 1996). The L3 
undergo several stages of development within the mucosa from early L3 (EL3), to late L3 
(LL3), to developing L4 (DL4) and then to fourth larval stages (L4) (Chapman et al., 1999). 
This process is reported to take a minimum of 1-2 months (Love and Duncan, 1992). L3 can 
also undergo a period of arrested development where they are thought to persist in host tissues 
for up to three years (Gibson, 1953). After development to the L4 stage is complete, larvae 
excyst and return to the gut lumen where they moult to the L5 stage and become adults. The 
pre-patent period of cyathostomin infections has been reported to be between 38-83 days (Love 
and Duncan, 1992). 
 
The inhibition of EL3 is an important factor in the epidemiology and pathogenicity of 
cyathostomin infections. There are several factors thought to be involved in this process, 
although the exact mechanisms are not fully understood. The proportion of inhibited larvae has 
been shown to be higher in young horses suggesting a link with immunity (Chapman et al., 
2001; Klei and Chapman, 1999; Love and Duncan, 1992). In temperate regions such as the 
UK, inhibited EL3 have also been shown to reach peak intensities in the winter when conditions 
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are unfavourable for egg development on the pasture, with resumption of larval development 
in spring (Chapman et al., 2001; Eysker et al., 1990; Ogbourne, 1975). This resumption of 
development plays a role in pathogenicity, as when this occurs simultaneously it can lead to a 
mass emergence of larvae from the mucosa causing serious disease (Giles et al., 1985; Love et 
al., 1999; Mair, 1994; Reilly et al., 1993). Inhibited EL3 are also difficult to control as they are 
refractory to the majority of available anthelmintics, see Section 1.1.6.2. 
 
1.1.2. Epidemiology and transmission of cyathostomins 
The transmission of cyathostomins is dependent on climatic conditions and therefore follows 
a seasonal pattern, which is dependent on the regional conditions (Nielsen et al., 2007). In 
northern temperate regions, faecal egg outputs peak during the warmer spring and early 
summer months, the warm conditions favour rapid development and hence peak pasture 
infectivity occurs during the summer and early autumn (Herd and Coles, 1995; Kornas et al., 
2010; Ramsey et al., 2004; Reinemeyer et al., 1986). Inhibition of EL3 stages occurs later in 
the autumn and explains the reduction in faecal egg output which is observed during this period, 
despite high pasture infectivity (Schankova et al., 2014).  During the colder winter months egg 
hatch and development is slowed or inhibited, and hence transmission is reduced further 
(Ogbourne, 1972). There is evidence that both eggs and IL3 can overwinter at freezing 
temperatures, although the number depends on the specific conditions, with both surviving 
long freezing periods better than repeated freeze thawing (Ogbourne, 1972; Polley, 1986).  
With warmer spring weather eggs start to develop, and inhibited EL3 develop to adulthood 
within the host, thus leading to an initial rise in transmission and faecal egg output in spring. 
In sub-tropical and tropical climates the cycle is altered somewhat as the dry hot conditions 
during the summer months cause desiccation of larval stages and do not favour dispersal of IL3 
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on pasture (Mfitilodze and Hutchinson, 1988). Hence peak transmission and faecal egg output 
occurs during the warm, wet winter months, or wet seasons in tropical regions (Chapman et 
al., 2001; Courtney, 1999; Getachew et al., 2008). Understanding the epidemiology of 
cyathostomins under different climatic conditions is important when considering optimal 
control regimens, which interrupt parasite transmission when it is at its peak and prevent or 
remove inhibited EL3. A recent study has created a model for the effect of different climatic 
conditions on the development and survival of L3 on pasture, and will aid in future prediction 
of cyathostomin transmission under different conditions (Leathwick et al., 2015). There is also 
evidence that age of the host and history of previous exposure have an effect on egg output, 
with young stock having a greater egg output; this must be taken into account when considering 
herd management regimens (Love and Duncan, 1992). 
 
1.1.3. Pathogenicity of cyathostomin infection 
Cyathostomin infection is associated with a range of clinical syndromes, which can be life-
threatening, however some individual equids have high levels of cyathostomin infection and 
do not appear to suffer adverse effects; this tolerance may be related to the host response to 
infection (Love et al., 1999). The mass emergence of inhibited larvae from the large intestinal 
mucosa can cause a serious protein-losing enteropathy, termed larval cyathostominosis (Love 
et al., 1999). This most commonly occurs in later winter and early spring in temperate regions 
and in younger animals, however the trigger factors for mass emergence are poorly understood. 
Cases typically suffer from diarrhoea, pyrexia, weight loss and subcutaneous oedema, and the 
prognosis is poor, with a 50% reported mortality rate (Giles et al., 1985; Mair, 1994; Reilly et 
al., 1993; Van Loon et al., 1995). Reports of larval cyathostominosis in equids other than horses 
are rare; a recent case study has confirmed that this condition also occurs in donkeys (Oryan et 
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al., 2015). Weight loss and poor weight gain has also been associated with cyathostomin 
infections in both horses and donkeys (Matthee et al., 2002b; Murphy and Love, 1997; Yoseph 
et al., 2005), with an improvement noted upon anthelmintic treatment. There are several 
epidemiological studies linking high cyathostomin burdens with certain types of colic and one 
clinical description of caeco-colic intussusception in a case of larval cyathostominosis (Archer 
and Proudman, 2006; Mair et al., 2000; Murphy and Love, 1997; Uhlinger, 1990).  
 
1.1.4. Immunity to cyathostomin infection 
There are consistent reports of lower faecal egg output in adult equids compared with foals and 
yearlings, which is suggestive of the development of a degree of acquired immunity to infection 
(Chapman et al., 2003a; Kornas et al., 2010; Love and Duncan, 1992; Sheferaw and Alemu, 
2015). Numbers of arrested larval stages also vary according to age, with younger horses 
having higher numbers in general (Klei and Chapman, 1999; Love and Duncan, 1992). One 
study has also shown that numbers of EL3 are increased in young animals in their second 
exposure to cyathostomins versus their first, suggesting that a degree of immunity to infection 
can actually promote arrested larval development in the first instance (Chapman et al., 2002b). 
Cyathostomin populations exhibit a classic negative binomial distribution within a herd of co-
grazing adult horses, suggesting that the majority of animals develop a reasonably effective 
acquired response to infection, whereas a minority remain consistently highly susceptible 
(Lester et al., 2013b; Relf et al., 2013). Identifying the differences between these groups could 
be key to identifying what constitutes an effective immune response to infection, however there 
have been no significant advances in this field. Studies to date have examined the local 
inflammatory response to mucosal larval stages and found significant positive association of 
mast cells, eosinophils and Th2 cytokine responses with infection levels (Collobert-Laugier et 
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al., 2002a; Davidson et al., 2005; du Toit et al., 2007; Pickles et al., 2010).  In a quest to identify 
suitable antigens for a diagnostic ELISA for mucosal larval stages, a significant IgG (T) 
antibody response to infection has also been identified (Dowdall et al., 2004).  
 
1.1.5. Diagnosis of cyathostomin infection 
The diagnosis of patent cyathostomin infection is by faecal egg count (FEC). This technique 
has been used for diagnosing GI nematode species for decades and is recommended by the 
World Association for the Advancement of Veterinary Parasitology (WAAVP) for 
measurement of the efficacy of anthelmintic drugs (Coles et al., 1992). A number of different 
FEC methods exist, which vary in their sensitivity (Lester and Matthews, 2014), but all of 
which are underpinned by faecal flotation. Essentially, faeces are mixed with saturated sodium 
chloride, within which eggs will float to the surface and can be recovered for microscopic 
enumeration. In populations of equids with low levels of infection, highly sensitive methods, 
such as centrifugal flotation, are preferred (Bello and Allen, 2009). There are numerous 
drawbacks to the use of FEC alone as a measure of cyathostomin infections. Firstly, as large 
strongyle and cyathostomin eggs are identical, larval culture is needed to differentiate between 
them (Lichtenfels et al., 2008). In addition it has been shown that FEC does not correlate well 
with adult worm burden in the gut (Nielsen et al., 2010), and it does not determine the number 
of inhibited or developing larval stages within individual hosts. There are also many causes of 
variation in the FEC that should be taken into consideration when interpreting samples. For 
example, there are variations in the number of eggs being shed over time which may be 
independent of the parasite load, such as the immune status of the animal (Warnick, 1992). In 
addition there has been shown to be an uneven distribution of eggs within the faecal pat which 
means that the sampling method can greatly affect the outcome of the FEC (Lester et al., 2012). 
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There is considered to be a need for standardisation of FEC techniques and improved training 
across the industry (Lester and Matthews, 2014).  
 
New and improved diagnostic tools are required for determining the burden of cyathostomin 
infection, particularly in relation to the pathogenic developing mucosal stages. To date, it has 
only been possible to determine levels of mucosal stages at post-mortem using various 
techniques such as transmucosal illumination, whereby mucosa is stretched over a light source 
and viewed with a dissecting microscope; and peptic digestion of the mucosa to allow the 
recovery of larvae for enumeration (Chapman et al., 1999). However, in recent years there has 
been considerable progress in the development of an ELISA to measure mucosal larval burden. 
A 25kDa antigen complex has been identified which leads to specific IgG (T) responses that 
correlate with larval burden (Dowdall et al., 2004; McWilliam et al., 2010). An ELISA of this 
sort will greatly aid the diagnosis of larval cyathostominosis cases, which often have negative 
FEC (Giles et al., 1985). 
 
1.1.6. Control of cyathostomins 
Control of cyathostomins is centred on effective environmental control coupled with 
anthelmintic treatments. 
 
1.1.6.1. Environmental control of cyathostomins 
Pasture management is key in controlling transmission of cyathostomins between equids, and 
thus preventing the successful completion of the cyathostomin life cycle within the host. The 
removal of faecal pats from the pasture before eggs hatch and develop into IL3 is the primary 
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mechanism of environmental control. It has been reported that twice-weekly faecal removal is 
an effective frequency to significantly reduce transmission and control cyathostomin infections 
(Proudman and Matthews, 2000). Different methods of faecal removal are employed such as 
manual on small holdings, and automatic suction machinery on larger establishments, and these 
have been shown to be equally effective (Corbett et al., 2014). Other complementary practices 
include reducing stocking densities, resting heavily grazed pastures, harrowing pastures in dry 
conditions to expose IL3 to desiccation and co-grazing/rotating pasture with ruminants  (Lyons 
et al., 1999). 
 
1.1.6.2. Anthelmintic treatments licensed to treat cyathostomins 
Since their introduction in the 1950s anthelmintic drugs have provided a major means of 
cyathostomin control, especially in large herds where environmental control is practically 
challenging. Anthelmintics which are currently licensed for use in horses fall into three 
categories, the benzimidazoles (BZs), the tetrahydropyrimidines (THPs) e.g. pyrantel (PYR), 
and macrocyclic lactones (MLs), such as ivermectin (IVM) and moxidectin (MOX).  The BZs 
were introduced in the 1960s as the first nematocidal anthelmintics to show broad-spectrum 
efficacy and low toxicity (Baker and Douglas, 1962; Turk et al., 1962). The advent of THPs 
followed in the 1970s (Lyons et al., 1974; Slocombe and Smart, 1975). IVM was introduced in 
the 1980s (Campbell et al., 1983; Slocombe and Cote, 1984), and more recently MOX has been 
developed (Lyons et al., 1992). The BZs work as microtubule inhibitors; THPs function as 
agonists of nicotinic acetylcholine receptors (nAChR) in nematode muscle, causing paralysis; 
and MLs are glutamate-gated chloride channel (GluClR) and gamma-aminobutyric (GABA) 
receptor potentiators which results in paralysis of pharyngeal pumping (Martin, 1997). 
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Along with a unique mode of action each class of drug differs in its efficacy against the 
different parasitic stages of cyathostomins. The BZs were initially found to be between 92.5-
100 % efficacious against adult cyathostomins (Bello et al., 1973; Bennett, 1973; Cairns and 
Holmden, 1977; Colglazier et al., 1977; Drudge et al., 1974, 1975; Duncan and Reid, 1978; 
Kates et al., 1975; Nawalinski and Theodorides, 1976; Neave and Callear, 1973; Walker and 
Knight, 1972), however lower efficacies against luminal L4, of between 47-100 %, have been 
observed (Colglazier et al., 1977; Duncan and Reid, 1978). The efficacy of a single dose of 5 
mg/kg fenbendazole against encysted larval stages is poor, however a five day course of 
fenbendazole at 7.5 mg/kg was shown to reduce mucosal LL3 and L4 stages by 99.4 % and 
EL3 by 91.5 % (Duncan et al., 1998). The faecal egg reappearance period (ERP) was initially 
reported to be two to four weeks for BZs (Lumsden et al., 1989). The THPs, such as PYR, have 
been shown to be efficacious against adult and L4 luminal stages, although they have little 
effect against encysted larval stages (Lyons et al., 1974). When first introduced PYR led to 
FEC reductions of between 99-100 % (Boersema et al., 1995; Slocombe and Smart, 1975), 
with a faecal ERP in the region of five weeks (Boersema et al., 1995; Lumsden et al., 1989; 
Piche et al., 1991). The ML IVM was marketed as having a longer ERP than either the BZs or 
THPs, of around eight to 13 weeks (Demeulenaere et al., 1997; Piche et al., 1991), and high 
efficacy against luminal adult and L4 stages, 99 % and 98 % respectively (Xiao et al., 1994). 
One study has reported an efficacy of 76.8 % against EL3 for IVM (Love et al., 1995), however 
the majority of studies showed little effect on encysted larval stages (Demeulenaere et al., 1997; 
Eysker et al., 1992; Xiao et al., 1994). The related MOX, was found to have an even longer 
ERP of 22-24 weeks, as well as a high efficacy against luminal adult and L4 stages 
(Demeulenaere et al., 1997; Xiao et al., 1994). Initial studies with MOX, where post-mortem 
was performed two weeks post-treatment, showed it to have a moderate efficacy against 
encysted LL3 and L4 stages (62.6-79.1 %), but no effect on EL3 hypobiosed stages (Bauer et 
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al., 1998; Xiao et al., 1994). More recent studies, where post-mortem was performed eight 
weeks post treatment, have shown that MOX actually has > 90 % efficacy against all encysted 
larval stages (Bairden et al., 2001; Bairden et al., 2006).  
 
Traditionally anthelmintics were used on a regular basis at intervals defined by their ERPs, 
however due to the development of drug resistance, increasing emphasis has been placed on 
using selective treatment regimens targeting horses with high FECs (Nielsen et al., 2014a). 
This method has been shown to reduce treatment to 18-50 % of horses within a herd, which 
not only reduces selection pressure for anthelmintic resistance on cyathostomins, but has been 
shown to have economic benefits (Lester et al., 2013a; Nielsen et al., 2014a; Salle et al., 2015). 
These regimens are not always taken up by yards and studs, indeed the evidence suggests that 
many equine establishments do not delay treatment in any animal beyond the defined ERP 
(Relf et al., 2013; Stratford et al., 2014a). In some countries, such as Denmark, anthelmintics 
have been made prescription-only medications requiring a veterinary surgeon to advise 
treatment. This has been shown to increase surveillance for strongyles, and therefore should be 
considered for other countries where resistance is an issue (Nielsen et al., 2006). One issue 
with targeted treatment regimens is that they have not been proven to be effective in groups of 
foals or young horses. Additionally there have been reports of the re-emergence of large 







1.2. Current threats to the control of cyathostomins 
The major threat to controlling cyathostomins infection in equids in developed countries is 
anthelmintic resistance (AR), whilst in some developing countries, a lack of access to effective 
anthelmintic treatments also constitutes a substantial obstacle to their effective control. 
 
1.2.1. Anthelmintic resistance in cyathostomins 
Anthelmintic resistance is recognised as a global problem affecting many hosts and nematode 
species, and cyathostomins are no exception. AR in cyathostomins has significant impacts for 
future control regimens, as currently no novel anthelmintics are likely to be licensed in equids 
in the short-to-medium term. Concerns over AR have led to the recommendation of 
surveillance based treatment regimens and improved environmental management in order to 
reduce the frequency of anthelmintic administration and hence selection for resistance.  
 
1.2.1.1. Detection of anthelmintic resistance in cyathostomins 
Detection of AR is dependent on having accurate and sensitive diagnostics for cyathostomin 
infection but, as discussed above in Section 1.1.5., this poses a significant challenge for 
cyathostomins. The gold standard for the measurement of efficacy of any anthelmintic are 
critical tests, which measure the actual worm burden after treatment at post-mortem (Bauer et 
al., 1998; Drudge et al., 1975; Eysker et al., 1992), however this is not a practical approach to 
routinely monitor for AR in the field. The faecal egg count reduction test (FECRT), has been 
recommended by the WAAVP for identifying AR in sheep. The FECRT defines resistance as 
a faecal egg count reduction (FECR) of < 95 %, with < 90 % for the lower confidence interval, 
10-14 days after treatment with an anthelmintic (Coles et al., 1992). In the absence of 
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standardised criteria for defining anthelmintic resistance in horses in the field, the equine 
research community has adopted these WAAVP guidelines. However, there is still 
considerable inconsistency in the study design, sensitivity of FEC methodology and statistical 
methods used to define resistance in the equine literature, which make it difficult to draw 
accurate conclusions and comparisons as to the presence or absence of resistance within a given 
population (Vidyashankar et al., 2012). Amongst the key factors that lack consistency in studies 
are: group sizes, FEC technique and FECRT values for inclusion in the study group. For 
example: Kaplan et al (2004) used a mean FECR of 80 % to define resistance, whilst Traversa 
et al (2009, 2012) used a mean FECR of 90 % and others used a mean FECR of 95 % (Craven 
et al., 1999; Larsen et al., 2011). Some studies looking at the efficacy of MLs also use a reduced 
ERP as a marker of developing AR in cyathostomins (Molento et al., 2008; Relf et al., 2014). 
In summary, there is a need for further clarification of guidelines for detection of AR in 
cyathostomins in vivo. 
 
A number of in vitro tests for detecting anthelmintic resistance have been developed and 
validated in sheep but are yet to be successfully validated for cyathostomins. The egg hatch 
test (EHT) involves the incubation of nematode eggs with increasing concentrations of drug, 
followed by a measurement of egg hatch percentage (Coles et al., 1992). This test has been 
widely validated for the detection of BZ resistance in ruminants (von Samson-Himmelstjerna 
et al., 2009) and studies have reported some utility of the EHT in horses (Craven et al., 1999; 
von Samson-Himmelstjerna et al., 2002; Wirtherle et al., 2004). However, the unique ovicidal 
activity of the BZs, means that the EHT is only effective for detecting resistance to the BZ 
class of anthelmintics, and in equids widespread BZ resistance is already well established. An 
in vitro test that has the advantage of detecting resistance to multiple classes of anthelmintic is 
the larval development test (LDT). The LDT involves the incubation of nematode eggs in 
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increasing concentrations of drug and growth medium for a period of 6-7 days, at which point 
the percentage of developed larvae verses total larvae is evaluated. The LDT is sold 
commercially for use in ruminants as Drenchrite ® (Dr Jennifer Gill, Microbial Screening 
Technologies, Smithfield, Australia), and it has been used successfully for small ruminants 
(Ancheta et al., 2004; Howell et al., 2008; Kaplan et al., 2007). It has also shown promise in 
cattle GI nematodes (Demeler et al., 2010b). However results for equids so far have shown 
poor reproducibility, poor correlation with in vivo FECRT data and narrow resistance ratios 
(Lind et al., 2005; Pook et al., 2002; Tandon and Kaplan, 2004). The larval migration inhibition 
test (LMIT), is primarily designed to detect ML resistance, and measures the ability of L3 to 
migrate across a nylon mesh after incubation with increasing concentrations of IVM. It was 
originally developed and refined for sheep GI nematodes (Kotze et al., 2006) and has been 
shown to correlate with in vivo resistance in cattle nematodes (Demeler et al., 2012; Demeler 
et al., 2010a; Demeler et al., 2010b). In horses, a recent study has demonstrated that this test 
can also be correlated with in vivo IVM efficacy in cyathostomins (McArthur et al., 2015), 
highlighting that it shows promise as an in vitro tool for evaluating relative ML efficacy in 
cyathostomins. However validation of the LMIT is not currently possible due to lack of a 
positive control population of cyathostomins that has been defined as unequivocally resistant 
to MLs. 
 
A genetic test would be ideal for detection of anthelmintic resistance within a given population 
of parasites, and a lot of work has been undertaken to identify molecular markers for resistance 
for each of the major anthelmintic classes (see Section 1.2.1.3.). For BZ resistance this has 
been successful, and a pyrosequencing assay has been developed to detect mutations in the 
beta-tubulin gene in cyathostomins (Lake et al., 2009). This test has not been applied clinically, 
largely due to the fact that BZ resistance is so widespread that it is now assumed in the clinical 
17 
 
setting. The complexity of the genetic basis of resistance to THPs and MLs leads researchers 
to conclude that it will be particularly challenging to develop a simple molecular test for 
resistance to these drug classes (Kotze et al., 2014). 
 
1.2.1.2. The extent of anthelmintic resistance in cyathostomins 
Reports of reduced efficacy of the BZs in cyathostomins was first reported soon after their 
introduction (Drudge and Lyons, 1965). Currently BZ resistance is widespread and has been 
reported in 15 countries (Table 1.1.). Resistance to PYR was first reported in 1996, and has 
now been reported in 13 countries (Table 1.1.). Resistance to the MLs, IVM and MOX, has 
been much slower to develop and has only recently been reported. As a consequence the MLs 
have been the mainstay of cyathostomin control over the last three decades (Nielsen et al., 
2014b). Unfortunately, there is now an increasing amount of evidence that resistance to MLs 
is beginning to emerge (Table 1.1.). There have been reports of IVM resistance based on the 
FECRT in Brazil, Finland, Italy and the UK (Canever et al., 2013; Milillo et al., 2009; Molento 
et al., 2008; Nareaho et al., 2011; Relf et al., 2014; Traversa et al., 2009b). There have been 
further reports of reduced ERPs for IVM in Brazil, Germany, Belgium, Italy, the Netherlands, 
the USA and the UK (Dudeney et al., 2008; Geurden et al., 2014; Little et al., 2003; Lyons et 
al., 2011b; Lyons et al., 2008; Molento et al., 2008; Relf et al., 2014; von Samson-
Himmelstjerna et al., 2007). The ERP of IVM when it was introduced was eight weeks, but it 
is now being reported as being as low as two weeks (Relf et al., 2014). The significance of this 
change is not fully understood, however there is evidence that it is associated with the survival 
of L4 stages post-treatment, hence they can develop rapidly into adult stages and start 
producing eggs (Lyons et al., 2009). There are few reports of critical tests demonstrating 
reduced IVM efficacy (Lyons et al., 2009), although this is probably because these are not 
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routinely carried out in equine research for ethical reasons. Compared to IVM, there are fewer 
reports of reduced efficacy of MOX and these are primarily in the form of reduced ERPs, which 
have been reported in Brazil, Belgium, Italy, the Netherlands, the UK and the USA (Geurden 
et al., 2014; Lyons et al., 2011a; Molento et al., 2008; Rossano et al., 2010; Trawford  et al., 
2005), there has also been one critical study demonstrating reduced MOX efficacy (Lyons et 
al., 2010). In summary the evidence suggests that, albeit slowly, resistance to the MLs is now 
developing in cyathostomins. Alarmingly, there are now reports of some farms that appear have 
resistance to all three major classes of anthelmintic (Canever et al., 2013; Molento et al., 2008; 
Relf et al., 2014; Traversa et al., 2009b). 
 
1.2.1.3. Mechanisms of anthelmintic resistance in cyathostomins 
It is outside the scope of this thesis to extensively report the findings of studies investigating 
mechanisms of resistance for nematodes. Several broad mechanisms have been proposed; drug 
target site mutations, altered detoxification pathways, increased drug efflux and reduced drug 
uptake, which were comprehensively reviewed by Kotze et al., (2014), and are only briefly 
outlined here. To date, mechanisms of anthelmintic resistance are poorly understood for all 
anthelmintic classes except the BZs, in which resistance has been attributed to mutations in the 
drug target isotype-1 beta-tubulin gene. The first mutation to be described was a single 
nucleotide polymorphism (SNP), an A to a T transversion, resulting in a tyrosine for 
phenylalanine substitution at codon 200 (the F200Y SNP) in Haemonchus contortus (Kwa et 
al., 1994). Further SNPs have been demonstrated at codons 167 (F167Y) and 198 (E198A) in 




Table 1.1. A summary of studies reporting resistance to the three licensed classes of anthelmintic in 
equids, benzimidazoles (BZ), tetrahydropyrimidines (THP) and macrocyclic lactones (ML). A tick 
indicates resistance has been reported. 
Country Publication BZ  THP ML 
Belgium (Geurden et al., 2014) √ √ √ 
Brazil (Pook et al., 2002) 
(Molento et al., 2008) 










Canada (Slocombe and Cote, 1977) 






Denmark (Bjorn et al., 1991) 
(Craven et al., 1998) 








Finland (Nareaho et al., 2011)   √ √ 
France (Traversa et al., 2012) 






Germany (Wirtherle et al., 2004) 






Italy (Geurden et al., 2014) 
(Traversa et al., 2007b) 
(Milillo et al., 2009) 













Netherlands (Geurden et al., 2014) √ √ √ 
Norway (Ihler, 1995) √ √   
Slovak Republic (Varady et al., 2000) 
(Cernanska et al., 2009) 
√ 
√ 
    
Sweden (Nilsson et al., 1989) 






Switzerland (Meier and Hertzberg, 2005) √ √   
Ukraine (Kuzmina and Kharchenko, 2008) √     
United Kingdom (Fisher et al., 1992) 
(Comer et al., 2006)  
(Traversa et al., 2009b) 
(Lester et al., 2013b)  
(Stratford et al., 2014b) 



















United States (Herd et al., 1981)  
(Chapman et al., 1996) 
(Woods et al., 1998)  
(Lyons et al., 2001) 
(Tarigo-Martinie et al., 2001) 
(Kaplan et al., 2004) 
(Rossano et al., 2010)  
(Lyons et al., 2010) 



























In cyathostomins it has been found that the F167Y and F200Y are responsible for resistance to 
BZs (Hodgkinson et al., 2008; Lake et al., 2009). Even where the BZs are not used for extended 
periods and subsequently re-introduced, reversion to a resistant phenotype is rapid (Borgsteede 
and Duyn, 1989; Lester et al., 2013b), leading to the conclusion that the development of BZ 
resistance in cyathostomins is irreversible, but this has yet to be confirmed with genetic studies. 
 
Mechanisms of resistance to the THPs, such as PYR and levamisole are less well understood. 
The body of literature, reviewed in Kotze et al (2014), suggests that phenotypic resistance is 
polygenic and involves changes in expression of nAChR subunits (Kopp et al., 2009), truncated 
receptor subunits (Fauvin et al., 2010; Neveu et al., 2010; Williamson et al., 2011), and 
mutations in receptor subunits (Barrere et al., 2014), as well as a possible contribution from P-
glycoprotein (P-gp) mediated increased drug efflux (Sarai et al., 2014). There has been no work 
looking at specific molecular mechanisms of PYR resistance in cyathostomins.  
 
The exact molecular mechanism behind resistance to MLs in parasitic nematodes remains 
elusive. Initial studies indicated that target site mutations in the GluClRs may play a role 
(Blackhall et al., 1998; Njue et al., 2004). Blackhall et al (1998) showed an increase in 
frequency of an allele in the alpha-subunit of the GluClR gene of IVM/MOX resistant H. 
contortus, however resistance in the strain used in this study was generated in the laboratory. 
Njue et al (2004) described a mutation in the GluClR, L256F, associated with decreased 
response to IVM in Cooperia oncophora. In addition some studies have demonstrated an 
association between IVM sensitivity and the absence of a glycine residue in the third 
transmembrane domain of the GluClR (M3-Gly) (Hibbs and Gouaux, 2011; Lynagh and 
Lynch, 2010, 2012). Recent studies however have failed to find a link between L256F or M3-
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Gly and ML resistance, and no additional polymorphisms have been associated with ML 
resistance (El-Abdellati et al., 2011; Williamson et al., 2011).  
 
As no clear link has been found between the target site gene and ML resistance, attention has 
recently focussed on alternative mechanisms of resistance such as increased drug efflux by P-
gps (Lespine et al., 2012). P-gps belong to a large group of proteins called the multidrug-
resistance ATP-binding cassette (ABC) transporters, which in turn belong to a well-conserved 
family of ABC membrane proteins. They will be discussed in greater depth in Section 6.1., but 
in summary their main function is the active efflux of structurally unrelated endogenous and 
exogenous compounds from parasite cells. There is a large body of evidence reporting that 
increased transcript expression and selection of P-gp variants are associated with reduced 
sensitivity to MLs (Ardelli et al., 2005; Dicker et al., 2011b; James and Davey, 2009; Janssen 
et al., 2013; Kerboeuf et al., 2003; Williamson et al., 2011). Another alternative resistance 
mechanism that has recently been highlighted is the acquisition of reduction of function alleles 
in the so called dye filling (dyf) genes, which cause amphid sensory neuron deficits and reduced 
drug uptake. This mechanism has been described for Caenorhabditis elegans and H. contortus; 
and field isolates of H. contortus across five continents have been shown to be enriched for a 
resistant haplotype in the dyf-7 gene (Dent et al., 2000; Urdaneta-Marquez et al., 2014). In 
summary the molecular basis of ML resistance in parasitic nematodes remains to be fully 
defined, but the evidence suggests it is multigenic. As ML resistance in cyathostomins is only 





1.2.2. A lack of availability of high quality, reliable anthelmintic formulations impacts on the 
control of cyathostomins in developing countries 
The two major issues currently limiting effective parasite control in cyathostomins in poor 
communities in developing countries are, a lack of access to treatment and the poor quality of 
available drugs. Rural communities are often far from clinics distributing anthelmintics and the 
poorest amongst them are unable to afford the treatment. There are also reports of poor quality 
and counterfeit products, which will not only be ineffective in controlling parasitism but may 
pose a health risk (Monteiro et al., 1998; Shakoor et al., 1997). The development of 
anthelmintic resistance could, in theory, be accelerated by the use of poor quality anthelmintics 
in these environments. To date, there have been no published reports investigating anthelmintic 
efficacy against cyathostomins in developing countries, however AR has been demonstrated in 
helminths of small ruminants, indicating that it is likely to occur under conditions of frequent 
anthelmintic use and under-dosing due to poor quality drugs (Eguale et al., 2009; Kumsa and 
Abebe, 2009; Sissay et al., 2006a, b). 
 
 
1.3. Novel options for controlling cyathostomins 
Due to AR and the constraints of treatment in developing countries there is a need for the 
development of novel treatment options and improved control strategies for cyathostomin 
infections. A number of management and treatment options are currently being investigated to 





1.3.1. Biological control of cyathostomins  
There has been considerable investigation into the use of biological control on pastures to 
minimise transmission of cyathostomins by direct antagonism of IL3 (Gronvold et al., 1996). 
Many organisms act as antagonists of parasites but one group to have shown potential is the 
nematophagus fungi. Research has focussed on Arthrobotrys oligospora, Arthrobotrys flagrans 
and Duddingtonia flagrans, with the majority of work on the latter (Bird and Herd, 1995; Braga 
et al., 2010; Larsen et al., 1996). These fungi produce nematode trapping organs that anchor 
nematode larvae whilst hyphae penetrate the cuticle and digest the worm. They have been 
shown to survive the equine GI tract (Larsen et al., 1995), and produce significant reduction in 
cyathostomin burdens and pasture infectivity resulting in improved growth rates in horses 
(Braga et al., 2009; Larsen et al., 1996). Recent work in the field has focussed on the extracts 
of D. flagrans that contains proteolytic enzymes, which can have a direct effect against 
cyathostomin IL3 in the absence of the fungus itself (Braga et al., 2013; Braga et al., 2015). 
Despite the evidence however the production and use of D. flagrans or its extract in equids has 
not yet been commercialised.  
 
1.3.2. Improving host resistance to cyathostomins 
For several decades breeding programs selecting for host resistance to GI nematode infections 
have been explored in ruminant production systems, in order to reduce reliance on 
anthelmintics and improve production. There is good evidence that improved host responses 
can be achieved by selecting for various parameters such as FEC, worm burden, serum 
antibodies, peripheral eosinophilia, packed cell volume, live weight and serum albumin 
concentrations (Hooda et al., 1999; Saddiqi et al., 2012; Windon, 1990). Recently the focus has 
been on defining the genetic basis for host susceptibility in sheep and cattle so that selection 
24 
 
can be refined by the use of multiple quantitative trait loci (McManus et al., 2014). The advent 
of high-throughput sequencing technologies has facilitated genome-wide association studies to 
identify such markers (Kim et al., 2014; Riggio et al., 2014; Salle et al., 2012). The success of 
breeding programs is dependent on the heritability and genetic variability of the trait. As with 
many aspects of cyathostomin biology the basis of host resistance to infection has not been 
adequately explored. One recent study evaluated the FECs in a large cohort of Arabian horses 
over time, and found that the trait has a mean heritability of 0.21 (±0.04) in adults (Kornas et 
al., 2015), which is comparable with values for ruminants (range of heritability 0.2-0.4) 
(Assenza et al., 2014; Davies et al., 2006; Kemper et al., 2011; Salle et al., 2012). This suggests 
that similar breeding programs could be implemented in horses, however there may be other 
obstacles to this taking place in the equine industry. For example, there is no regulation of 
breeding horses in the UK, and in those establishments where selective breeding may be 
appropriate such as large thoroughbred studs, breeding for racing success takes priority. 
 
1.3.3. Vaccine development 
Given that AR is such a major issue globally, vaccines represent an attractive long-term option 
for the control of GI nematodes. A considerable amount of research has gone into the 
development of vaccines against parasitic nematodes, with only a few commercial vaccines 
delivered to date. In the 1960s a vaccine was developed for the cattle lung worm Dictyocaulus 
viviparous, which uses irradiated larvae (Jarrett et al., 1958), and a similar vaccine was 
developed for the dog hookworm Ancyclostoma caninum (Miller, 1978). Both vaccines have 
been made available commercially, however these vaccines are made in vivo, are expensive 
and have a short shelf life, hence there is ongoing research to develop recombinant forms of 
these vaccines. A recent study in cattle showed some efficacy using a recombinant paramyosin 
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vaccine, however the commercial vaccine, Bovilis ® Dictol, still far exceeds any recombinant 
preparation (Strube et al., 2015). Unfortunately vaccines based on irradiated larvae have not 
been successful for a number of other parasitic nematodes (Smith et al., 1982; Urquhart et al., 
1966). Native extracts from dead parasites have also shown some promise in nematode 
vaccines, for example a commercial vaccine, Barbervax ®, made from the intestinal lining of 
the worm, has recently been developed against H. contortus (Bassetto and Amarante, 2015). 
One of the inhibiting factors in the use of native antigens is the need to generate large numbers 
of parasites, usually requiring live animals, which can be prohibitively expensive. Fortunately 
in the case of Barbervax® such a low dose is needed that the product is commercially viable 
(Bassetto and Amarante, 2015). 
 
The gold standard to produce a commercially viable vaccine for any parasitic nematode is to 
use recombinant protein expression to generate large amounts of antigen with which to 
stimulate an effective immune response. Unfortunately despite decades of research the 
development of such vaccines for parasitic nematodes has proved difficult, with many 
recombinant vaccine trials producing poor results in vivo (Geldhof et al., 2007; Geldhof et al., 
2008; Meyvis et al., 2007; Newton and Meeusen, 2003). The most promising recombinant 
vaccine to date has been produced against Teladorsagia circumcinta, where a multicomponent 
recombinant vaccine has been shown to reduce FECs and worm burdens by > 70 % (Nisbet et 
al., 2013). In cyathostomins little progress has been made towards vaccine development, a 
recombinant protein has been produced as an immunodiagnostic marker to aid in development 
of an ELISA for encysted larval stages, however there is no evidence that it produces protective 
responses if given as a vaccine (McWilliam et al., 2010). In addition it is widely accepted that 
horses do not develop a fully effective immunity against cyathostomins, which means that the 
development of an effective vaccine would be fundamentally extremely challenging. 
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1.3.4. Novel anthelmintics to treat cyathostomins 
There is ongoing investigation into the discovery of novel anthelmintics for use in veterinary 
species, the extent of which will not be reviewed here, but it is important to note that 
anthelmintic discovery is a slow process and does not appear to keeping pace with the 
development of AR. Over the last decade three novel classes of anthelmintic have been brought 
to the market, these include emodepside in combination with praziquantel (Profender ®), 
monepantel (Zolvix ®) and derquantel in combination with abamectin (Startect ®). 
Emodepside is a cyclooctadepsipeptide, which causes inhibition of pharyngeal pumping, 
paralysis and death, by binding to the pre-synaptic latrophilic-like receptor (HC110-R), and 
through pre and post-synaptic interactions with a Ca2+ activated K+ channel (SCO-1) (Guest et 
al., 2007; Harder et al., 2003; Harder and von Samson-Himmelstjerna, 2001; Holden-Dye et 
al., 2012; Martin et al., 2012). It is currently licensed in cats and dogs in combination with 
praziquantel for the treatment of GI nematode and cestode infections. It is reportedly effective 
against small strongyles (Epe and Kaminsky, 2013; Harder and von Samson-Himmelstjerna, 
2002), however there has been no indication of its development for use in equids, possibly due 
to formulation, cost or safety issues. Monepantel is an amino acetonitrile derivative, which acts 
as a positive allosteric modulator of the nematode specific nAChR MPTL-1 and causes 
depolarisation of muscle cells leading to paralysis (Kaminsky et al., 2008; Rufener et al., 2010; 
Rufener et al., 2009). It is currently licensed to treat all GI nematodes of sheep and has a good 
safety profile, however, there is no indication of its development for use in equids. In addition, 
there have already been reports of resistance to monepantel in sheep after a minimum of two 
years since its introduction (Scott et al., 2013; Van den Brom et al., 2015), which raises concern 
over its long term efficacy in the horse should it ever be introduced. Finally derquantel belongs 
to the spiroindol class, and is a semisynthetic compound derived from a fermentation product 
of Penicillium simplicissimum (Lee et al., 2001). It interferes with a B-subtype nAChR causing 
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flaccid paralysis and is effective against all major GI nematodes in sheep (Lee et al., 2001; 
Qian et al., 2006; Robertson et al., 2002). Unfortunately there are reports that derquantel is 
highly toxic to horses and therefore it is extremely unlikely to be developed as an anthelmintic 
for use in equids (Epe and Kaminsky, 2013; Woods, 2012).  
 
It appears unlikely that any new anthelmintic will be introduced for equids in the short-to-
medium term, and to the author’s knowledge there are no groups currently working on the 
development of therapeutics specifically for use in equids against cyathostomins.  
 
1.3.5. Combination therapies 
Due to the difficulties of developing new anthelmintic molecules there has been increasing 
emphasis on extending the useful lifespan of the anthelmintics which are currently available. 
This area of research is likely to be of particular relevance for treating cyathostomins given the 
challenges of AR and lack of new drugs. One way of improving the lifespan of anthelmintics 
is to reduce their use by implementing targeted treatment regimens. Another method is to 
improve the efficacy of currently available anthelmintics through the use of drug combination 
therapies. There are three major types of drug combination that are currently in use or being 
investigated for treating veterinary parasitic nematodes. These are: the use anthelmintic 
combinations to expand the spectrum of efficacy; the use of anthelmintic combinations to 
prevent and tackle drug resistance; and the combination of anthelmintics with potentiating non-
anthelmintic compounds. It is important to consider any pharmacokinetic and 
pharmacodynamic (PK/PD) interactions between drugs in such combinations, as there may be 




1.3.5.1. Anthelmintic combinations to expand the spectrum of activity  
In order to improve the spectrum of activity and reduce the need for multiple treatments, some 
veterinary anthelmintics, which have efficacy against different types of GI helminth, have been 
combined. These products are well established for equids, for example IVM and praziquantel 
in Eqvalan duo ®, and MOX and praziquantel in Equest Pramox ®; in order to target both 
nematodes and cestodes in one treatment (Grubbs et al., 2003; Rehbein et al., 2003). Such 
combinations are also used in ruminants, for example a combination of MOX and closantel is 
used in sheep for the control of GI nematodes and the trematode Fasciola hepatica. 
Interestingly it has also been shown that combination with MOX increases the half-life of 
closantel by 47 % (Suarez et al., 2013). Interactions could potentially also be antagonistic 
leading to a reduction in the efficacy of one or both of the drugs. There is no published evidence 
that these potential interactions have been investigated in equids.  
 
1.3.5.2. Anthelmintic combinations to prevent and tackle drug resistance  
An increasingly common practice in ruminants is to combine anthelmintics with a different 
mode of action on the same parasites in order to reduce the chance of resistance developing to 
either compound (Anderson et al., 1988; Barnes et al., 1995; Leathwick et al., 2009). This 
approach has also been proposed as a method to treat animals in areas where anthelmintic 
resistance is already widespread (Suarez et al., 2014; Sutherland and Leathwick, 2011). Such 
methods rely on the PK/PD interactions between drugs being either additive (total efficacy 
greater than either drug alone but not greater than the sum of the efficacy of both) or synergistic 
(total efficacy greater than the sum of both). For example derquantel has been shown to act 
synergistically with abamectin in vitro (Puttachary et al., 2013). The majority of interactions 
between anthelmintic combinations in vivo have been shown to be additive, and there have 
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been several studies which have shown mild to moderately improved efficacy of combinations 
in ruminants which harbour drug resistant GI nematodes (Anderson et al., 1988, 1991; Miller 
and Craig, 1996; Suarez et al., 2013; Suarez et al., 2014). There are however concerns over the 
sustainability of this approach on farms where there is resistance to all classes of anthelmintic 
(Lanusse et al., 2015; Suarez et al., 2014). In equids such combinations are not currently 
licensed in the UK. 
 
1.3.5.3. Combining anthelmintics with potentiating non-anthelmintic compounds  
The combination of anthelmintics and non-anthelmintic compounds, which enhance efficacy 
by interfering with drug transformation, excretion or efflux mechanisms, is gaining increased 
attention. Anthelmintics are often marketed at the lowest effective dose of 95% to reduce the 
possibility of toxic side effects. When resistance occurs, and efficacy levels fall below 90%, 
there is evidence that exposure of helminths to increased levels of anthelmintic improves 
efficacy (Alvarez et al., 2015; Barrere et al., 2012; Lloberas et al., 2015; Moreno et al., 2004; 
Varady et al., 1996). Metabolic modulators such as methimazole and piperonyl butoxide, which 
inhibit flavin monooxigenase and cytochrome P450 mediated oxidation respectively, have 
been shown to increase the efficacy in vivo of some BZs in ruminants (Benchaoui and 
McKellar, 1996; Lanusse and Prichard, 1992). In horses piperonyl butoxide has been shown to 
increase the plasma availability and efficacy of oxifendazole (Sanchez Bruni et al., 2005).  
 
Of particular relevance to MLs is the potential of pharmacological interference with cell 
transporter systems such as P-gps; which are implicated to play a role in ML resistance, see 
section 1.2.1.3. P-gps are involved in the active efflux of MLs from both host and parasite 
tissues, thus in theory blocking this process can lead to increased plasma concentrations and 
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longer half-life of MLs, as well as increased ML levels in parasite tissues. In vivo trials 
examining the action of P-gp inhibitors on MLs have shown positive effects on the PK 
disposition of MLs, and improvements in ML efficacy against ML resistant GI nematodes 
(Bartley et al., 2012; Lifschitz et al., 2010a; Lifschitz et al., 2010b). These effects were not 
consistent in all studies. Further research is needed in this field to establish which combinations 
are likely to be of most clinical use in each host-parasite system. There has been no work 
investigating the potential of chemical modulation of P-gps in optimising ML efficacy against 
cyathostomins.  
 
1.3.6. Ethnoveterinary medicines 
Ethnoveterinary medicine is defined as the study of folk beliefs, knowledge, skills and practices 
relating to the health care of animals. Lack of availability of drugs, cost and risk of drug 
resistance are all barriers to the uptake of synthetic anthelmintics in developing countries. This 
means that many traditional plant-based treatments are still used for parasitic infections 
(Githiori et al., 2006). In developed countries increasing resistance to anthelmintics has led to 
interest in potential alternatives to anthelmintics, such as bioactive plant supplements, and the 
possibility of novel anthelmintic drug discovery from bioactive plant compounds. Plants are 
known to be a rich source of bioactive compounds that have potential beneficial 
pharmacological properties. This has been demonstrated with plants such as Artemisia annua, 
which is the origin of the widely used malaria treatment artemisinin (Klayman, 1985). Another 
example is Salix alba, from which the anti-inflammatory salicylic acid (aspirin) was originally 
isolated (Lafont, 2007). Surveys of plants used for anthelmintic activity have been performed 
in developing countries across the globe (Githiori et al., 2006). The majority of evidence for 
plant-based anthelmintics is observational rather than in controlled studies (Hammond et al., 
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1997). However, as interest in this area increases, in vitro and in vivo studies are being carried 
out in order to validate claims of anthelmintic activity. Amongst the plants that have shown 
promise in in vivo studies against GI nematodes, are plants rich in tannins (Hoste et al., 2006) 
and commonly used herbs such as Zingiber officinale (ginger) (Iqbal et al., 2006a). 
 
Prior to its adoption as a novel method for parasite control it is important that there is a thorough 
assessment of the anti-parasitic and potential toxic effects of a plant. Scientific evidence 
supporting the anti-parasitic properties of plants comes mostly from in vitro studies 
(Athanasiadou and Kyriazakis, 2004). The advantage of in vitro tests is that large numbers of 
plant extracts and purified compounds can be tested at relatively low cost. The most commonly 
used tests in the screening process are the EHT (Coles et al., 1992), the LDT (Demeler et al., 
2010b; Gill et al., 1995), the LMIT (Demeler et al., 2010a) and the adult worm motility test 
(AWMT) (Smout et al., 2010). Using more than one type of test to screen plants is important 
as anthelmintic activity may be stage specific (Marie-Magdeleine et al., 2010b).  
 
These tests were originally developed for the identification of anthelmintic resistant nematodes 
and to indicate the efficacy of chemically synthesised compounds. For licensed anthelmintics 
strong correlation has been shown between in vitro and in vivo efficacy (Coles et al., 1992). In 
horses the EHT and LMIT have proven the most useful when comparing in vitro and in vivo 
efficacy for BZs and MLs respectively, see Section 1.2.1.1. It is not clear whether a similar 
relationship is applicable when testing plant extracts. Some studies show a correlation between 
in vitro and in vivo efficacy (Ademola et al., 2004; Bachaya et al., 2009), however Costa et al. 
(2008) found that an ethanol extract of Azadirachta indica inhibited egg hatch by 99.7% in H. 
contortus whilst a study in vivo showed no efficacy (Costa et al., 2008; Costa et al., 2006). This 
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highlights the fact that bioavailability of anthelmintic plant compounds in vivo cannot be 
assumed and the parasites may be exposed to little or none of the compounds being tested in 
vitro. Despite the possible pitfalls in extrapolating efficacy from in vitro to in vivo methods, it 
remains a useful preliminary screening technique, primarily due to reduced costs and the 
practical difficulty of screening large number of plants in controlled clinical trials. Ultimately 
randomised controlled trials using the same formulation of the plant extract in vivo as in vitro 
are an essential part of a scientific approach.  
 
In horses there has been little investigation into the potential of bioactive plants to aid control 
of GI nematode infections. One in vitro study has demonstrated the efficacy of some Australian 
plants against free-living cyathostomins infections, but this has yet to be followed up by a 
randomised controlled in vivo trial (Payne et al., 2013). Given that feed supplements have a 
significant market in the equine industry, the value of bioactive plants in reducing reliance on 











1.4. Aims and objectives 
The aim of this thesis is to explore novel therapeutic options for the control of cyathostomins 
in both developing and developed countries, with a particular focus on ethnoveterinary 
medicines and novel drug combinations. The specific objectives are: 
 
- To identify plants with potential anthelmintic activity against cyathostomins using an 
evidence-based approach for equids in both developed and developing country settings. 
- To test these plant candidates using in vitro parasitological tests for two different life-
cycle stages of cyathostomins. 
- To evaluate the role of the protein efflux channels, P-gps, in emerging resistance to 
MLs in cyathostominsTo use in vitro tests to explore the potential of anthelmintic/P-gp 











































This chapter will describe the in vitro parasitological tests that were used throughout this thesis, 
and their optimisation. The details of optimisation experiments are referred to in Appendix 1. 
Methods specific to each chapter will be included in the specific materials and methods for that 
chapter.  
 
2.1. Standard laboratory solutions 
The source of all chemicals and drugs for the preparation of standard solutions and reagents 
are stated in the text. Standard solutions which were not made in the laboratory, but were 
purchased directly from a manufacturer, are referred to in the text along with their source.  
 
Saturated sodium chloride: Sodium chloride (NaCl) granules (Sigma-Aldrich, UK) were 
added to 2 L of tap water (H2O) and shaken until there was a significant amount of undissolved 
NaCl. The solution was left overnight, shaken again and more NaCl added, until there was a 
significant excess of granules. The granules were allowed to settle and the solution from the 
top was decanted for use in the laboratory. 
 
L-cysteine solution: 10 mM (for the larval migration test) and 5 mM (for the egg hatch test) 
L-cysteine solutions were prepared by the addition of L-cysteine crystals (Sigma-Aldrich, UK) 
to distilled H2O (dH2O) (Sigma-Aldrich, UK). The pH of the solutions were adjusted to 7 and 
the solution was used directly in tests. Fresh solution was made at the time of each test.  
 
Growth medium for the larval development test: Yeast solution was prepared by the 
addition of 1 g yeast (Sigma-Aldrich, UK) to 90 ml of 0.9 % NaCl (Sigma-Aldrich, UK) in 
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dH2O (18.2 MOhms MilliQ water, Millipore, UK). This was sterilised by autoclaving and 
combined in a 9:1 ratio with 10 X Earles salt solution (Sigma-Aldrich, UK). This solution was 
combined in a 2:1 ratio with 1.5 mg/ml lyophilised Escherichia coli K12 (Sigma-Aldrich, UK), 
in dH2O (18.2 MOhms MilliQ water, Millipore, UK), which had been previously sterilised by 
autoclaving. 
 
LB solution with ampicillin for cloning: This consisted of 10 g LB powder (Sigma-Aldrich, 
UK) in 500 ml dH2O (18.2 MOhms MilliQ water, Millipore, UK), which was sterilised by 
autoclaving.  Before use 1 ml of 50 mg/ml ampicillin (Sigma-Aldrich, UK) was added. 
 
2.2. Collection and storage of cyathostomins eggs and third stage larvae for use in in vitro 
tests 
Throughout this thesis, cyathostomin samples were taken from either horses or donkeys for use 
in in vitro tests. The horse samples were obtained from a local yard in Warrington, UK, and 
the donkey samples were obtained from the Donkey Sanctuary (DS), Sidmouth, UK. Where 
there were specific criteria for selection, based on previous treatment and faecal egg counts 
(FEC), they are stated in the specific materials and methods of the relevant chapter. 
 
2.2.1. Equid strongyle egg collection and extraction  
Strongyle egg collection and extraction were performed in equid faeces to provide egg samples 
for use in the egg hatch test (EHT) and larval development test (LDT). Equid faeces were 
collected immediately after being passed, only the top part of the faecal pat was collected, to 
minimise the risk of environmental contamination. Faeces were placed in air tight polythene 
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bags (Fisher, UK) and the eggs extracted within 1 h of collection or, if this was not practical, 
then the faeces were stored anaerobically in tap H2O at room temperature for no longer than 
one week before use. This storage method was optimised in preliminary experiments, see 
Appendix 1.1. Approximately 10 ml of tap H2O was added per gram of faeces and thoroughly 
mixed. The suspension was then washed over sieves in order of decreasing aperture; 2 mm, 
750 µm, 150 µm, 75 µm, 38 µm (Fisher, UK). The retentate was collected on the 38 µm sieve 
and washed into 13 ml polyallomer centrifuge tubes (Beckman Coulter, UK) using tap H2O. 
These were centrifuged at 200 g for 2 min (MSE, Mistral 3000i) and the supernatant removed 
by suction. The pellet was re-suspended with saturated sodium chloride (NaCl) (Sigma-
Aldrich, UK) solution by gentle inversion and re-centrifuged at 200 g for 2 min. The tubes 
were clamped just below the meniscus with artery forceps and the top layer decanted onto a 38 
µm sieve and rinsed with dH2O (Sigma-Aldrich, UK). The clean eggs were decanted into 50 
ml plastic pots (VWR, UK) and the concentration of eggs ascertained by counting the number 
of eggs in 5 X 10 µl using a microscope at 100 x magnification (Leica, Stereo), and taking an 
average of each count X 100 to give number of eggs/1000 µl. Egg suspensions were used 
immediately after extraction, in the EHT or LDT. A subset of each faecal sample was cultured 
to larval stages, as described in Section 2.2.2, to identify whether there were any large 
strongyles present. Only samples with pure cyathostomin infections were used in in vitro tests. 
 
2.2.2. Larval culture 
Larval culture was performed on faecal samples from horses and donkeys to harvest third stage 
larvae (L3) for use in the larval migration inhibition test (LMIT). Faeces were collected from 
the top of the faecal pat to minimise contamination, they were packaged in air tight polythene 
bags (Fisher, UK) and transported overnight to the University of Liverpool. The faecal samples 
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were divided into 100 g portions and moulded into a spherical shape. These were arranged in 
a plastic tray, placed in a polyethene bag (205 x 280mm resealable, Fisher, UK) with holes for 
ventilation. The trays were left at room temperature (approximately 20 °C) for 14 days. The 
trays were filled with luke warm tap H2O and left for 4 h. The H2O was then decanted through 
a 1 mm sieve and the filtrate collected on a 38 µm sieve (Fisher, UK). The retentate was poured 
over a three layer filter (Littlelamb Flushable Paper Nappy Liner) and the filter placed in the 
top of a jam jar filled with luke warm tap H2O. After 12 h the filter was removed and the 
volume of H2O reduced by suction, leaving a concentrated suspension of L3 in the jam jar 
which was transferred into a 25 ml culture flask (Nunc, UK). Each L3 sample was examined 
for the presence of large strongyles, only samples with pure cyathostomins were used in in 
vitro tests. It has previously been shown that this suspension can be stored at 4 °C and used in 
LMITs for up to three months, however motility is optimal before eight weeks (Pers comm, 
McArthur, C.). Hence only L3 that had been stored for less than eight weeks were used in the 
LMIT. The concentration of L3 for each sample was ascertained by counting the number of L3 
in 5 X 10 µl using a microscope at 100 X magnification (Leica, Stereo), and taking an average 
of each count X 100 to give the number of L3/1000 µl. 
 
2.3. The egg hatch test  
This test was originally described to detect benzimidazole (BZ) resistance in ruminants (Coles 
et al., 1992). The Moredun Research Institute adapted this method to develop an in house EHT 
protocol for ruminant eggs. Here, the Moredun EHT was performed with increasing 
concentrations of thiabendazole (TBZ), in order to validate the test for use in cyathostomin 
samples. This test was then adapted for use in Chapters 4 and 5 of this thesis to evaluate the 
effect of plant extracts against cyathostomins. Preliminary optimisation included, evaluating 
cyathostomin percentage egg hatch in tap versus dH2O. It was found that percentage egg hatch 
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was significantly better in dH2O, see Appendix 1.2., hence this was used in all further tests. In 
addition the effect of the drug solvent dimethyl sulfoxide (DMSO) on egg hatch was 
established in preliminary tests, it was found that egg hatch significantly reduced at DMSO 
concentrations higher than 5 % v/v, see Appendix 1.3., hence no greater than 5 % DMSO was 
used in further tests. 
 
2.3.1. The egg hatch test with thiabendazole 
The EHT was carried out to measure the effect of an anthelmintic compound, TBZ, on 
cyathostomin egg hatch. Working solutions of TBZ were prepared using 1000 ppm TBZ 
(Sigma-Aldrich, UK) in DMSO (Sigma-Aldrich, UK), according to Table 2.3.1.  
 





















The volume of egg suspension containing 100 eggs was calculated (X µl) and 2000 µl – (X µl 
+ 10 µl) dH2O (Sigma-Aldrich, UK) was added to each well of a 24 multiwell plate (Nunc, 
UK).  Ten µl of each working stock solution of TBZ was added to duplicate wells. Duplicate 
negative controls for dH2O and DMSO (final concentration 0.05%) were included. The 
multiwell plate was placed in an incubator for 48 h at 26 °C. Upon removal, 10 µl of neat 
Lugol’s iodine solution (Sigma-Aldrich, UK) was added to each well to stop further egg hatch. 
The number of first stage larvae (L1) and eggs were counted for each well using an inverted 
microscope at 400 X magnification (Olympus CK). Percentage egg hatch was calculated as 
follows: % egg hatch = (no. L1 /(no. L1 + no. unhatched eggs)) X 100. The results of 
preliminary experiments with TBZ on cyathostomins egg samples from horses and donkeys 
are shown in Appendix 1.4. 
 
2.3.2. Adaptation of the egg hatch test, for evaluating the anthelmintic activity of plant extracts 
The EHT was used to evaluate the effect of crude plant extracts from the UK and Ethiopia in 
Chapter 4 and 5. For this the EHT was adapted directly from the EHT with TBZ in Section 
2.3.1., see Chapters 4 and 5 for specific materials and methods. The EHT required further 
optimisation for testing papaya latex supernatant (PLS) in Chapter 5. A range of L-cysteine 
concentrations have been suggested for incubation with PLS, from 1-16 mM (Mansur et al., 
2014b; Stepek et al., 2006). Here a concentration of 10 mM was used initially, but was found 
to inhibit egg hatch. It was reduced to 5 mM for use in further EHT with PLS, and at this 
concentration it had no significant effect compared to dH2O. The EHT with PLS, was initially 
performed with PLS over a 48 h period. However it was found that after 48 h there was 
complete destruction of all eggs and L1. The incubation time was thus reduced to 24 h, which 
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allowed visualisation of parasites. Examples of dose response curves for preliminary EHTs 
with PLS are shown in Appendix 1.5., Figure A.1.5. 
 
2.4. The larval migration inhibition test  
The LMIT for evaluating ivermectin (IVM) efficacy, has been previously optimised for 
cyathostomins at the Moredun Research Institute (McArthur et al., 2015). This method was 
validated for the cyathostomins populations used in this thesis, and adapted for testing plant 
extracts, in Chapters 4 and 5, and P-glycoprotein inhibitors in Chapter 6. Basic parameters that 
were optimised in preliminary tests, were the mesh size for distinguishing between live and 
dead L3, and a comparison of the LMIT with sheathed and ex-sheathed L3. A mesh size of 25 
µM was found to be suitable, See Appendix 1.6. Ex-sheathed L3 were found to migrate better 
than sheathed, as a proportion of sheathed L3 became stuck in the mesh, hence ex-sheathed L3 
were used for all further tests, see Appendix 1.7. In addition a titration of DMSO concentrations 
was performed to evaluate the effect of drug solvent alone on larval migration. As for the EHT, 
it was found that larval migration was inhibited at concentrations higher than 5 % v/v, and 
hence no greater than 5 % DMSO was used in further tests. 
 
2.4.1. The larval migration inhibition test with ivermectin 
The volume of L3 solution required for 4800 L3 was calculated from a stock of L3 that had 
been cultured and refrigerated within the last eight weeks. This volume was made up to 10 ml 
with tap H2O and ex-sheathed with 7 % sodium hypochorite (Miltons) for 3.5 min. The L3 
were washed three times by centrifugation at 200 g for 2 min, followed by removal of 9 ml of 
supernatant and addition of 9 ml of dH2O (Sigma-Aldrich, UK). The L3 were baermannised 
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through two layers of filter paper (Littlelamb Flushable Paper Nappy Liner) at 26 ºC for 2 h to 
ensure that only viable motile L3 were included in the test. Working concentrations of IVM 
(Sigma-Aldrich, UK) were made up as outlined in Table 2.4.1. from a stock solution of 3000 
µg/ml in DMSO (Sigma-Aldrich, UK). Six µl of each working concentration were added to 0.5 
ml amber microtubes (Bioquote, UK), a negative control of 3 % DMSO and dH2O were 
included. The L3 were centrifuged, reduced to 1 ml solution and 1.8 ml of dH2O added. Then, 
194 µl of the L3 solution were added to each microtube with 6 µl of each working concentration 
of IVM. The final IVM concentrations to which the L3 were exposed are shown in table 2.4.1. 
The mixture was incubated for 2 h at 26º C. 




















Custom made migration sticks with 25 µm nylon mesh (HPC Gears) were placed in a 24 well 
plate (Nunc, UK), as previously described (Demeler et al., 2010a). To each well 1910 µl of a 
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solution of IVM made up to the final concentrations outlined in table 2.4.1., was added in 
duplicate. After incubation for 2 h, 90 µl of the incubated L3 were added to each migration 
well of the corresponding IVM concentration. Plates were covered with aluminium foil to 
prevent light degradation of IVM, and incubated at 26 ºC for 2 h. The LMIT was halted by 
removal of the migration sticks from the plate. The bottom of the migration chambers were 
rinsed into the wells of the multiwall plate containing migrated L3, using 600 µl of dH2O. The 
sticks were then turned over and the contents of the migration chambers washed out in adjacent 
wells of the multiwell plate, using 2 ml of dH2O. Finally 200 µl of ethanol (Sigma-Aldrich, 
UK) was added to each well to fix the L3 for counting. The number of L3 in each well were 
counted using an inverted microscope at 400 X magnification (Olympus CK inverted) and the 
percentage larval migration calculated as follows: % L3 migration = (L3 migrated/(L3 migrated 
+ L3 not migrated) X 100. Examples of preliminary LMITs with cyathostomin samples from 
horses and donkeys are shown in Appendix 1.9. 
 
2.4.2. Adaptation of the larval migration inhibition test for evaluating the effect of plant 
extracts on cyathostomins 
The LMIT was used to evaluate the effect of crude plant extracts from the UK and Ethiopia in 
Chapters 4 and 5. For this, the LMIT was adapted directly from the LMIT with IVM in Section 
2.4.1., see Chapter 4 and 5 for specific materials and methods. The LMIT required further 
optimisation for testing papaya latex supernatant (PLS) in Chapter 5. It was necessary to use 
L-cysteine solution in all incubations, instead of dH2O. It was found that 10 mM L-cysteine 
had no effect on L3 migration in controls and hence it was used at this concentration for further 
experiments. Different incubation times with PLS in the LMIT were also evaluated, See 
appendix 1.10., and it was found that there was a measurable dose response effect at all 
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incubation times between 2 and 24 h, with the response improving with longer incubation 
times. For practical reasons the incubation time was kept at 16 h for future LMITs with PLS, 
so that the test could be run overnight. Examples of some preliminary LMITs with PLS are 
shown in Appendix 1.11.   
 
2.4.3. Adaptations of the larval migration inhibition test for evaluating the effect of P-
glycoproteins on ivermectin efficacy against cyathostomins 
In Chapter 6 the LMIT with IVM was performed with the addition of three P-glycoprotein (P-
gp) inhibitors pluronic 85 (P85) (BASF, USA), ketoconazole (Sigma-Aldrich, UK) and 
ivermectin aglycone (IVM-AG) (synthesised at Toxalim, Institut national de la recherche 
agronomique (INRA), Toulouse, and kindly donated by Dr Anne Lespine). The method was 
adapted directly from that described in Section 2.4.1., as detailed in Chapter 6. Preliminary 
optimisation included the evaluation of the effect of P85, ketoconazole and IVM-AG, on larval 
migration, to ensure that they were used at concentrations which had no effect alone in the 
LMIT. The LMIT was adapted and performed with dose titrations of all three P-gp inhibitors, 
see Appendix 1.12. The concentration of P85 and ketoconazole that lead to maximum P-gp 
inhibition have been reported previously as 22 µM and 10 µM, respectively (Bartley et al., 
2009). Given that there was no effect on larval migration at these concentrations, they were 
used in all further tests. The concentration of IVM-AG that leads to maximum P-gp inhibition 
has not been previously established. Thus here an additional test was run, where increasing 
concentrations of IVM-AG were compared with increasing concentrations of IVM-AG plus 1 
µM IVM. This was done to determine the concentration at which the addition of IVM-AG 
optimally improved inhibition of larval migration compared to IVM alone. The optimal 
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concentration was found to be 60 nM, see Appendix 1.13, and this was used in all further 
LMITs with IVM-AG.  
 
2.5. The larval development test  
The method for the LDT was adapted from a study (Demeler et al., 2010b) where its use was 
described for ruminant nematodes. It has been reported that a different growth medium is 
optimal for equid strongyles (Coles et al., 2006), hence the test was first optimised for growth 
medium, and amphotericin B concentration, see Appendix 1.14. The growth medium described 
in Demeler et al (2010b) was found to be optimal in the cyathostomin samples used here. An 
amphotericin B concentration of 0.25 µg/ml was chosen for all tests as there was no effect on 
development at this concentration and it is the concentration most often cited (Coles et al., 
2006; Demeler et al., 2010b).   Dose titrations with DMSO were also performed in preliminary 
tests, see Appendix 1.15. It was found that DMSO began to inhibit larval development at 
concentrations higher than 0.5 %, and hence no greater than 0.5 % DMSO was used in further 
tests. 
 
2.5.1. The larval development test with ivermectin 
The concentration of a cyathostomin egg suspension was adjusted to 100 eggs in 20 µl. To each 
well of a 48 well plate (Nunc, UK), the following were added in this order: 
1) 20 µl of egg suspension  
2) 30 µl of amphotericin B (0.25 mg/ml) (Sigma-Aldrich, UK) 
3) 190 µl of dH2O (Sigma-Aldrich, UK) 
4) 30 µl of growth medium (see Section 2.1.) 
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5) 30 µl of increasing concentrations of IVM (Sigma-Aldrich, UK) solution, see table 
2.5.1. 
 
For each concentration of IVM, duplicate repeats were included. Duplicate negative controls 
of dH2O were also included. The plates were sealed and covered with foil, before being 
incubated for 7 days at 26 ºC. The test was halted by adding 20 µl of lugols iodine (Sigma-
Aldrich, UK) to each well. The number of first, second and third stage larvae (L1, L2 and L3) 
were counted and the percentage larval development calculated as follows: % larval 
development = (no. L3/(no. L3 + L1 + L2)) X 100. Examples of the LDT with IVM in 
preliminary experiments are shown in Appendix 1.16.  
 
Table 2.5.1. Working concentrations of ivermectin (IVM) (1.5 µl of which were added to 28.5 µl of 
distilled water to be added to the larval development test), and final concentrations of IVM. 
 
Working 
concentration of IVM 
in DMSO (nM) 
Final concentration in 















2.5.2. Adaption of the larval development test for use with P-glycoprotein inhibitors 
In chapter 6, as for the LMIT, the LDT with IVM was performed with the addition of three P-
gp inhibitors P85, ketoconazole and IVM-AG. The method was adapted directly from that 
described in Section 2.5.1., see Chapter 6 for specific materials and methods. Preliminary 
optimisation included the evaluation of the effect of P85, ketoconazole and IVM-AG, on larval 
development, to ensure that they were used at concentrations which has no effect alone in the 
LDT. The LDT was adapted and performed with dose titrations of all three P-gp inhibitors, see 
Appendix 1.17. The concentration of P85 and ketoconazole that lead to maximum P-gp 
inhibition have been reported previously as 22 µM and 10 µM, respectively (Bartley et al., 
2009). Given that there was no effect on larval development at these concentrations, they were 
used in all further tests. For IVM-AG the concentration that leads to maximum P-gp inhibition 
has not been previously established, it was found to be 60 nM in the LMIT, however, for the 
LDT it was observed that at concentrations greater than 12.5 nM there was an independent 
effect on larval development (Appendix 1.17) and thus, IVM-AG was used at a lower 
concentration of 8 nM in all further LDTs.  
 
2.6 Analysis of dose response data 
There is more than one commonly used method for the statistical analysis of dose response 
data (Ademola and Eloff, 2011; AlGusbi et al., 2014; Bachaya et al., 2009; Bartley et al., 2009; 
Maciel et al., 2006; McArthur et al., 2015). In this thesis PROBIT analysis in SPSS version 21 
(SPSS Inc., Chicago IL), the four parameter sigmoidal model in GraphPad Prism version 6.00 
for Windows (GraphPad Software, La Jolla California USA, www.graphpad.com) and a 
general linear mixed model in R studio (R Core Team, 2014) were used. These different models 
were selected based on the complexity of the dataset and the analysis required in each chapter. 
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The details of these methods are given where they are used within the specific materials and 




























3. IDENTIFICATION OF PLANTS WITH POTENTIAL 
























The challenges of controlling equid helminth infection using conventional anthelmintics have 
led to a growing interest in alternative control strategies. In developed countries anthelmintic 
resistance is the primary challenge, however in developing countries the limiting factors are 
often financial or logistic, with poor rural communities worst affected. The use of bioactive 
plants to reduce parasite burden, is an alternative strategy that may aid effective control in both 
scenarios. Ethiopia is an example of a developing country which is rich in flora, and there have 
been numerous studies detailing the medicinal properties of native plant species (Assefa et al., 
2010a; Assefa et al., 2010b; Bekalo et al., 2009; Chekole et al., 2015; Kidane et al., 2014b; 
Tolossa et al., 2013; Yigezu et al., 2014; Yineger et al., 2007; Yineger and Yewhalaw, 2007). 
Some studies have also reported plants that are believed to have efficacy against internal 
parasites of ruminants, chickens and/or humans (Assefa et al., 2010b; Bamikole and Ikhatua, 
2009; Githiori et al., 2004; Hussain et al., 2008; Maphosa and Masika, 2010; Mwale and 
Masika, 2009), however none of these studies have described plant-based treatments used 
specifically for equids. Participatory research techniques, such as participatory rural appraisals 
(PRA) are well established approaches to obtaining ethnobotanical information from rural 
communities (Chekole et al., 2015; Kidane et al., 2014a; Kidane et al., 2014b; Njoroge and 
Bussmann, 2006; Yigezu et al., 2014). A PRA focuses on investigating and representing what 
people know and understand and initiating group-led plans for future adaptations (Chambers, 
1994), it represents a flexible approach encompassing both quantitative and qualitative data.  
 
In contrast to Ethiopia, the UK is highly developed country where general knowledge of native 
plant species is sparse. In recent years there has been investigation into the potential use of 
bioactive forages in UK livestock (Athanasiadou and Kyriazakis, 2004; Athanasiadou et al., 
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2005), but these studies were not led by farmer knowledge. These circumstances necessitate a 
different approach in identifying suitable plant candidates with potential anthelmintic activity.  
 
The present study was performed in collaboration with the Donkey Sanctuary (DS), and the 
aim was to identify plants which have potential for treating equid gastrointestinal (GI) 
nematodes in two countries where the DS operates, the UK and Ethiopia. This chapter describes 
the selection process that was used to identify suitable candidates for in vitro screening for 
anthelmintic activity. A PRA was used to identify plants which are currently used as 
ethnoveterinary treatments in equids in rural Ethiopian communities, in order to make 
recommendations for poor communities who struggle to access synthetic anthelmintics for 
financial or logistic reasons. In the UK a literature review was chosen to identify suitable plants 
for further testing, for which there was existing evidence of anthelmintic activity. 
 
3.2. Materials and Methods 
3.2.1. Identification of plants with potential anthelmintic activity in Ethiopia using a 
Participatory Rural Appraisal 
The PRA was designed and carried out in collaboration with a research assistant, Dr Claire 
Scantlebury and was divided into part a) focus group discussions and part b) key informant 
interviews. The methods and results of the focus group discussions were led by Dr Scantlebury 
and have been published (Scantlebury et al., 2013), however the sections relevant to plant 
selection are presented here for completeness. The author visited Ethiopia with Dr Scantlebury 
for part b) and assisted in the key informant interviews, collected plants named in part a) and 
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b) for identification, and triangulated results with a literature review in order to select a shortlist 
of plants for in vitro testing.  
 
3.2.1.1. Study area 
The study area consisted of 14 kebeles (neighbourhoods) in the Oromia region of Ethiopia, five 
of these were Donkey Sanctuary (DS) clinic sites and nine were non-DS sites. The kebeles 
were selected for their topographic variation and accessibility, to maximise the range of 
sampled flora. Data collection was conducted over a six week period during June and July 
2011.  
 
3.2.1.2. Focus group discussions 
As stated above focus group discussions were conducted by Dr Claire Scantlebury and the 
methods have been published (Scantlebury et al., 2013). Briefly, participants from each kebele 
were selected via the local development agent (DA) from each region. Each DA was briefed 
about the study and asked to select donkey owners of a range of ages (>16 years of age). Two 
groups per village were requested, with a maximum of 6-8 people per group. The group 
sessions were of a semi-structured format including some key questions on the use of plants to 
treat parasitic infections in livestock and donkeys, along with opportunities for open discussion. 
Additionally, each group participated in constructing two sets of matrices drawn on laminated 
white card. Photographs were taken of the matrices to record the data. The names of the 
volunteered plants were listed along one side of the matrix. For each plant, brief details of 
method of preparation, plant location, how owners know that this is an effective treatment and 
any reported side effects, were recorded. If a number of plants were named for use in donkeys, 
53 
 
the group were asked to arrive at a consensus of how these were ranked in terms of 
effectiveness. All groups were asked if they could name a local person or local traditional healer 
who was known to have knowledge of plant based treatments for animals and, particularly, 
preparations with believed anti-parasitic properties.  In this way a list of names was compiled 
at the time of each focus group from which key informants were selected. At the end of the 
focus group a leaflet was given to all participants explaining practical approaches to controlling 
GI parasites in their donkeys.  
 
3.2.1.3. Data handling for focus group discussions 
Data analysis for focus groups was carried out by Dr. Claire Scantlebury and has been 
published (Scantlebury et al., 2013). The discussions were translated into English at the time 
and recorded on a digital Dictaphone. The English translation from the focus groups was 
transcribed. Audio recordings and English transcriptions are available for each group 
discussion. Microsoft Office Excel software was used to tabulate the photographed matrices 
and NVivo qualitative data analysis software (QSR International Pty Ltd. Version 8) was used 
to thematically code the content of the portions of open discussion occurring during the focus 
groups. A list of plants named for each species was generated including frequency tables of 
how many groups named each plant type. Where applicable, ranking data was tabulated to 
show the perceived effectiveness of the plants for use in donkeys. A table summarising the 






3.2.1.4. Key Informant interviews 
Key informant interviews were led by Dr. Claire Scantlebury, and carried out in collaboration 
with the Author. From the list of key informants identified during the focus group discussions, 
the DAs from each region contacted and recruited two people from each village to participate 
in interviews. At the beginning of each interview the participant was introduced, informed of 
the nature and aims of the study and invited to take part voluntarily. Verbal informed consent 
was gained and recorded from each participant. A semi-structured interview approach was used 
with the help of a co-facilitator/translator, (Appendix 2.1.) for the interview outline. 
Information gained during the interviews was written down at the time of the interview on the 
prepared data sheet to facilitate data entry and all interviews were recorded on a digital 
dictaphone. Participants were first asked to describe which plants/plant based treatments they 
used to treat worms in any species and to detail information relating to the description of the 
plant, method of preparation and administration and side effects for each plant. Additionally, 
some of the highly ranked plants from the focus group discussions and some key plant 
candidates from previous key informant interviews were named at the end of the interview, and 
participants were asked if they knew of their use for any species and for what conditions/disease 
presentations they were used for. If they reported knowing about one of these plants, further 
details relating to the preparation and dosage and side effects were obtained. This was one of 
the methods by which the data from the focus group discussions was triangulated. Data were 
entered into and analysed using Excel (Microsoft) and NVivo 8 (QSR), as described above. 
 
3.2.1.5. Plant collection, identification and selection 
Where possible, plants named by participants were sampled. In some cases the plant was too 
far from the study site or out of season.  Cutting samples of each plant were taken, incorporating 
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the leaves, stem, flowers and seeds where possible (Forman and Bridson, 1989). These samples 
were pressed and dried before transportation to the National Herbarium, Addis Ababa, 
Ethiopia, where they were formally identified. Photographs were taken of plants to include 
details of the leaf/branch structure and any flowers or seed heads to aid identification. 
Subsequent to identification, results were triangulated with available literature for each plant 
to provide supportive evidence for use against GI nematodes and to identify any reports of 
toxicity. Four plants were shortlisted based on the following criteria: identification in the PRA, 
ranking in the PRA, supportive evidence of in vitro or in vivo efficacy in the literature, a lack 
of reported severe side effects in the literature and availability.  
 
3.2.2. Identification of UK plant candidates using a literature review 
Plants were shortlisted by means of a literature review using the PubMed search engine 
(www.ncbi.nlm.nih.gov>NCBI>Literature). The search criteria entered were ‘plant’ AND 
‘anthelmintic’. The data from the literature search was tabulated using Microsoft Office Word 
(2007) under the following headings: number of citations supporting efficacy against parasitic 
nematodes in vitro, number of citations supporting efficacy against gastrointestinal (GI) 
nematodes in vivo, reports of toxicity and local availability. Supervisors and advisors from the 
DS, UK and Ethiopia, independently used these data to rank each plant, and the results were 
collated to create a preliminary shortlist of plants. Plants were excluded if there were significant 
reports of toxicity in the literature. Once a preliminary shortlist of plants had been identified, a 
more general search, using google scholar (www.scholar.google.co.uk), was performed to 
identify additional references for the chosen plant extracts. The total number of citations 
supportive of each plant ranged between 4 and 26. Investigations into availability at the time 




3.3.1. Ethiopian plant selection using a participatory rural appraisal 
A total of 50 plants/plant mixtures were identified during the focus group discussions and key 
informant interviews. For 37 of these, cutting samples were taken for identification. For some 
plants it was only possible to identify to family and genus level due to the lack of flowering 
parts at the time of collection. Table 3.3.1. shows the plants that were identified during the 
focus group discussions, including the frequency with which each plant was mentioned within 
groups for treatment in donkeys, other livestock species and humans. A total of 22 out of 29 
groups reported using plant preparations to treat GI parasites in donkeys, whereas all groups 
described their use in livestock and humans. Table 3.3.2. shows the ranking of plants, named 
by groups, for donkeys, according to the frequency of use and opinions on efficacy. Table 
3.3.3.a. shows the plants mentioned by key informants for efficacy against GI parasites in 
donkeys; Table 3.3.3.b. shows plants mentioned by key informants for efficacy against GI 
nematodes in mixed species. This data was collected as some people did not treat donkeys. The 
reported efficacy, side effects, method of preparation and dosing were also recorded where 
possible from focus groups and key informants (Table 3.3.4.a and b). It was noted for some 
plant species that the method of preparation of the plant before administration varied widely 
between participants. The reported side effects also frequently varied from none, to severe 
diarrhoea and death; toxicity was usually reported to be dosage dependant. This data was 
triangulated with a literature review and plants were shortlisted, as described in Section 
3.2.1.5., for collection and testing in in vitro parasitological tests, see Table 3.3.5.  A fifth plant, 
Acacia nilotica (L.), was also included, identified directly based on its availability in the region 




3.3.2. UK plant selection using a literature review  
The PubMed search yielded 2480 results, 138 of which reported the in vitro or in vivo effect of 
plants on nematodes (Appendix 2.2.).  Plants were shortlisted as described in Section 3.2.2. 
Table 3.3.6. shows the preliminary shortlist of plants that were chosen for UK testing after 
ranking by independent researchers. The final shortlist of plants was Carica papaya L., Allium 




Named plants Vernacular plant names Frequency named for 
use in donkeys - no. of 
groups and % freq (out 
of 22 groups which 
used plants in donkeys) 
Frequency named for 
use in other livestock 
- no. of groups and % 
freq (out of all 29 
groups) 
Frequency named 
for use in people -
no. of groups and % 
freq (out of all 29 
groups) 
TOTAL frequency 
named for use in all 
species – no. of 
groups and % freq  
Hagenia abyssinica J. F. G 
mel. 
Koso 9 (40.0%) 9 (31%) 23 (79.3%) 26 (89.7%) 
Unknown Mixed roots / leaves / trad 
remedy / unknown 
8 (36.4%) 12 (41.4%) 3 (10.3%) 22 (75.9%) 
Embelia schimperi Vatke Enkoko / Hanku  4 (18.2%) 0 18 (62.1%) 20 (67%) 
Nicotiana tabacum L. Tobacco 0 10 (34.5%) 0 19 (65.5%) 
Vernonia amygdalina 
Delile 
Grawa 7 (31.8%) 13 (44.8%) 0 15 (51.7%) 
Unknown Metere 0 0 8 (27.6%) 8 (27.6%) 
Cucumis prophetarum L. Holoto 3 (13.6%) 2 (6.9%) 2 (6.9%) 4 (13.8%) 
Trigonella foenum-
graecum L. 
Abish 1 (4.5%) 2 (6.9%) 0 3 (10.3%) 
Verbascum sinaiticum 
Benth. 
Donkey Ear / Gurra Harre 3 (13.6%) 0 0 3 (10.3%) 
Withania somnifera (L.) 
Dunal 
Wahale / Gizawa 3 (13.6%) 1 (3.4%) 0 3 (10.3%) 
Unknown Senebecki 0 0 2 (6.9%) 2 (6.9%) 
Unknown Dodoho 0 1 (3.4%) 2 (6.9%) 2 (6.9%) 
Table 3.3.1. Plants named by focus groups for use in donkeys, other livestock and humans, with the frequency of groups naming them (adapted 






Delensisa 0 2 (6.9%) 0 2 (6.9%) 
Unknown Gime kitel/Sara-aja 0 2 (6.9%) 0 2 (6.9%) 
Melia azedarach L. Milia 0 1 (3.4%) 0 1 (3.4%) 
Tapinanthus globuliferus 
Tiegh. 
Harmo 1 (4.5%) 0 0 1 (3.4%) 
Phytolacca dodecandre L. 
Her 
Endod 1 (4.5%) 0 0 1 (3.4%) 
Unknown Bean Straw 1 (4.5%) 0 0 1 (3.4%) 
Unknown Keskesco 0 1 (3.4%) 0 1 (3.4%) 
Unknown Bure (root) 1 (4.5%) 0 0 1 (3.4%) 
Unknown Feto 0 1 (3.4%) 0 1 (3.4%) 
Unknown Abdul Salim 1 (4.5%) 1 (3.4%) 1 (3.4%) 1 (3.4%) 
Capparis cartilaginea 
Decne. 
Delensisa 0 2 (6.9%) 0 2 (6.9%) 
Dodonea angustifolia L. f. Kitkita 1 (4.5%) 0 0 1 (3.5%) 
Unknown Kedida 0 0 1 (3.4%) 1 (3.5%) 
Croton macrostachyus 
Hochst. ex. Delile 
Bisana 1 (4.5%) 0 0 1 (3.5%) 
Myrsine Africana L. Kechamo 0 0 1 (3.4%) 1 (3.5%) 
Unknown Chobi 0 1 (3.4%) 1 1 (3.5%) 
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Table 3.3.2. Plant rankings for perceived effectiveness in donkeys (focus groups) (taken from (Scantlebury et al., 2013)) 
 















































L. Her ) 
Average rank 
score 
2.2 2 3 1 2.5 1 1 2 2 2 3 3 
Combined 
rank score 
27 23 14 8 5 4 4 3 3 3 2 2 
Number of 
groups ranked 
(out of 22) 
6 6 4 2 2 1 1 1 1 1 1 1 
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Table 3.3.3.a. Plants named by key informants with reported efficacy against gastrointestinal helminths in donkeys 
Interview code Plant species Vernacular plant names Species given to 
22.06.11 Dire Participant 1 Cyphostemma adenocaule (Steud.) Desc. Hindirifa Equids  
22.06.11 Dire Participant 2 Echinops kebericho Mesfin Balawaraanti Equids 
21.06.11 Bekejo Participant 2 Unknown Bure Cattle / donkeys 
21.06.11 Bekejo Participant 2 Unknown Derartu Cattle / donkeys 
21.06.11 Bekejo participant 3 Ranunculus multifidus Forssk. Not Known Cattle, people and donkeys 
27.06.11 Boru Lencha Participant 2 Verbascum sinaiticum Benth. Gurra hare Donkeys 
21.06.11 Insilale Participant 1 Eucalyptus staigeriana F. M. Bailey 




Cattle / donkeys 
27.06.11 Boru Lencha Participant 1 Vernonia amygdalina Delile Grawa Cattle / donkeys 
28.06.11 Jawi Cilalo Participant 2  Vernonia amygdalina Delile 






22.06.11 Dire Participant 3 Verbascum sinaiticum Benth. 
Ferula communis L. 





21.06.11 Insilale Participant 1 Solanum incanum L. 




21.06.11 Bekejo Participant 2 Cyphostemma adenocaule (Steud.) Desc. Hindirifa Donkeys / cattle 
















28.06.11 Sibu Abidire Participant 2 Stephania abyssinica Walp. Kalala All species 
27.06.11 Boru Lencha Participant 1 Hagenia abyssinica J. F. G Mel Koso Cattle / donkeys 
28.06.11 Sibu Abidire Participant 2 Arisaema shimperianum Schott Yekib bokolo Equids 
28.06.11 Debeye Adere Participant 1 Unknown Abdul Salim All species 
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Table 3.3.3.b. Plants named by key informants with reported efficacy against gastrointestinal helminths in mixed species 
Interview code Plant species Vernacular plant names Species given to 
29.06.11 Gasala Chicha Participant 2 Grewia ferruginea Hochst. Alanquatta (Tekonu) Cattle, sheep and goats 
21.06.11 Bekejo Participant 2 Unknown Bure Cattle / donkeys 
21.06.11 Bekejo Participant 2 Unknown Derartu Donkeys and cattle 
21.06.11 Bekejo participant 3 Ranunculi multifidus Forssk Doesn't know name Cattle, people and donkeys 
21.06.11 Insilale Participant 1 Eucalyptus staigeriana F. M. Bailey 




Cattle / donkeys 
21.06.11 Bekejo Participant 1 Withania somnifera (L.) Dunal Gizawa Cattle, sheep and goats 
27.06.11 Boru Lencha Participant 1 Vernonia amygdalina Delile Grawa Cattle and donkeys 
21.06.11 Insilale Participant 1 Vernonia amygdalina Delile 




Cattle, sheep and goats 
28.06.11 Jawi Cilalo Participant 2  Vernonia amygdalina Delile 





All types of animals 
29.06.11 Dawe Guticha Participant 1 Tapinanthus globiferus Tiegh. Harmo People 
23.06.11 Boset Participant 1 Gomphocarpus fruticosus (L.) W.T.Aiton Hatifachisa Calves 
21.06.11 Bekejo Participant 2 Cyphostemma adenocaule (Steud.) Desc. Hindirifa Donkeys and cattle 
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22.06.11 Dire Participant 1 Ijaji 8 plants mixed 
Unknown 
Rumex abyssinicus Jacq 
Verbascum sinaiticum Benth. 
Unknown 
Unknown 
Zehneria scabra Sond. 
Plectranthus lanuginosus (Benth.) Agnew 
Aerva javanica Juss. 
Stephania abyssinica Walp. 












28.06.11 Sibu Abidire Participant 2 Stephania abyssinica Walp. Kalala All species 
27.06.11 Boru Lencha Participant 1 Hagenia abyssinica J. F. G mel. Koso Cattle and donkeys 
28.06.11 Sibu Abidire Participant 2 Hagenia abyssinica J. F. G mel. Koso People 
22.06.11 Chole Sonkole Participant 2 Hagenia abyssinica J. F. G mel. Koso People 
22.06.11 Chole sonkole participant 1 Verbascum sinaiticum Benth. 





21.06.11 Bekejo Participant 1 Foeniculum vulgare 
Calpurnia aurea (Lam.) Benth. 
 
Justicia schimperiana T.  Anderson 
Withania somnifera (L.) Dunal 
Insilale 





28.06.11 Debeye Adere Participant 1 Asteraceae/Solanaceae Osole People 
28.06.11 Debeye Adere Participant 2 Unknown Abdul Salim All species 




Table 3.3.4.a. Focus groups: summary of methods of preparation, where obtained, effectiveness and side effects of plants named for use in donkeys  
Named plants Range of methods of preparation 
described 




F. G mel. 
-Crush and mix with water, either use 
straight away or keep for 1 – 3 nights 
and drench in morning 
-One group specified a dose of one 
handful leaves 
-One group crush it, sometimes mix 
with oil seed, keep for 1 night, and 
drench in the morning 
Market / some find 
it growing wild in 
highland regions 
 -Not reported in donkeys 
-Will cause diarrhoea in adults if more than one glass full given 
-If poor body condition will cause diarrhoea 
-Beyond 1 coke bottle will kill 
-Severe diarrhoea can kill 





-Crush (plus / minus mix with salt) 
and water and drench  
-One group crush with salt and keep 
one night before giving to animal, 
n.b. donkeys may drink voluntarily  
Grow it : general 
purpose plant e.g. 
used as fence 
 -None 
-If overdose severe diarrhoea, give little by little 
-None in donkeys but if mix with lots of salt will kill animal 





-Crush, mix with water and drench  
-One group keep one night and 
drench juice part in morning 
-One group use root 
-Crush with water and drench juice 
part - use wood mouth gag 
Wild in the 
lowlands, dies back 
in dry season.  
 -Severe diarrhoea and can kill 
-None if proper dosage depends on size of donkey if overdose 
will kill 








Crush and mix with barley plus or 
minus salt and feed 
Market Improves body condition 
Tablets preferred as 
enkoko eliminates 
worms over 4 days. 
-Does cause diarrhoea but not like Koso 
-None 
-Induces severe diarrhoea in people.  
-Overdose, causes abdominal pain can kill people.  
-No side effects 






-Crush mix with water and salt and 
drench (may also mix with garlic) 
Grows wild (in 
lowlands) 






-Mix with water and drench 
traditional person knows dose 
   
Abdul Salim 
(root) 
-Crush mix with garlic and drop in 
nostril of donkey. 







-Crush it mix with water (sometimes 
mixed with wahale sometimes grawa, 
or salt) and drench  
Grows wild Grawa plus donkey ear 
as effective as tablet 
-None 
Harmu  -Collect and crush, keep for 1 night Collected from 
different trees: 
Wadesa, Bekenisa, 








Roots of plant 
mix 
Crush just with water for donkeys no 
boiling 
-Crush mix with water and drench 
use mouth gag in donkeys 
Traditional person Induces diarrhoea and 







-Powder, mix with water and drench Grow or buy seed 
but expensive 





-Crush, mix with Sensete and salt 
drench with water (use coke bottle)  
Grows wild 
everywhere 
 -Endod is like acid so will burn inside which causes animal to 
shiver 
Bean straw -‘Smoking’ used for general disease 
and coughing 
   





-Crush with water and drench juice Grow it  -Severe diarrhoea and can kill 
Sara-aja leaf 
and root 




Expels worms (Alelu 










 -Crush, mix with water and drench 
juice 





Table 3.3.4.b.  Key informant interviews: summary of preparation of plants for use in donkeys 




Root part Chop root then dry then crush 
then dry again. Mix with 
water and then sieve it and 
immediately drench to donkey 
One finger pinch of dry root 
powder for donkey, 
sometimes mixed with other 
plants (arita / masarata) 
Drench juice, use 
beer bottle 







Root Chop root, then dry then crush 
to powder and dry and keep 
for when want to use. People 
buy and mix with water at 
home before giving to animal. 
Keeps for long time dried. 
Boil for one night and in 
morning mix with cold water 
and sieve it then mix with 
chilli, salt butter then drench 
one beer bottle full for 
donkey.  
Use a handful for donkey Drench in nostril or 
with wooden mouth 
gag 
Just given once a year 
for worms, will last 
all year. May repeat if 
other problems. 
Animal will eat and 
become good body 
condition. No side 
effects reported 
Bure Root of 
plant looks 
like onion 
Same prep as Hindirifa but 
less volume as very strong. 
Does not matter if stored. 
Coffee cup full of juice 
sometimes mix bure and 
hindirifa 




immediately and then 
diarrhoea, is strong 
cause bad diarrhoea 
and may debilitate 
Derartu  Root part Same as Hindirifa sometimes 
mi with crushed leaf same 
plant 








Roots Crush with salt and sieve fill 
bottle like glass bottle (~500 
ml). 
About 10cm of root crushed 
and mixed in 500ml bottle 
Drench through 
nostril for donkeys 
Just when have 
problem, one off, if 
no relief then will 
repeat 
Will eat after 









Root Chop it crush with mortar 
crush add water immediately 
sieve it with juicy part drench 
juice part one litre.  
Six inches times three of the 
plants roots. 













Crush together and mix with 
water and sieve it. Mix from 
half to 1 litre of water and 
drench  
Four leaves eucalyptus and 




 None donkey will 
start eating and come 






Leaf Crush leaf plus salt and water 
keep in covered container for 
one night in morning sieve. 
Let drink juice if not willing 
to drink then drench. 
Two handfuls of leaf, donkeys 
doesn't matter amount of leaf 
as animal eats sometimes 
itself (~10cc salt half local 
coffee cup). 
Leave to drink or 
drench. All animals 
will eat normally 
from fence 
Whenever see loss 
body condition given 




in dry or wet season. 




condition no worms 
in faeces days later 
not as many and no 
bad effects. Salt 
should be proper 
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amount maybe half 









Leaf Crush leaf, mix with salt for 
drenching sieve keep for one 
night or use immediately 
 Donkeys, drenched 
as not willing to 
drink drench 
through nostril with 
glass bottle, one litre 
Only once Will be worms in 
faeces after drenching 











punctate R. Br. 
Leaves and 
roots 
Crush roots and leaf together 
and make pie (about two 
handfuls worth) for an animal 
let it dry in sun keep it in 
closed container give whole 
pie for one animal (horses / 
donkeys) 
Crush dry pie, mix with three 
litres of water, keep overnight 
drench one litre after sieving  
Drench Give 1st day and then 
every other day for 
three days 
Positive reports from 
people using 
treatment. Effective 
and people ask for 
more to keep at 
home. Animal eats 
and it induces 
diarrhoea and the 







Roots Equal shares of hidi and 
holoto, sometimes use 
eucalyptus leaf to make it 
strong. Mix it with salt 
(handful) and chilli (two 
teaspoons of chilli) sieve one 
litre and use immediately 
 Drench, after 
drenching do not let 
animal drink after 
drenching as believe 
will make strong 
 Animals not willing 
to drink no side 
effects 
Hindirifa Root part, 
any part of 
root 
Crush mix with salt and 
drench juicy part after sieving, 
prepare and use immediately 
 Use beer bottle  Induce diarrhoea 
wash all disease away 






may prepare and keep for two 
months, storing strengthens it 
allows fermentation. Keep in 
glass bottle, use beer bottle 
full (300ml) 
worms will see 













Use fistful of root, crush and 
salt and sieve, fill bottle like 
glass ~500ml 
Use 500 ml water plus ~15cm 
root 
Drench though nose 
of donkey use 
immediately 
Whenever there is a 
problem with the 
animal, may repeat if 
necessary 
Will eat after 
drenching / moving / 
stopped rolling / mix 
with other donkeys 





Root Root, crush in mortar, then 
mix with water then 
immediately drench sieve it 
and drench juice of root. 
Difficult to estimate as long 
thin roots. 
Drench Like koso, follow 
faeces of donkeys / 
horse will drench 
once daily follow 
droppings of animals 
everyday for as long 
as need to. 
No side effects but 
can be used for 
coughing as well. 
Effectivity known by 
clinical sign of 
animal free from 
worms / coughing 
believe that is cure. 
Koso 
Hagenia 




Crush mix with water leave 
one night in morning add 
water when ready drench put 
in bottle and drench. 
One litre in donkeys. Drench Only once see if 
improves if no 
improvement then 
repeat after 15 days. 
Use whenever 
worms, bloating also 
as purgative and 
given at beginning of 
Worms in donkeys 
maybe stronger than 
in cattle worms look 
bigger and when 
coming out of faeces. 
Better appetite, body 
condition. Can cause 
severe diarrhoea if 
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rainy season when 
grassy. 









Dig it up in gorge, bring root. 
Cannot estimate amount used, 
collect root chop and crush 
mix with water and drench 
juicy part (drench root). 
Take whole part of root and 
use one root per animal but 
depends on size of root very 
much an estimate. 
Drench Will repeat every 
two-three until the 
animal gets relief, is 
cured and can walk 
and eat. 
No side effects, if 
used early can treat 
dourine, as long as 
animal recumbent 
then will not cure. 
Abdul Salim Root Brought root and washed in 
water chopped single root into 
three. Use own interpretation, 
spiritual interpretation (with 
name of god) blessed - then 
ask God to help make 
effective. Crush it together, 
then mix with water and sieve. 
It can be used for all animals, 
beer bottle coca cola bottle 
drench through nostril for 
equines. Not for other 
animals. Bless before giving.  
One coke bottle, one finger of 
root for one animal. 
Drench through 
nostril 
Given every morning 
for three consecutive 
days horses / donkeys 
half cup of coffee 
Will get worms out, 
in case coughing lots 
discharging for 9 
days then no more 
case. Might elicit 
gastritis burns G.I.T. 
Ulceration of mucous 
membranes if beyond 
proper dose. Slough 




Table 3.3.5. Final short list for plant extractions and in vitro testing – Ethiopia 
Plant Species Vernacular 
Name  
Ranking in PRA Part of plant used Evidence in literature Reference 
Vernonia 
amygdalania Delile 
Grawa 1 (3.3.2) 
 
Leaves Ascaridia galli, Haemonchus 
contortus, Toxocara canis, 
Ancyclostoma caninum and mixed 
GI nematodes in vitro and  in vivo  
(Adedapo et al., 2007) 
(Alawa et al., 2003) 
(Hördegen et al., 2006) 
(Iqbal et al., 2006b) 
(Siamba et al., 2007) 
(Yeap et al., 2010) 
Rumex abyssinicus 
Jacq 
Gubdu Key informant 
(3.3.3b) 
Root Pheretima posthuma and 
Haemonchus contortus, in vitro 








Wahale 5 (3.3.2) Root Anecdotal and Pheretima posthuma, 
in vitro 
(Jabbar et al., 2006) 
(Kirtiman, 2012) 
(Purwal et al., 2010) 
Acacia nilotica (L.) 
Delile 
Cheba NA Fruit Trichostrongylus spp. and mixed GI 
nematodes in vivo 








Table 3.3.6. Preliminary short list for plant extractions and in vitro testing – UK 
Plant species Part of plant used Anthelmintic activity in vivo Host species Reference 
Carica papaya L. 
 





Mice, sheep, pigs (Stepek et al., 2007c) 
(Stepek et al., 2006) 
(Buttle et al., 2011) 
(Levecke et al., 2014) 
Allium Sativum L. Rhizome Aspiculuris tetraptera Mouse (Ayaz et al., 2008) 
Cocos nucifera L. Tree bark Gastrointestinal nematodes  Mouse (Costa et al., 2010) 
Zingiber officinale Roscoe. Rhizome Gastrointestinal nematodes  Sheep (Iqbal et al., 2006a) 
Fumaria parviflora Lam. Whole plant Trichostrongylus colubiriformis, 
Haemonchus contortus 
Lambs (Hordegen et al., 2003) 
Chenopodium album L. Aerial parts Trichostrongylids Sheep (Jabbar et al., 2007) 
Artemisia absinthium L. Aerial parts Gastrointestinal nematodes Sheep (Tariq et al., 2009) 
Cichorium intybus L. Aerial parts Haemonchus contortus, 
Gastrointestinal nematodes 
Sheep (Heckendorn et al., 2007) 
(Athanasiadou et al., 2007) 
Lespedeza cuneate G. Don Aerial parts Haemonchus contortus 
Gastrointestinal nematodes 
Sheep, goats (Lange et al., 2006) 






This study used evidence from a PRA and literature review to shortlist plants from Ethiopia 
and the UK for in vitro screening for anthelmintic activity. 
 
3.4.1. Plant selection in Ethiopia 
For Ethiopia, the four plants included in the final shortlist that were identified from the PRA 
were Vernonia amygdalania Delile, Rumex abyssinicus Jacq, Cucumis prophetarum L. and 
Withania somnifera (L.) Dunal. Acacia nilotica was not identified in the PRA but was present 
in abundance in the regions of interest and there are reports of good efficacy in vivo in the 
literature (Bachaya et al., 2009). The plant which was ranked highest for donkeys in the PRA, 
according to frequency with which it was mentioned in the interviews, and on opinions 
regarding its efficacy, was V. amygdalina; a perennial shrub that is abundant in tropical Africa 
including the study region in Ethiopia. It has been used for centuries by humans for the 
treatment of multiple ailments, and recent research has indicated that it may have a number of 
health benefits such as antimalarial, antimicrobial, antifungal, antitumor, anti-diabetic and 
anthelmintic effects (Ijeh and Ejike, 2011). One of the first indications of its medicinal potential 
was when ill chimpanzees were observed ingesting the leaves, which are very bitter and 
therefore not normally a preferred food (Huffman and Seifu, 1989). There have also been 
several studies demonstrating its potential as an anthelmintic for veterinary parasites (Adedapo 
et al., 2007; Alawa et al., 2010; Iqbal et al., 2006b). In the PRA there was mention of its 
potential toxicity in focus group discussions, with people describing severe diarrhoea and in 
worst cases death (Appendix 3.5.2 a). The method of preparation of V. amygdalina often 
included mixing with table salt, in order to improve palatability; it was noted by some 
participants that side effects were usually associated with excessive co-administration of salt. 
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In support of this there are no reports of significant adverse side effects in the literature (Amole 
et al., 2006), however toxicity studies and careful consideration of dosing would be necessary 
in any future in vivo trials.  
 
Cucumis prophetarum and W. somnifera were ranked three and five respectively in the PRA 
for use in donkeys and there was some evidence for anthelmintic activity in the literature. 
Withania somnifera has been mentioned in previous surveys of ethnoveterinary medicines 
(Jabbar et al., 2006) as has C. prophetarum (Gachathi, 1989; Njoroge and Bussmann, 2006). 
In addition an in vitro study showed a significant effect of the aqueous extract of W. somnifera 
against the free living annelid Pheretima posthuma, although it should be noted that free living 
species are not necessarily good models for parasitic helminths (Kirtiman, 2012). Rumex 
abyssinicus was not ranked in group discussions in the PRA but was referred to by key 
informants in relation to treating parasitic diseases of livestock. It was included in the shortlist 
as it was available in large quantities in the study region, and there are studies reporting good 
anthelmintic activity in vitro against GI nematodes such a H. contortus (Eguale et al., 2011; 
Raju and Yesuf, 2010). 
 
Some plant species were ranked highly in the PRA but were not shortlisted for extractions, 
namely Hagenia abyssinica J. F. G mel. (koso) and Embelia schimperi Vatke (enkoko). These 
were rejected because evidence for efficacy in the literature is restricted to anti-taenicidal 
activity in humans (Bogh et al., 1996; Desta, 1995; Githiori et al., 2004), and there were reports 
of significant toxicity in the PRA and in the literature (Arragie, 1983; Low et al., 1985). In 
addition, Melia azedarach L. (Milia), which was identified by one participant in focus groups 
for use in livestock, had supportive evidence for in vitro efficacy in the literature (Kamaraj et 
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al., 2010), but there were also reports of toxicity and hence this species was discounted 
(Cooper, 2007; Mendez et al., 2002a; Mendez et al., 2002b).  
 
3.4.2. Plant selection in the UK 
In the UK, the most important selection criteria was evidence of in vivo efficacy against GI 
nematodes in the literature and reports of a lack of significant toxicity. Once these criteria had 
been satisfied, the limiting factor for inclusion was the availability of the plant material in large 
enough quantities for extraction. The final species chosen to take forward were C. papaya, A. 
sativum, A. absinthium, C. album and Z. officinale. Carica papaya (papaya) is one of the 
earliest known medicinal anthelmintic plants. It has been shown to be effective in vitro and in 
vivo for a number of species of GI nematode(Behnke et al., 2008; Buttle et al., 2011; Levecke 
et al., 2014; Satrija et al., 1994). This anthelmintic activity is attributable to enzymes called 
cysteine proteinases (CPs), which occur naturally in the latex of fruits such as papaya, 
pineapple and figs (Stepek et al., 2004). Due to its previous reported effects against nematodes, 
and low toxicity in multiple host species, C. papaya was considered to be a good candidate for 
in vitro testing. As the active compound is an enzyme, the extract of this plant has to be 
prepared and handled in a specific way to preserve efficacy, hence it was sourced and tested 
separately to other shortlisted species (see Chapter 5). 
 
Allium sativum (garlic) has been used as an anthelmintic for centuries and has been shown to 
have antibacterial, antiprotozoal and antifungal activity (Harris et al., 2001). There have been 
a number of in vitro and in vivo studies supporting its potential use of as an anthelmintic (Ayaz 
et al., 2008; Iqbal et al., 2001; Mantawy et al., 2011). One study has reported that chronic high 
level A. sativum consumption can lead to anaemia in horses (Pearson et al., 2005), but 
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considering its current use as an equine feed supplement (Williams and Lamprecht, 2008) and 
wide scale availability, it was selected for in vitro testing here. Artemisia absinthium, 
commonly called wormwood, is used in indigenous medicine as an anthelmintic, insecticide, 
antipyretic, anti-inflammatory, antispasmodic and antiseptic (Koul, 1997) and there is evidence 
of in vivo activity against GI nematodes in sheep (Tariq et al., 2009), as this plant was available 
at the time of the study, it was also chosen for in vitro testing. Chenopodium album is a highly 
abundant, common native UK plant which has been shown to have good efficacy in vivo against 
GI nematodes in sheep, with no significant toxicity (Akhtar et al., 1999; Jabbar et al., 2007). 
The final plant shortlisted for in vitro testing was Z. officinale, which has been used as a 
traditional Chinese medicine for centuries. There have been studies reporting in vivo efficacy 
against GI nematodes in sheep (Iqbal et al 2001; 2006), it was reported as ‘safe’ at the doses 
that have been tested and is currently marketed by livestock feed companies as an equine feed 
supplement (Williams and Lamprecht, 2008), which would facilitate any future in vivo trials. 
 
Species that were on the preliminary shortlist but were not taken forward for in vitro testing 
included Cocos nucifera L., Fumivaria parviflora Lam., Cichorium intybus L. and Lespedeza 
cuneate G. Don. Cocos nucifera bark extract has been shown to be effective in vitro against H. 
contortus, but it was not found to be effective in vivo against sheep, with mixed infections with 
GI nematodes (Oliveira et al., 2009). Using a higher dose the butanol extract of the bark has 
subsequently shown good efficacy against GI nematodes in mice (Costa et al., 2010), however 
it was not shortlisted here due to concerns regarding sourcing sufficient bark for extraction. 
Fumivaria parviflora is used as an anthelmintic in ruminants in Pakistan and Saudi Arabia 
(Akhtar et al., 2000; Alyemeni et al., 2010; Jabbar et al., 2006). It also grows in the UK mainly 
in arable areas in chalky soils in the south east of the UK, although its abundance has decreased 
recently due to agricultural intensification. It has shown good in vitro and in vivo activity 
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(Hördegen et al., 2006; Hordegen et al., 2003), however at the time of the study it was not 
available in large quantities. The final two plants of interest, C. intybus and L. cuneate, are 
known as bioactive forages, as they have nutritional and medicinal values and can be fed as 
part of a balanced diet. The mode of action of L. cuneate due to high levels of condensed 
tannins and flavinol glycosides (Bahuaud et al., 2006; Barrau et al., 2005), whereas 
sesquiterpine lactones are thought to be the active compounds in C. intybus (Foster et al., 2006). 
When small ruminants are grazed on pastures rich in these forages a significant reduction in 
faecal egg count has been observed (Athanasiadou et al., 2007; Heckendorn et al., 2007; Lange 
et al., 2006). These forages have a relatively high nutritional value compared to poor quality 
hay, which may prohibit their use in UK donkeys, as obesity and its consequences are one of 
the primary causes of morbidity in this population (Burden, 2012). Hence, they were not 
selected for further testing here. 
 
3.4.3. Methodology for selecting plants in Ethiopia and the UK  
There were some drawbacks to both methods of plant selection used in this study. For Ethiopia 
the choice of plants was based on the findings of the PRA in combination with supportive 
evidence from literature. This method has been reported in the literature as a useful way of 
identifying plants with potential anthelmintic activity (Hussain et al., 2008; Lans et al., 2000; 
Nabukenya et al., 2014a; Tolossa et al., 2013). Here a total of 13 plant treatments were not 
identified to species level. In some cases this was due to the plant not being available nearby, 
and for other plants the content of the plant preparation described was not provided by 
participants; for example the ‘mixed root and leaf’ and ‘mixed root’ preparations mentioned in 
the focus groups. Some roots, for example Abdul Salim and Bure, were commonly found in 
markets and used medicinally, but there was no information regarding plant appearance, or 
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location. There was also a possibility, especially with key informants, who were often locally 
revered traditional healers, that information regarding the plants which they used for their 
medicines was being withheld. By triangulating the data collection process, it was hoped that 
knowledge gaps regarding the processing of specific plants would be eliminated as much as 
possible. Raising the possibility that information may have been deliberately retained also 
highlights the potential intellectual property issues that might arise should any new therapeutic 
be discovered based on local knowledge (Abramova and Greer, 2013). This is an issue that 
applies particularly to medicines that are not common knowledge, i.e. the remedies known only 
to key informants. In an attempt to address this, there was published evidence for all plants 
taken forward for in vitro testing. Nevertheless, should the plants identified here be taken 
forward for in vivo trials intellectual property issues may arise and these may need careful 
consideration. 
 
In the literature review to identify plants for the UK, there were also potential issues which 
may have led to plant candidates being missed. Firstly, only one database was used for the 
initial search. In addition, when plant species were identified in the PubMed literature search, 
they were then entered into a google scholar search to find further references pertaining to their 
efficacy. In doing this it was possible to find additional publications of variable quality, often 
from non-peer reviewed journals that cannot be found on general databases. This may mean 
that there are reports demonstrating the anthelmintic efficacy of plant species that were not 
identified by this study. However it is likely that important species, for which the evidence is 




The major constraint in choosing plants with good reported activity in both Ethiopia and the 
UK, was their availability in large enough quantities for extraction at the time of the study. In 
particular the geographical location and abundance were important factors, but there were also 
restrictions due to the season of collection, as some plants and their parts were seasonal. 
Examples of plants which were not selected due to lack of availability include Verbascum 
sinaiticum Benth. and Trigonella foenum-graecum L. in Ethiopia, and C. nucifera and F. 
parviflora in the UK.  Future work might therefore include repeating the study at different 
times of year to increase the spectrum of plants tested. Presumably in the UK, should a plant 
be found to be effective, it could be grown for purpose and distributed, whereas in developing 
countries, it would be sensible to recommend a plant treatment which is widely available at the 
times of year when treatment is recommended.  
 
3.4.4. Considerations for future in vivo studies 
The long term goal here, was to take promising candidates forward to in vivo studies. The PRA 
recorded information about potential side effects and methods of preparation and 
administration of plant treatments. It was hoped that this information could be used to design 
future in vivo studies based on currently used methods, eliminating some of the ethical 
considerations posed by this type of study (Githiori et al., 2003a). However, for a number of 
different treatments severe side effects were recorded, these ranged from diarrhoea, to 
neurological signs and even death (Table 3.3.4.a and b). It is probable that the perceived 
efficacy of a plant treatment is based on it having a purgative effect, which results in the passing 
of parasites in the faeces. Indeed some of the key informants described diarrhoea as part of the 
curative effect rather than a negative side effect. Potential toxicity of the plants makes 
calculation of the correct doses critical, however it was noted that preparation and dosing of 
the same plant species varied between groups and individuals. It would therefore be difficult 
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to choose a ‘currently used’ formula of the correct dose. Another important ethical concern was 
the method of administration (usually oral or nasal drenching) which can pose a serious risk of 
aspiration pneumonia in equids (Scarratt et al., 1998). All of these issues suggest that strict 
quality control procedures, alongside dosing and administration protocols, would need to be in 
place to prevent adverse side effects. As a consequence their distribution would best be carried 
out by government clinics, thus reducing availability for the most remote and impoverished 
people. 
 
The PRA here revealed that plant treatments were not administered to equids with such 
frequency as they are to other livestock, see Table 3.3.1. As this is the first study to focus a 
PRA of anthelmintic practices specifically on equids, it is not known if this is also the case in 
other developing countries. The reason behind this discrimination may be due to the fact that 
equids are not used as production animals, and therefore their body condition is not of such 
importance from an economic point of view. In addition disease caused by intestinal parasitism 
in donkeys may not be as obvious to owners as with other livestock species. Interestingly body 
condition scores of donkeys have been shown to be highest in the rainy season when grass has 
a higher nutrient value, despite a concurrent rise in faecal egg count (FEC) at this time due to 
the abundance of food (Getachew et al., 2008; Yoseph et al., 2005). This suggests that if a 
donkey has enough food then parasites do not tend to cause a poor body condition. However 
other clinical syndromes associated with high parasite burdens which are known to occur in 
developing countries, such as colic and sudden death, may not be directly associated with 
parasitism by owners (Borji et al., 2014).  In some small ruminant systems in developing 
countries, proxies for parasite infections based on clinical examination, have been defined to 
provide an indication for treatment (Nabukenya et al., 2014b; Vilela et al., 2012). This is 
especially useful where there are no facilities to perform FECs. Future work in working equids 
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to improve awareness surrounding parasitic disease might include developing similar proxies 
for GI parasitism in equids.  
 
3.5. Conclusion 
This study has used evidence based techniques to identify plants from Ethiopia and the UK 
with potential anthelmintic activity. These plant candidates were taken forward for in vitro 
testing in the next stage of the project. In addition the PRA revealed potential issues 













































Scientific evidence supporting the anti-parasitic properties of plants comes mostly from in vitro 
studies (Athanasiadou and Kyriazakis, 2004), the advantage being that large numbers of plant 
extracts can be tested at relatively low cost. In equids the egg hatch test (EHT) and larval 
migration inhibition test (LMIT) have shown the best correlation with in vivo anthelmintic 
efficacy, see Section 1.2.1.1. When this study was initiated there were no reports of the use of 
bioactive plants for treating cyathostomin infections, although subsequently Payne et al, (2013) 
demonstrated moderate to good in vitro efficacy for 17 crude plant extracts with the activity 
for 12 of them attributed to tannins. Here, the EHT and LMIT, were used to evaluate plant 
candidates sourced from the UK and Ethiopia in Chapter 3, against cyathostomin eggs and third 
stage larvae (L3).   Tannin inhibition was performed on the most efficacious plant extracts and 
tests repeated to ascertain whether tannins were the active component. 
 
4.2. Materials and Methods 
4.2.1. Identification of plants for use in in vitro tests 
Plants with potential anthelmintic activity for in vitro testing were identified from Ethiopia and 
the UK as described in Chapter 3. For Ethiopia the shortlist was: Vernonia amygdalania Delile 
(leaves), Rumex abyssinicus Jacq (root), Cucumis prophetarum L. (fruit), Withania somnifera 
(L.) Dunal. (root) Acacia nilotica (L.) Delile (fruit). For the UK the shortlist was: Allium 
sativum L. (garlic) (rhizome), Artemisia absinthium L. (aerial parts), Chenopodium album L. 
(aerial parts) and Zingiber officinale Roscoe. (ginger) (rhizome). 
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4.2.2. Preparation of crude extracts of plants for testing effects on cyathostomins  
Ethiopia: Collection of fresh plant material was carried out in November 2011 in the Oromia 
region of Ethiopia, within a radius of 90 km of Addis Ababa. Approximately 4 kg, per plant 
species, of plant material were dried for five days at 50 ºC and then milled to particles of less 
than 1 mm. The identity of the plants was confirmed by the Ethiopian National Herbarium, 
Addis Ababa. Dried milled plant material was weighed and dissolved in 70 % methanol 
(Sigma, UK) in a 1:10 ratio of grams to millilitres. The mixture was macerated using a bench 
top shaker (Grant, UK) at 300 rpm for 24 h at room temperature, then vacuum filtered to 
remove solid plant material; the solvent was removed by rotary evaporation leaving solid crude 
extract (Buchi, UK). These extracts were stored at room temperature in amber vials before 
transportation to the University of Liverpool, UK. UK: Plant material was collected between 
November 2011 and August 2012 from the University of Liverpool Botanical Garden, Ness, 
UK. The plant material was dried by lyophilisation to reduce the potential for degradation of 
active components (Mechatech, UK). The extractions were carried out following the method 
described for Ethiopian plants, above. Solid crude extracts were kept at 4 ºC for no longer than 
four months before testing and were dissolved as required in dimethyl sulfoxide (DMSO) 
(Sigma-Aldrich, UK) and dH2O (Sigma-Aldrich, UK) at 200 mg/ml to give stock solutions for 
use in in vitro tests. These were stored at 4 ºC whilst in use, and stock solutions were kept for 
no longer than one week. Working solutions of crude plant extracts were made by serial dilution 
of the stock in either dH2O or DMSO: two solvents were used as some extracts showed poor 
solubility in an aqueous solvent. Within each test, these were added to dH2O in a 5:100 ratio to 






4.2.3. Parasite sample collection 
Faecal samples were collected from donkeys at the Donkey Sanctuary UK, and strongyle eggs 
and third stage larvae (L3) were collected, stored and extracted/cultured as described in Section 
2.2.1 and 2.2.2., respectively. Once extracted, eggs were used immediately in tests. Once 
cultured L3, were kept at 4 ºC and used within eight weeks. 
 
4.2.4. Larval migration inhibition test 
The LMIT was initially performed on L3 samples from two donkeys for each extract. If an 
efficacy of greater than 20 % reduction in larval migration was seen, the test was repeated on 
L3 samples from a further two donkeys. The protocol for testing plant extracts in the LMIT 
was adapted from the LMIT with IVM as described in general Section 2.4.1. At the incubation 
stage of the test, a total of 10 μl of each working concentration (Section 4.2.2.) of plant extract 
in dH2O (Sigma-Aldrich, UK) or DMSO (Sigma-Aldrich, UK) was added to 190 µl of the L3 
sub-samples. Negative controls of DMSO (5 %) and dH2O and a positive control of 150 µg/ml 
(IVM) (Sigma-Aldrich, UK) were included, to demonstrate that the test was accurately 
differentiating motile from immotile L3. The L3 were incubated at 26 ºC for 24 h. During the 
migration stage, 100 µl of working concentration of plant extract in dH2O and DMSO were 
added to dH2O to make 1,910 μl of plant extract solution at the final concentrations described 
in Section 4.2.2. This volume was added in duplicate to the migration wells and 90 µl of the 
L3/extract suspension from each eppendorf added in duplicate to the migration chambers of 







4.2.5. Egg hatch test 
As with the LMIT, the EHT was initially performed on egg samples from two donkeys for each 
extract. If an efficacy of greater than 20 % reduction in egg hatch was seen, the test was 
repeated on egg samples from a further two donkeys. The test was adapted from the EHT with 
TBZ as described in Section 2.3.1. Instead of TBZ, 100 µl of each working concentration of 
plant extract in dH2O and DMSO were added to dH2O, to make up 1900 µl of plant extract 
solution at the final concentrations described in Section 4.2.2. This was added in duplicate to a 
24-well plate (Nunc, UK), and 100 µl of egg suspension added. Duplicate negative controls for 
dH2O and DMSO (5 %) and positive controls of thiabendazole (TBZ) at 1.5 µg/ml (Sigma-
Aldrich, UK) were included. The test was completed as described Section 2.3.1.  
 
4.2.6. Inhibition of tannins with polyvinylpolypyrrolidine 
Preliminary tannin inhibition tests were performed on four extracts from the UK and Ethiopia 
which had shown good efficacy in the EHT; A. nilotica, C. prophetarum, A. sativum and C. 
album. These tests were performed two years after initial testing (extracts had been stored at -
20 ºC for this period and were thawed before use). The working concentrations of extract in 
dH2O were prepared from the extract as described in Section 4.2.2. They were mixed with 
polyvinylpolypyrrolidine (PVPP) (Sigma-Aldrich, UK) at a concentration of 50 mg/ml and 
incubated overnight at room temperature. The extracts were then centrifuged at 200 g for 5 min 
and the supernatant used for inclusion in tests. The EHT was continued according to the method 
in Section 4.2.5, with untreated extract as a control.  
 
4.2.6. Statistical analysis 
A minimum threshold of 70 % egg hatch or larval migration in control wells was used to 
determine inclusion of data in subsequent analyses. If this was not achieved, tests were 
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repeated. Logarithmic dose response curves were plotted for each test using Microsoft Office 
Excel, 2010. The mean maximum reduction in percentage larval migration or egg hatch, 
compared to the negative controls (MPR), was calculated for each plant extract. Repeated 
measures analysis of variance (ANOVA) with the Greenhouse-Geisser correction for sphericity 
was carried out on data for each plant extract to detect statistically significant differences 
between controls and treated parasites. PROBIT regression analysis, with correction for natural 
mortality, was performed on data to give a median effective concentration (EC-50 value) for 
each plant extract. Where maximum efficacy was low, data did not accurately fit a PROBIT 
model and therefore an EC-50 value was not presented. All statistical data analysis was 




4.3.1. In vitro evaluation of candidate plants 
The results of in vitro testing are divided by country, test and solvent. The maximum percentage 
reduction (MPR) in egg hatch/larval migration seen at the highest concentration of extract for 
Ethiopian and UK plant extract is shown in Figure 4.3.1.a-d. These readings were taken 
between 2.5-10 mg/ml of extract, as readings were not always possible at the highest 
concentrations due to poor solubility of some extracts. Table 4.3.1. details the MPR in egg 
hatch/larval migration, the results of repeated measures ANOVA and EC-50 values calculated 
using PROBIT analysis for each extract. Figure 4.3.2. shows dose response curves for extracts 
with a maximum efficacy greater than 60 %. In all tests, there was 100 % reduction in larval 





4.3.1.1. Ethiopian plant extracts 
For the LMIT there was a statistically significant difference in migration between negative 
controls and L3 exposed to plant extract with R. abyssinicus in dH2O and DMSO 
(p=<0.001:0.010), but in no other extracts (Table 4.3.1.a).  The maximum percentage reduction 
in migration in these tests was 50.2 (±14.2) and 56.0 (±12.3) %, respectively (Figure 4.3.1.b).  
The EC-50 values could not be calculated, as the data did not accurately fit a PROBIT model. 
For the EHT there was a statistically significant difference in egg hatch between negative 
controls and eggs exposed to plant extract with A. nilotica in dH2O and DMSO 
(p=<0.001:<0.001), C. prophetarum in dH2O and DMSO (p=<0.001:0.036) and R. abyssinicus 
in dH2O and DMSO (p=0.016: <0.001) (Table 4.3.1.a). The maximum percentage reduction in 
egg hatch in these tests was; 96.4 (±1.7), 77.7 (±14.1), 93.4 (±8.6), 49.1 (±7), 29.0 (±5.9) and 
74.8 (±6.1), % respectively (Figure 4.3.1.a). The EC-50 values were 0.18 (CI 0.06-0.3) and 0.2 
(CI 0-2.6) mg/ml for A. nilotica in dH2O and DMSO, 1.1 (CI 0.9-1.4) mg/ml for C. 
prophetarum in dH2O and 1.1 (CI 0.2-2.2) mg/ml for R. abyssinicus in DMSO (Table 4.3.1.a). 
It was not possible to calculate an accurate EC-50 value for C. prophetarum or R. abyssinicus 
in DMSO as the maximum percentage efficacy was below 60% and thus the data did not fit a 
PROBIT model.  
 
4.3.1.2. UK plant extracts 
For the LMIT there was a statistically significant difference in migration between negative 
controls and L3 exposed to plant extract with A. sativum in dH2O and DMSO 
(p=0.029:<0.001), A. absinthium in dH2O (p=<0.001), C. album in dH2O (p=<0.001) and Z. 
officinale in dH2O and DMSO (p=0.007: <0.001) (Table 4.3.2.b). The maximum percentage 
efficacy in these tests was; 23.0 (±13.3), 53.3 (±7.9), 24.5 (±7.6), 61.7 (±10.3), 30.3 (±10.3) 
and 28.7 (±4.5) % (Figure 4.3.1d). The EC-50 value for C. album was 8.91 (CI 7.06-13.21) 
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mg/ml (Table 4.3.1.b). It was not possible to calculate an accurate EC-50 value for the other 
extracts as efficacy was relatively low and the data did not fit a PROBIT model. For the EHT 
there was a statistically significant difference in percentage egg hatch between negative 
controls and eggs exposed to plant extract with A. sativum in dH2O and DMSO (p=<0.001: 
<0.001), A. absinthium in dH2O (p=0.009), C. album in dH2O (p=<0.001) and Z. officinale in 
dH2O and DMSO (p=<0.001: <0.001) (Table 4.3.1.b). The maximum percentage efficacy in 
these tests was; 100 (±0), 100 (±0), 17.2 (±8.3), 88.7 (±9.1), 86.9 (±10.1) and 95.9 (±6.2) %, 
respectively (Figure 4.3.1.c). The EC-50 values were 1.99 (CI 1.56-2.31), and 1.09 (CI 0.89-
1.29) mg/ml for A. sativum in dH2O and DMSO, 2.29 (CI 1.95-2.97) mg/ml for C. album in 
dH2O and 0.9 (CI 0.55-1.26) and 0.3 (CI 0.22-0.38) mg/ml for Z. officinale in dH2O and DMSO 
(Table 4.3.1.b). It was not possible to calculate an accurate EC-50 value for A. absinthium in 

































Figure 4.3.1. Graphs showing the mean maximum percentage reduction (MPR) in hatch and migration 
compared to the controls in the egg hatch test (EHT) (a,c) and larval migration inhibition test (LMIT) 
(b,d) seen at the highest concentration of extract for Ethiopian (a-b) and UK (c-d) crude plant extracts 
in distilled water (dH2O) (grey) and dimethyl sulfoxide (DMSO) (hatched). Each extract was tested 
either in two separate parasite samples (if there was less than 20% efficacy in the first test) or in four 











Table 4.3.1.a. Results of repeated measures ANOVA (significant P values are highlighted bold), mean 
maximum percentage reduction (MPR) in larval migration or egg hatch and EC-50 value, where 
relevant, for Ethiopian plant extracts in distilled water (dH2O) and dimethyl sulfoxide (DMSO) in the 









Plant extract Assay Solvent Repeated 
measures 




reduction in hatch 








Acacia nilotica (L.) 
Delile. 
EHT dH2O <0.001 96.4 ±1.7 (n=4) 0.18 (0.06-
0.3) 
 EHT DMSO <0.001 77.8 ±14.1 (n=4) 0.2 (0-2.6) 
 LMIT dH2O 0.13 13.2 ±9.6 (n=2) - 
 LMIT DMSO 0.22 9.9 ±11.2 (n=2) - 
Cucumis prophetarum 
L. 
EHT dH2O <0.001  93.4 ±8.6 (n=4) 1.1 (0.9-1.4) 
 EHT DMSO 0.036 49.1 ±7.0 (n=4) - 
 LMIT dH2O 0.515 1.3 ±10.7 (n=2) - 
 LMIT DMSO 0.243 15.8 ±16.9 (n=2) - 
Rumex abyssinicus 
Jacq. 
EHT dH2O 0.016  29.0 ±5.9 (n=4) - 
 EHT DMSO <0.001 74.8 ±6.1 (n=4) 1.1 (0.2-2.2) 
 LMIT dH2O <0.001 50.2 ±14.2 (n=4) - 
 LMIT DMSO 0.010  56.0 ±12.3 (n=4) - 
Vernonia amydalina 
Delile. 
EHT dH2O 0.285 5.0 ±17.9 (n=2) - 
 EHT DMSO 0.696 1.9 ±1.5 (n=2) - 
 LMIT dH2O 0.143 18.7 ±4.3 (n=2) - 
 LMIT DMSO 0.162 -7.3 ±9.5 (n=2) - 
Withania somnifera 
(L.) Dunal. 
EHT dH2O 0.396 3.4 ±1.5 (n=2) - 
 EHT DMSO 0.341 -5.5 ±0.6 (n=2) - 
 LMIT dH2O 0.480 8.8 ±10.2 (n=2) - 
 LMIT DMSO 0.173 6.0 ±3.4 (n=2) - 
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Table 4.3.1.b. Results of repeated measures ANOVA (significant P values are highlighted bold), mean 
maximum percentage reduction (MPR) in larval migration or egg hatch and EC-50 value, where 
relevant, for UK plant extracts in distilled water (dH2O) and dimethyl sulfoxide (DMSO) in the egg 

















reduction in hatch 
or migration from 







Allium sativum L. EHT dH2O <0.001 100 ±0 (n=4) 2.0 (1.6-
2.3) 
 EHT DMSO <0.001 100 ±0  (n=4) 1.1 (0.9-
1.3) 
 LMIT dH2O 0.029 23.0 ±13.3 (n=4) - 
 LMIT DMSO <0.001  53.3 ±7.9 (n=4) - 
Artemisia absinthium 
L. 
EHT dH2O 0.009  17.2 ±8.3 (n=2) - 
 EHT DMSO 0.157 -4.3 ±7.0 (n=2) - 
 LMIT dH2O <0.001 24.5 ±7.6 (n=4) - 
 LMIT DMSO 0.104 16.8 ±8.8 (n=2) - 
Chenopodium album 
L. 
EHT dH2O <0.001 88.7 ±9.1 (n=4) 2.3 (1.9-
2.7) 
 EHT DMSO 0.094 -0.4 ±6.3 (n=2) - 
 LMIT dH2O <0.001 61.7 ±10.3 (n=4) 8.9 (7.1-
13.2) 
 LMIT DMSO 0.053 24 ±9.9 (n=2) - 
Zingiber officinale 
Roscoe. 
EHT dH2O <0.001  86.9 ±10.1 (n=4) 0.9 (0.6-
1.3) 
 EHT DMSO <0.001  95.9 ±6.2 (n=4) 0.3 (0.2-
0.4) 
 LMIT dH2O 0.007  30.3 ±10.3 (n=4) - 







Figure 4.3.2. Dose response curves for plant extracts with a maximum percentage efficacy greater than 
60 % in the egg hatch test (EHT) or larval migration inhibition test (LMIT), in either distilled water 








4.3.1.3. Tannin inhibition with PVVP 
Logarithmic dose response curves for tests with and without pre-incubation with PVPP are 
shown in Figure 4.3.3.a-d. For A. nilotica without PVPP the EC-50 value was 0.12 (CI 0.03-
0.24) mg/ml (similar to original observation, see Table 4.3.1.a.). Controls were found to be 
significantly different from treated parasites using repeated measures ANOVA, p=0.001 and 
the maximum percentage reduction in egg hatch was 100 %. The maximum percentage 
reduction in egg hatch after incubation with PVPP was only 19.56 (±0.07) and the difference 
between controls and treated parasites was no longer significant, p=0.161. This suggests that 
tannins are the main active components in the A. nilotica extract. For A. sativum, the EC-50 
value calculated was 4.70 (CI 3.97-5.31) mg/ml, this is higher than that previously calculated 
for the same extract, see Table 4.3.1.b, suggesting that the extract has lost some activity over 
time. The mean percentage reduction in migration at the maximum concentration was 97.53 
(±0.46) %. The EC-50 increased slightly after incubation with PVPP, to 5.42 (CI 4.14-6.39) 
mg/ml and the MPR reduced slightly to 93.60 (±6.40) %, suggesting that, although they may 
have a small effect, tannins are not the main active compound in A. sativum. For C. 
prophetarum extract, incubation with PVPP had no impact on efficacy with EC-50 values of 
0.815 (CI 0.73-0.91) and 0.892 (0.73-0.92) mg/ml before and after PVPP incubation, 
respectively, and MRPs of 100%. All tests with A. sativum and C. prophetarum showed a 
significant effect of treatment compared to controls in the repeated measures ANOVA, 
p=<0.001. Unfortunately, the efficacy of C. album was not reproducible in the EHT in the 
untreated control extract, presumably due to degradation of the active compound, hence results 










Figure 4.3.3. The results of pre-incubation with polyvinylpolypyrrolidine (PVPP) in the egg hatch 
test (EHT) for Acacia nilotica a), Allium sativum c) and Cucumis prophetarum d). In addition the 













This study has evaluated plants from two different regions for anthelmintic activity against 
cyathostomin eggs and L3. After an evidence-based shortlisting process and systematic in vitro 
testing using two techniques and two solvents, seven out of nine plant extracts selected showed 
anthelmintic activity in vitro.  
 
4.4.1. The effect of Ethiopian plant extracts in the egg hatch test and larval migration inhibition 
test 
Three of these were Ethiopian plant extracts; the most potent of which was A. nilotica.  Acacia 
nilotica is a native African tree, commonly found in Ethiopia (Thulin, 1983). Its fruiting pods 
are distinctive and, in some regions, these are fed to ruminants as a forage supplement (Uguru 
et al., 2014). Here, the extract of the dried pods showed a strong inhibitory effect in the EHT 
in both dH2O and DMSO, with a maximum percentage reduction in egg hatch of 96.4 (±1.7) 
and 77.7 (±14.1) %, respectively, and EC-50 values of 0.18 (CI 0.06-0.3) and 0.2 (CI 0-2.6) 
mg/ml. Acacia nilotica pods are high in tannins, which have been shown to have an 
anthelmintic effect in a number of studies (Hoste et al., 2006; Moreno et al., 2012; Williams et 
al., 2014). Here repeating the EHT after incubation of A. nilotica with PVPP to inhibit tannin 
activity led to a marked reduction in efficacy, suggesting that tannins are at least in part, the 
active component of this extract. A study on sheep gastrointestinal (GI) nematodes has shown 
A. nilotica fruit to have an EC-50 of 0.513 and 0.195 mg/ml in the EHT and larval development 
test (LDT), respectively, which is comparable to the findings here (Bachaya et al., 2009). The 
same study demonstrated that administration of the extract to sheep naturally infected with GI 
nematodes resulted in a mean reduction in faecal egg count (FEC) of 78 % 13 days after 
treatment. Therefore, given the abundance of A. nilotica in Ethiopia, it may be a viable option 
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to use as a bioactive forage in equids when there is no access to synthetic anthelmintics. 
However, tannins fed at high levels have been associated with anti-nutritional effects in 
ruminants (Hoste et al., 2006). As the effect of tannins on equids has not been investigated, in 
vivo trials to evaluate efficacy and safety in these species would be essential before any 
recommendations could be made.  
 
The C. prophetarum crude fruit extract also showed a strong inhibitory effect in the EHT, 
which was greater in dH2O than DMSO, with maximum percentage reduction in hatch of 93.4 
(±8.6) and 49.1 (±7) %, respectively, and an EC-50 value of 1.1 (CI 0.9-1.4) mg/ml in dH2O. 
It is a tropical plant of the family Cuburbitaceae native to Africa and the Arabian Peninsula. It 
has a small yellow/green fruit which is very bitter due to high levels of cucurbitacins, which 
can be toxic at high levels (Afifi et al., 1999). It was clear from the PVPP inhibition study here 
that tannins do not play a role in this extract’s anthelmintic activity. The cucurbitacins are 
known to be the cause of its cytotoxic effect and this has led to investigations for its potential 
use as an anti-tumor agent (Ayyad et al., 2011). It is possible that these compounds are also 
responsible for the effects seen here, and further work would be needed to confirm this. 
Cucumis prophetarum has been identified in previous surveys of medicinal plants in 
developing countries (Gachathi, 1989; Njoroge and Bussmann, 2006), however, this is the first 
study to demonstrate its anthelmintic activity. Plants in the same family, Cucurbitaceae, are 
also used as taenicidals (Li et al., 2012), and a recent study identified a related species Cucumis 
moschata Duch. as having an anthelmintic effect against Haemonchus contortus in vitro 
(Marie-Magdeleine et al., 2009). Cucumis prophetarum was identified from the PRA in the 
Oromia region of Ethiopia (Scantlebury et al., 2013), and is currently used as an anthelmintic 
there, although there were some reports of toxicity at high doses. Thus it would be possible to 
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encourage its use in equids, however further work is necessary to evaluate its efficacy and 
toxicity in vivo. 
 
Rumex abyssinicus root was one of the medicinal plants, identified from interviews with 
traditional healers, as being used in the Oromia region and was the only extract from Ethiopia 
to have a significant effect in both the LMIT and the EHT in dH2O and DMSO. The efficacy 
measured was higher in DMSO, the maximum percentage reduction in migration and hatch 
being found to be 50.2 (±14.2), 56 (±12.3), 29.0 (±5.9) and 74.8 (±6.1) %, respectively, in these 
tests. The EC-50 for the EHT in DMSO was 1.1 (CI 0.2-2.2) mg/ml. Rumex abyssinicus is a 
perennial shrub which commonly grows in the highland regions of Eastern Africa (Hedberg, 
2000). Its roots are edible and are used as a wild vegetable; it usually grows as a weed around 
the edge of plantations (Katende et al., 1999; Ruffo et al., 2002). There is in vitro evidence for 
its medicinal use as an antibiotic and an anti-inflammatory (Getie et al., 2003), and a study 
showing anthelmintic activity in vitro (Eguale et al., 2011), where Rumex abyssinicus had a 
significant inhibitory effect on H. contortus egg hatch and larval development.  Indeed, in the 
EHT, the EC-50 value was comparable to the one measured here for cyathostomins. Further 
analysis needs to be done to reveal the active component of this extract against cyathostomins; 
previous studies have found the roots to be high in crysophanol, physcion and emodin, and so 
these may be of interest in future in vitro tests (Midiwo et al., 2002). Rumex abyssinicus is 
widely available in Ethiopia and considered safe in humans (Giday et al., 2007; Yineger et al., 
2007), given the encouraging results here, further work is indicated to validate its anthelmintic 




The remaining two extracts from Ethiopia, V. amygdalina and W. somnifera, did not show a 
significant anthelmintic effect in the LMIT or EHT. Vernonia amydalina was the most 
commonly reported plant-based anthelmintic used in livestock in one study within the Oromia 
region (Scantlebury et al., 2013). There have been studies demonstrating its anthelmintic effect 
in vitro against H. contortus (Ademola and Eloff, 2011); and in vivo, in dogs and calves, against 
mixed, natural GI helminth infections (Adedapo et al., 2007; Alawa et al., 2010). Possible 
reasons for the differences indicated here, could be that the active compound was denatured in 
the drying and extraction process, or that the extract has an effect on a different lifecycle stage 
to those tested. There may also be another mechanism by which this extract reduces parasite 
egg output in vivo, such as a purgative effect. Indeed, one of its reported side effects is 
diarrhoea, which would support this hypothesis (Scantlebury et al., 2013). Withania somnifera 
also had no effect in either test; this plant was ranked five in the PRA from the region 
(Scantlebury et al., 2013). It is also mentioned in surveys of ethnoveterinary plants in Pakistan 
(Jabbar et al., 2006), and has shown activity in vitro against Pheretima posthuma (earthworm) 
(Kirtiman, 2012), but there have been no studies to date evaluating its anthelmintic activity 
against GI nematodes. 
 
4.4.2. The effect of UK plant extracts in the egg hatch test and larval migration inhibition test 
For the UK-sourced plant extracts, all four showed significant anthelmintic activity in the 
LMIT and/or EHT. Allium sativum (garlic) showed a strong inhibitory effect in both dH2O and 
DMSO in the EHT, with maximum percentage reduction in hatch of 100 (±0) % for both, and 
an EC-50 of 2.0 (CI 1.6-2.3) and 1.1 (CI 0.9-1.3) mg/ml, respectively. There was also a 
moderate effect in the LMIT in DMSO with a maximum percentage reduction in migration of 
53.3 (±7.9) %. A. sativum has been used as a traditional anthelmintic for centuries (Rivlin, 
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2001) and has been shown to have a wide variety of other effects such as antiprotozoal and 
antifungal activity (Harris et al., 2001). There have been a number of studies supporting the 
use of A. sativum as an anthelmintic (Ahmed et al., 2013; Ayaz et al., 2008; Iqbal et al., 2001). 
The most convincing study described an efficacy of 91 % in vivo against adult Aspiculuris 
tetraptera in mice (Ayaz et al., 2008). Here, it was shown that tannins are not the main active 
compound in garlic, as incubation with PVPP had little effect on efficacy. Allicin is a major 
constituent of garlic and has been shown to have a potent antimicrobial effect (Fujisawa et al., 
2009); however, there are many other potential bioactive compounds in garlic so further testing 
would be required to identify which has/have anthelmintic activity. Garlic supplements are 
already widely marketed in the equine feed industry (Williams and Lamprecht, 2008), therefore 
it could be relatively straightforward to test and market this extract. There is evidence, however, 
that chronic garlic consumption at a maximum voluntary intake of 0.25 mg/kg can lead to 
anaemia in horses, due to an oxidative effect on red blood cells (Pearson et al., 2005). 
Therefore, in vivo trials would be necessary to determine the dose at which an anthelmintic 
effect is seen against parasitic stages, and to ensure that anaemia is not induced. 
 
Chenopodium album leaf and stem extract also showed a strong inhibitory effect in the EHT 
and moderate in the LMIT, but only in dH2O. The maximum percentage reduction in hatch and 
migration were 88.7 (±9.1) and 61.7 (±10.3) %, respectively, with EC-50 values of 2.3 (CI 1.9-
2.7) and 8.9 (CI 7.1-13.2) mg/ml. Chenopodium album is a common weedy plant native to 
Europe, and traditionally it has been used as food for humans and animals (Luczaj and 
Szymanski, 2007; Raghuvanshi et al., 2001). Before the widespread introduction of synthetic 
anthelmintics, oil of Chenopodium was listed in the British veterinary codex (1953;1965) as a 
veterinary anthelmintic. This oil was derived from a related species Chenopodium 
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ambrosioides L. Subsequent studies have demonstrated the anthelmintic effect of extracts of 
C. ambrosioides in vitro on H. contortus and Heligmosoides bakeri (Eguale and Giday, 2009; 
Pone et al., 2011); however, its use in vivo has been associated with toxicity attributable to the 
active compound, ascaridole (MacDonald et al., 2004).  In contrast, studies with C. album have 
demonstrated in vivo anthelmintic effects with no apparent toxicity. One study demonstrated a 
mean reduction in FEC of 87 % in sheep naturally infected with mixed GI nematode species 
after a dose of 2 g/kg of aqueous extract of C. album (Akhtar et al., 1999). The fact no side 
effects have been observed and that an aqueous extract is used rather than an oil, may indicate 
that the active compound in aqueous extract of C. album is not ascaridole, but further work is 
needed to confirm this. A later study demonstrated a mean FEC reduction of 82 % in sheep 
given a hydro-alcoholic extract of this plant at 3 g/kg (Jabbar et al., 2007). Hence, there appears 
to be good evidence to support efficacy of C. album in vivo. Given its abundance in the UK 
and the ease with which it can be grown, further investigation into the efficacy of this plant 
extract against nematodes in equids is indicated.  
 
Zingiber officinale (ginger) rhizome was shown to have an anthelmintic effect in the EHT, in 
both dH2O and DMSO, with maximum percentage reductions in hatch of 86.9 (±10.1) and 95.9 
(6.2) % and EC-50 values of 0.9 (CI 0.6-1.3) and 0.3 (CI 0.2-0.4) mg/ml, respectively. There 
was also a mild effect in the LMIT, with a mean reduction in migration of 30.3 (±10.3) and 
28.7 (±4.5) %, respectively. Zingiber officinale has been used as a Chinese traditional medicine 
for over 2500 years (Wang and Wang, 2005). Studies have demonstrated that it possesses 
antimicrobial, anti-oxidant, anti-tumour, anti-emetic and anthelmintic activity and it has been 
shown to be relatively safe toxicologically (Ali et al., 2008). Iqbal et al. (2001) showed 100 % 
efficacy of methanol extracts in vitro against H. contortus. Subsequently, the same group 
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demonstrated a mean reduction in FEC of 66.6 % in sheep naturally infected with mixed GI 
nematode species infections, using 1-3 mg/kg of the crude aqueous extract of dried ginger 
(Iqbal et al., 2006a). The main bioactive constituents of Z. officinale rhizome appear to be 6-
gingerol and 6-shogaol (Connell and McLachlan, 1972), but further work would be needed to 
elucidate which was the active compound here.  Given its wide availability and palatability, it 
could be considered for further trials in equids.  
 
The final UK extract, A. absinthium, had a statistically significant inhibitory effect on hatch in 
the EHT and on migration in the LMIT in dH2O, but maximal efficacy was only 17.2 (±8.3) 
and 24.5 (±7.6) %, respectively. It was noted in the EHT that there was death of L1 shortly 
after hatching, but this effect was not quantifiable within the context of the tests as there was 
no control for larval development. A larval development test (LDT) would be indicated to 
investigate this further. Artemisia spp. are an important group of medicinal plants; Artemisia 
annua L. has given rise to a treatment for malaria based on the compound, artemisinin 
(Klayman, 1985). Many species have been shown to have anthelmintic activity (Ferreira, 
2009), for example, a mean reduction in FEC of 90 % was demonstrated when sheep naturally 
infected with mixed GI nematode species were given a crude ethanolic extract of A. absinthium 
at a dose rate of 2.0 g/kg (Tariq et al., 2009). The reason for the low efficacy seen here, may 
be that it does not act on the stages of parasite tested or it may reduce FEC by another 
mechanism, such as reducing fecundity of adult female worms. It is unlikely that the active 
compounds had been deactivated in the drying and extraction process as the UK-sourced plants 





4.4.3. The use of in vitro tests to evaluate the anthelmintic activity of plant extracts 
The range of EC-50 values calculated for extracts here was 0.18-8.9mg/ml. These are higher 
than the EC-50 values for thiabendazole in the EHT (0.052, 0.043 µg/ml) and ivermectin 
(0.472-8.391 µg/ml) in the LMIT, which have been previously calculated for the populations 
used in this study, see Appendix 1.4. and 1.9. This is expected when working with crude 
extracts as they contain many components, the majority of which have no effect. The actual 
EC-50 value of the active compound is likely to be much lower. Other studies looking at the 
efficacy of crude extracts in bioassays often report EC-50 values in the same range (Ademola 
et al., 2004; Alawa et al., 2003; Assis et al., 2003; Maciel et al., 2006; Marie-Magdeleine et al., 
2010b), and some go on to demonstrate in vivo efficacy (Bachaya et al., 2009). This highlights 
that EC-50 values in relation to crude plant extracts can only be used with confidence to 
compare the relative effects of extracts within similar experiments, rather than drawing 
conclusions about efficacy compared to synthetic drugs. 
 
In addition to identifying plants with in vitro anthelmintic activity, these data have highlighted 
that the results of in vitro testing of extracts can be dependent on the life cycle stage of the 
parasite in the test and the solvents used to deliver the extracts. In the present study, the EHT 
showed a higher sensitivity in detecting anti-parasitic activity, with seven out of nine extracts 
showing activity compared with five for the LMIT, the maximum percentage effects were also 
higher in the EHT. This might indicate that the EHT is a more useful technique for screening 
bioactive plant extracts; however, the results should be interpreted with caution as this effect 
may not translate in vivo. For example, if an extract shows significant activity in the LMIT and 
the EHT, such as R. abyssinicus and C. album, it is probably more likely to be efficacious in 
vivo. In the EHT with A. absinthium and Z. officinale, there was evidence of death of the L1 
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after hatching in exposed samples, but it was not possible to measure this effect within the test. 
This emphasises the need to test every life cycle stage. For two extracts, the delivery solvent 
had a differential effect on efficacy, with C. album performing better in an aqueous solvent and 
R. abyssinicus in DMSO. This suggests that the active compounds in the two extracts dissolve 
better in aqueous and DMSO solvent, respectively. Most studies evaluating crude plant extracts 
in vitro use only an aqueous solvent, though some use DMSO (Alawa et al., 2003; Assis et al., 
2003). The results here highlight that multiple solvents with varied polarity should be used to 
maximise the chance of detecting anthelmintic activity.  
 
4.4.4. Implications of in vitro findings for control of cyathostomins and future work 
Here, plant extracts were tested for their effect in vitro against cyathostomins from donkeys. 
The relative prevalence of different cyathostomins species in samples from the same donkey 
population have previously been shown to be 80 % C. tetracanthum, C. catinatum and C. 
pateratum, with some C. longibursatus and C. nassatus (Cwiklinski et al., unpublished data). 
Studies on horses have shown a different spectrum of species, however there are some species 
in common (Chapman et al., 2003b; Ogbourne, 1976; Reinemeyer et al., 1984). Given the 
similarity in biology of all cyathostomins, it is likely that there will be a similar susceptibility 
to plant extracts in samples from horses. However there have been studies demonstrating 
differential drug susceptibility for different cyathostomin species (Traversa et al., 2009a), and 
tests would need to be repeated on samples from horses to confirm susceptibility. In Ethiopia 
it is also likely that there will be a high prevalence of other GI nematodes such as the large 
strongyles and a different range of cyathostomin species (Getachew et al., 2010), hence testing 
on parasite samples from populations in Ethiopia would be necessary to confirm sensitivity 
before recommending in vivo trials in these regions.  
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When designing experiments to extract plant compounds and testing them in vitro, the future 
practical application of the findings should be taken into account. In a developed region, 
technology exists to produce extracts on an industrial scale and it is useful to refine extraction 
techniques to achieve optimal results. However, if the plant needs to be available for use by 
farmers in a developing region, it is important to use techniques that can be replicated in that 
environment. If the aim is to develop a novel anthelmintic, rather than feeding the whole plant 
as forage, the active compound in the crude extract must be identified. This can be done by 
bioassay-guided fractionation of extracts, followed by high performance liquid 
chromatography and mass spectrometry or nuclear magnetic resonance analysis (Shi et al., 
2009). Another method, if the index of suspicion is high, is to use inhibition assays for plant 
secondary compounds known to harbour anthelmintic activity, such as tannins (Manolaraki et 
al., 2010; Payne et al., 2013). Here, preliminary tests were conducted to evaluate the role of 
tannins in some of the extracts, but further work is needed to elucidate the active compounds. 
In every scenario, regardless of the active compound, toxicology and efficacy trials in vivo are 
essential before the plant or its purified, active compound(s) can be recommended as an 
anthelmintic treatment (Githiori et al., 2003a).  
 
4.5. Conclusion 
This study has identified bioactive plant extracts from the UK and Ethiopia that have potential 
as anthelmintic feed supplements in equids. It has highlighted the need for a high throughput 
systematic approach in the evaluation of such extracts for use as anthelmintics. In light of the 
ever-increasing prevalence of anthelmintic resistance, it is important to continue the search for 








5. IN VITRO EVALUATION OF THE EFFECT OF PAPAYA 
























The threat drug resistance poses to effective parasite control has led to increased efforts in the 
search for novel anthelmintic compounds. In addition to screening large libraries of synthetic 
compounds, there has been increasing interest in natural products, historically used as 
traditional ethnomedical/veterinary treatments. One particularly promising group of 
compounds are the cysteine proteinases (CPs), derived from the fruits of plants such as papaya 
(Carica papaya), pineapple (Ananas comosus) and figs (Ficus spp.). Used for centuries for the 
treatment of human ascarid and hookworm infections (Berger and Asenjo, 1939, 1940; 
Caldwell and Caldwell, 1929; Fernan-Nunez, 1927; Mueller and Mechler, 2005; Robbins, 
1930), in recent years their efficacy against a number of veterinary parasitic nematodes and 
cestodes has been validated both in vitro and in vivo (Buttle et al., 2011; Levecke et al., 2014; 
Mansur et al., 2014a, b; Satrija et al., 1994; Satrija et al., 1995; Stepek et al., 2005; Stepek et 
al., 2006, 2007b, c, d). They appear to be widely effective and hold promise as novel broad 
spectrum anthelmintics, however CPs have not yet been tested for efficacy against 
cyathostomins. The aim of this chapter was to evaluate the efficacy of papaya latex supernatant 
(PLS), a crude preparation from C. papaya containing CPs, against free living stages of 
cyathostomins, using the egg hatch test (EHT) and larval migration inhibition test (LMIT). The 
EHT and LMIT were first optimised for testing PLS (Sections 2.3.2. and 2.4.2). Next 
measurement of exact concentrations of active CPs in the PLS were ascertained using enzyme 
active site titration. The optimised LMIT and EHT tests were repeated with four samples of 
cyathostomins. Finally the role of CPs in the observed anthelmintic activity of PLS, in both the 





5.2. Materials and methods 
5.2.1. Parasite sample collection and storage 
Freshly voided faecal samples were collected from donkeys at the Donkey Sanctuary (DS) UK 
and horses at a yard in North West England. Strongyle eggs and third stage larvae (L3) were 
collected, stored and extracted/cultured as described in Section 2.2.1 and 2.2.2. Once extracted, 
eggs were used immediately. Once cultured L3 samples were stored at 4 ºC and used within 
eight weeks. 
 
5.2.2. Preparation of papaya latex supernatant and measurement of its cysteine proteinase 
concentration 
The preparation of PLS used in this study was kindly donated by Professor Behnke at the 
University of Nottingham. PLS contains several CPs: chymopapain, glycyl endopeptidase, 
caricain and papain in order of relative abundance (Buttle et al., 1990). It was prepared as 
previously described by Buttle et al (2011). The extract was sent on dry ice to the University 
of Liverpool, where it was aliquoted into individual vials and immediately stored at -80 ºC. 
The extract was thawed before use and the molar active CP concentration measured using 
enzyme active site titration adapted from Barrett et al (1981) and Zucker et al (1985). In brief 
PLS was incubated with increasing concentrations of the CP specific inhibitor, L-trans-
epoxysuccinyl-L-leucylamido-(4-guanidino butane) (E64) (Sigma-Aldrich, UK), with 4 mMol 
L-cysteine (Sigma-Aldrich, UK) as a reducing agent and N-α-benzoyl-arginyl-p-nitroanilide 
(BAPNA) (Bachem Ltd, UK) as a substrate (Barrett et al., 1981; Zucker et al., 1985). As CPs 
and E64 bind in a 1:1 molar ratio, the concentration of E64 which completely inhibited CP 
activity was taken to be equal to the concentration of PLS in the assay, thus allowing calculation 
of the concentration in the stock PLS solution. Active enzyme site titration was performed on 
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each aliquot of PLS before use. An example showing the titration of enzyme activity with 
increasing concentrations of E64 can be seen in Figure 5.2.1. A simple linear trend line was 
fitted to data in each assay using Graphpad prism 6.00 (GraphPad Software, La Jolla California 
USA, www.graphpad.com). The regression equation describing the line, which in the example 
in Figure 5.2.1 was y = -1.131x + 0.215, was used to calculate the value of X when Y = 0 (i.e. 
the E64 concentration when the enzyme activity is 0), in this case 0.19 µM.  
 
                               
Figure 5.2.1. Graphical representation of active enzyme site titration to measure papaya latex 
supernatant concentration. Absorbance, representing cysteine proteinase activity, is plotted against 
increasing L trans-epoxysuccinyl-L-leucylamide-(4-guanidine) (E64) concentration. The concentration 
of E64 at which absorbance is 0, represents the concentration of cysteine proteinase (CP) within the 
assay. 
 
For use in in vitro tests the stock PLS solution was made up to 12 mM, serially diluted in 5 
mM (EHT) or 10 mM (LMIT) L-cysteine (Sigma-Aldrich, UK) (See section 2.1) at pH 7 to 
give working concentrations which were added in a 3.3 % ratio to 5 mM/10 mM L-cysteine 
(pH 7) in tests. The final concentrations in the tests were; 0.10, 0.20, 0.39, 0.78, 1.56, 3.13, 
6.25, 12.5 and 25 µM for the EHT and 1.56, 3.13, 6.25, 12.5, 25, 50, 100, 200 and 400 µM in 
the LMIT.  
 

















5.2.3. Evaluation of the effect of papaya latex supernatant on cyathostomins in the egg hatch 
test 
The EHT was repeated in samples from four equids (two horses and two donkeys). This method 
was adapted from the egg hatch test with thiabendazole (TBZ) described in Section 2.3.1. The 
test was optimised for L-cysteine concentration and incubation time (Section 2.3.2). Instead of 
TBZ solutions, working and final solutions of PLS were made as described above in Section 
5.2.2. Approximately 100 eggs were incubated with each PLS concentration in duplicate for 
24 h and the test continued as described in Section 2.3.1. Duplicate negative controls for 5 mM 
L-cysteine and dH2O, and positive controls of TBZ at 1.5 µg/ml (Sigma-Aldrich, UK) were 
included, to ensure the test accurately differentiated between live and dead eggs. In order to 
assess whether the active compound was a CP the test was repeated in one sample with PLS 
concentration constant at EC-99 (0.41 µM), measured as described in Section 5.2.5. For this, 
prior to the addition of egg suspension, the PLS was incubated for 15 min at 40 ºC with E64 at 
increasing concentrations; 0.3, 0.6, 0.9, 1.2, 1.5, 1.8, 2.1, 2.4, 2.7, and 3 µM.  The EHT was 
then performed as described above. A negative control of 5 mM L-cysteine, and 3 µM E64 and 
positive control of PLS at EC-99 were included in the test. 
 
5.2.4. Evaluation of the effect of papaya latex supernatant on cyathostomins in the larval 
migration inhibition test  
The LMIT with PLS was repeated in samples from four equids (two donkeys and two horses). 
The method for evaluation of PLS was adapted from the LMIT with IVM described in Section 
2.4.1. The LMIT was first optimised for L-cysteine concentration and incubation time (Section 
2.4.2.). Instead of IVM solutions, working concentrations of PLS were prepared as described 
above (Section 5.2.2). These were added in a 3.3 % dilution at the incubation and migration 
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steps of the LMIT. The L3 were ex-sheathed and washed as described in Section 2.4.1., but 
immediately prior to the incubation period they were re-suspended in 10 mM L-cysteine in 
dH2O, pH7. The incubation phase of the LMIT was extended to 16 h. The test was then 
completed as described in Section 2.4.1. Duplicate negative controls of 10 mM L-cysteine pH 
7 and dH2O, and a positive control of 150 µg/ml ivermectin (IVM) (Sigma-Aldrich, UK) were 
included, to demonstrate that the test was accurately differentiating between motile and 
immotile L3. To ascertain whether CPs were the active component of PLS in the LMIT the test 
was repeated in one sample with PLS concentration constant at EC-99 (225 µM), measured as 
described in Section 5.2.5. For this, the PLS was incubated for 15 min at 40 ºC with the CP 
inhibitor E64 at increasing concentrations; 50, 100, 150 and 200 µM, prior to its addition in the 
test at both the incubation and migration stage. As these concentrations of E64 did not restore 
L3 migration, the concentrations were subsequently increased to 500, 100, 1500, 2000 µM E64, 
to ensure that all CPs were inhibited.  A negative control of 10 mM L-cysteine and 200/2000 
µM E64 and positive control of PLS at EC-99 were included in these tests. 
 
 
5.2.5. Analysis of dose response data from in vitro tests 
Percentage egg hatch or larval migration at each concentration and in control reactions was 
calculated. The percentage egg hatch or larval migration in negative controls in each test was 
defined as the ‘natural mortality’ and the raw data were corrected for ‘natural mortality’ at each 
concentration and the percentage egg hatch or larval migration calculated.  For each individual 
test repeated measures analysis of variance (ANOVA), in SPSS version 21 (SPSS Inc., Chicago 
IL), was used to compare untreated controls with treated parasites, where p<0.05 it was 
concluded that treatment had a significant effect. The corrected data were used to calculate 
logistic sigmoid dose response curves in Graphpad Prism 6.00 (GraphPad Software, La Jolla 
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California USA, www.graphpad.com). For each test four parameters were defined in a model 
according to the equation: y=bottom+(top-bottom)/(1+10(logED-50-x)*hillslope), where x = log 
concentration, y = percentage hatch/migration, bottom is the y value at the bottom plateau, top 
is the y value at the top plateau, and hillslope describes the gradient of the curve. This enabled 
calculation of the median effective concentration (EC-50) and the 99 % effective concentration 
(EC-99) for comparison of efficacy between tests. Goodness of fit for each model was 
evaluated by the R2 value and the confidence intervals. Where appropriate parameters (top, 
bottom, and/or hill slope) were constrained to allow statistical comparison between repeats 




5.3.1. Papaya latex supernatant in the egg hatch test 
Papaya latex supernatant had a potent effect in the EHT. Repeated measures ANOVA 
demonstrated highly significant differences between untreated controls and PLS treated eggs 
in all repeat samples (p<0.001) and EC-50s were in the range of 0.12-0.20 µM, see Table 5.3.1. 
Logarithmic dose response curves representing the models from which EC-50 values were 
calculated are shown in Figure 5.3.1a. R2 values for the curves were all high and confidence 
intervals for EC-50s were small indicating the models describing the data were accurate, see 
Table 5.3.1. A statistically significant difference between repeats was found using the sum of 
squares F test, p<0.001. It was observed that at concentrations of PLS up to 6.25 µM, the first 
stage larvae (L1) developed inside the eggs but disintegrated suddenly at around 22 h when the 
eggs in control wells were hatching, this gave the appearance of an ‘exploded egg’, see Figure 
5.3.2. At the higher concentrations, between 6.25-25 µM, there was no development of larvae 
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inside the egg, suggesting the PLS was preventing egg development. The EHT was repeated in 
sample 4 keeping PLS concentration constant at EC-99 (0.41 µM), and adding increasing 
concentrations of the CP inhibitor E64 to the PLS for 15 minutes at 40 ºC before inclusion in 
the test. Successful egg hatch was completely restored at 2.1 µM E64, (Figure 5.3.1.c.). This 
suggested that CPs are the active compound inhibiting egg hatch in the PLS extract. All positive 
control wells had 0 % egg hatch and negative controls had 83.8 ± 3.7 % average percentage 
hatch, this was corrected for during analysis.  
 
5.3.2. Papaya latex supernatant in the larval migration inhibition test 
Papaya latex supernatant inhibited larval migration in the LMIT after a 16 h incubation with 
PLS. Repeated measures ANOVA demonstrated highly significant differences between 
untreated controls and PLS treated samples in all repeats, p<0.001 and EC-50s were in the 
range of 67.35-106.31 µM, see Table 5.3.1. Logarithmic dose response curves representing the 
models from which EC-50 values were calculated are shown in Figure 5.3.1.b. R2 values for 
were all high indicating the models describing the data were accurate, see Table 5.3.1. There 
was a statistically significant difference between repeats measured using the sum of squares F 
test, p<0.001. The larvae remained intact at all concentrations, although non-migrated L3 were 
visibly immotile. When the LMIT was repeated in sample 4 with PLS at EC-99 (225.0 µM) 
and incubated with increasing concentrations of E64 there was no effect on inhibition of 
migration, (Figure 5.3.1.d.). The concentration of E64 used in the LMIT was increased to 
ensure CPs were inhibited, however there remained no inhibition of the effect of PLS on larval 
migration. This suggests that CPs were not the active compound leading to immobility and 
death of L3. All positive control wells had 0 % larval migration and negative controls had 90.4 




Table 5.3.1. Summary of the results of statistical analysis on dose response data from the egg hatch test 
(EHT) and larval migration inhibition test (LMIT) with papaya latex supernatant. Specifically detailed 
are: results of repeated measure ANOVA to compare control and treated parasites within individual 
tests, EC-50 values calculated from the logistic sigmoid response curve for each repeat sample in the 
EHT and LMIT, R2 values as indicators of model fit for the dose response curves and sum of squares F 
test results for evaluation of statistical significance between repeat tests. 
 
* in comparison to control group, p value significant if < 0.05 





























1 (H) p<0.001 0.20 (0.20-0.21) 0.99 p<0.001 
 2 (H) p<0.001 0.22 (0.21-0.23) 0.99  
 3 (D) p<0.001 0.12 (0.12-0.13) 1.00  
 4 (D) p<0.001 0.13 (0.12-0.13) 0.99  
LMIT PLS 
repeats 
1 (H) p<0.001 106.31 (93.23-121.52) 0.90 P<0.001 
 2 (H) p<0.001 68.77 (59.19-79.88) 0.91  
 3 (D) p<0.001 67.35 (58.11-78.24) 0.97  













Figure 5.3.1. Graphical representation of the dose response relationship between papaya latex 
supernatant (PLS) and: a) percentage egg hatch in the egg hatch test (EHT); and b) percentage larval 
migration in the larval migration inhibition test (LMIT) in repeats 1-4. The effect of incubation with 
increasing concentrations of L trans-epoxysuccinyl-L-leucylamide-(4-guanidine) (E64) on the activity 
PLS at concentration EC-99 (0.41 µM in EHT and 225 µM in LMIT) is shown in graph (c) for the EHT 










Figure 5.3.2. Digital photographic images demonstrating the effect of papaya latex supernatant (PLS) 
on cyathostomin eggs and first stage larvae (L1) around the time of hatching. After incubation for 18 h 
the L1 has developed inside the egg and is motile, at 21 h the L1 starts to lose definition and becomes 
immotile and at 24 h the decomposed material from the dead L1 emerges from the egg shell. 
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These data demonstrate that CPs have a potent effect on cyathostomin eggs and L1 stages, and 
that PLS has a moderate effect on L3 in the LMIT. This is the first report of susceptibility of 
the free living stages of helminth parasites to CPs or PLS, and suggests that cyathostomins are 
highly sensitive to the effects of these enzymes. Adult stages were not tested here, due to the 
challenge of obtaining large numbers of adult cyathostomins, and maintaining their viability in 
vitro.  
 
5.4.1. The effect of papaya latex supernatant in the egg hatch test and larval migration 
inhibition test against cyathostomins 
In the EHT the EC-50 values calculated were in the range of 0.12-0.20 µM, which are low in 
comparison to a previous study by Stepek et al. (2006), who demonstrated an EC-50 of 5 µM 
against the adult stages of the rodent nematode Trichuris muris. In addition, previous studies 
looking at the effect of CPs over time against adult nematodes, consistently use 25 µM CP to 
demonstrate good effects (Stepek et al., 2007d). The low values seen here, suggest that 
cyathostomin eggs and L1 are highly sensitive to CPs in comparison to adult parasitic 
nematodes. The PLS preparation also had a significant effect on the migratory ability of 
cyathostomin L3, however it was not possible to attribute this to the activity of CPs, as their 
inactivation with E64 prior to use in the test, did not affect activity. The range of EC-50 values 
seen here, 67.35-106.31 µM after incubation for 16 h, was relatively high in comparison to 
concentrations used in previous studies on adult worms, suggesting that here, either different 
mechanism of action, or a lower sensitivity to CPs is present (Stepek et al., 2007b, d). In adult 
nematodes of other species it has been shown that CPs target the worm cuticle, which blisters, 
and then is weakened sufficiently to enable the internal hydrostatic pressure to rupture the body 
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wall resulting in the disintegration of the worm and death (Behnke et al., 2008; Phiri et al., 
2014; Stepek et al., 2007c, d).  Here, the L3 remained visibly intact at 400 times magnification 
after 16 h at 400 µM PLS, suggesting that the cuticle was not significantly damaged. Future 
work in cyathostomins might include the use of electron microscopy to examine the cuticle at 
higher resolution and look for signs of microscopic damage. In summary, the results here 
indicate that there is another active compound in PLS which affects L3 motility. 
 
This is the first study to date to demonstrate the effect of CPs or PLS on the free living stages 
of a parasitic GI nematode. Previous studies have stated that no effect was seen on egg 
development, L1, L2 or L3 stages, except in the case of T. muris, for which egg hatch and larval 
development take place within the host (Stepek et al., 2006, 2007b, d). Hence, it is possible 
that the free living stages of cyathostomins differ to other parasitic nematodes in their structural 
biology making them more susceptible to CPs.  The hypothesis behind tolerance of CPs in free 
living stages is that the cuticle differs in composition, or secretes inhibitors to CPs (Behnke et 
al., 2008).  This theory is supported by the fact that some soil dwelling bacteria secrete CPs 
into the environment, which could have driven the evolution of protective mechanisms in free 
living stages (Oh et al., 1999). In addition it has been shown that the CP inhibitors, cystatins, 
are responsible for the resistance of Caenorhabditis elegans to the effects of CPs in vitro (Phiri 
et al., 2014). The possibility that cyathostomins may differ in their structural biology from other 
GI nematodes warrants further investigation, as it may be possible to exploit this apparent 






5.4.2. Supportive evidence for the use of cysteine proteinases against cyathostomins in vivo 
In this study we have demonstrated the efficacy of CPs against cyathostomins sampled from 
both horses and donkeys. The individual species in each group were not identified, however it 
is known from previous studies that differences in the spectrum and relative abundance of 
cyathostomin species are seen between the two equid hosts (Eysker and Pandey, 1989; 
Getachew et al., 2010; Ogbourne, 1976; Reinemeyer et al., 1984). Hence it can concluded that 
CPs/PLS show activity against a wide range of cyathostomin species that infect equids. A 
recent study has also found that PLS has excellent in vitro efficacy against the equid tapeworm 
Anoplocephala perfoliata (Mansur et al., 2015). As for the cyathostomins, A. perfoliata, was 
found to be highly sensitive to the effects of CPs in comparison to murine cestodes. This finding 
supports the potential use of CPs as novel broad spectrum anthelmintics in equids. Additionally 
there have been a number of studies demonstrating their efficacy in vivo for other veterinary 
GI nematodes. Potent effects have been demonstrated in murine models against 
Heligmosomoides bakeri (polygyrus), T. muris and Protospirura muricola (Stepek et al., 2006, 
2007b, c). Furthermore efficacy against Haemonchus contortus in sheep, and Ascaris suum and 
Trichuris suis in pigs show that good effects can be achieved in larger hosts against both 
ruminant and mono-gastric species (Buttle et al., 2011; Levecke et al., 2014; Satrija et al., 
1994). In the mouse stomach worm, P. muricola, the pre-administration of cimetidine was 
necessary for efficacy to raise stomach pH, as acidic conditions can inactivate the enzymic 
activity of CPs (Huet et al., 2006; Stepek et al., 2007b). This was not necessary in sheep for 
treatment of H. contortus as infected sheep have a raised abomasal pH (Buttle et al., 2011). 
There is also good evidence that CPs show activity against cestodes by causing degradation of 
the outer tegument (Mansur et al., 2014a, b). In mouse models measurement of CP activity 
throughout the GI tract after oral dosing shows that, although CP activity in the stomach is 
reduced due to low pH, its activity is restored when it reaches the intestines (Hale, 2004; Stepek 
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et al., 2007b). Of particular relevance to cyathostomins, is that CPs actually concentrate and 
increase in relative activity in the large intestines of mice, where adult cyathostomins are found 
in equids (Stepek et al., 2007b). This is thought to be due to absorption of water from the gut 
contents as they move through the GI tract. CPs have proven not to be effective against mucosal 
stages in H. bakeri and T. muris (Stepek et al., 2006, 2007c), hence they are unlikely to be 
effective against encysted L4 stages of cyathostomins. In the majority of studies with CPs no 
significant toxicity has been seen at the doses used, however toxicity has previously been 
described to traditional anthelmintics containing the CP ficin, in both mouse models and 
humans (de Amorin et al., 1999; Hansson et al., 2005). In both cases enzyme preparations were 
from Ficus insipida, it is likely that this species is significantly more toxic that other CP rich 
fruits, however the possibility of toxicity in all CP preparations is possible and should be 
evaluated.  
 
5.4.3. Considerations for taking cysteine proteinases forward for in vivo testing in equids 
The broad spectrum of activity of CPs mean that it could hold great promise as a novel 
anthelmintic for use in equids. It would first be necessary to evaluate efficacy against 
cyathostomins in vivo and also against other pathogenic GI helminths of equids, such as the 
large strongyles, Parascaris equorum and A. perfoliata. An important point when considering 
their use in equids, is that previous studies have used large volumes of CP preparations to 
achieve in vivo efficacy (Levecke et al., 2014), which may make dosing practically challenging 
in equids. However, given the sensitivity of cyathostomin eggs to CPs demonstrated in this 
study, it is possible that relatively lower doses would be needed in equids. Currently 
investigations are underway to improve CP formulation (Buttle, personal communication), the 




As CPs are proteins, one potential issue regarding their use in vivo which has been raised, is 
the possibility for development of host immunity. CPs are known to be highly immunogenic 
in some contexts (Dando et al., 1995). Antibodies to bromelain have been detected in mice 
treated for a period of 18 weeks, although no reduction in enzyme activity was noted as result 
(Hale, 2004). With any novel anthelmintic the possibility of development of resistance should 
also be considered. There is suggestion that resistance would be slow to develop to CPs as the 
enzymes target several different constituent proteins that maintain cuticular structure (Stepek 
et al., 2004). However the evolution of broader mechanisms of resistance, such as the secretion 
of protease inhibitors, is also a possibility. In order to evaluate the risk of immunity and 
resistance in equids, in vivo trials involving repeated CP administration and re-infection with 
surviving parasites would be necessary. 
 
5.5. Conclusion 
In conclusion, this study has demonstrated that PLS has a potent effect against free living stages 
of cyathostomins and that, for eggs and L1, this effect is due to the action of CPs. A novel 
active compound in PLS affecting L3 has also been found, and requires further identification. 
This is the first example of sensitivity of the free living stages of a parasitic nematode to CPs, 
suggesting that cyathostomins are particularly sensitive to these enzymes. Given their proven 
efficacy in vivo and broad spectrum of action in other host species, the CPs are a good candidate 









6. INVESTIGATION INTO THE POTENTIAL FOR P-
GLYCOPROTEIN INHIBITORS TO IMPROVE 

























There is increasing evidence that cyathostomins are developing resistance to the macrocyclic 
lactone (ML) anthelmintics, ivermectin (IVM) and moxidectin (MOX) (Canever et al., 2013; 
Milillo et al., 2009; Molento et al., 2008; Nareaho et al., 2011; Relf et al., 2014; Traversa et al., 
2009b; Trawford  et al., 2005; Trawford, 2009). The evidence for emerging resistance has come 
primarily from reduced egg reappearance periods (ERPs) after treatment. There has been 
extensive investigation into the mechanisms underlying ML resistance in other parasitic 
nematodes such as Haemonchus contortus, Teladorsagia circumcincta and Onchocerca 
volvulus, and a simple mechanism, for example a target site mutation in a glutamate gated 
chloride channel, has yet to be identified (El-Abdellati et al., 2011; Williamson et al., 2011). 
However, there is one group of genes that has been strongly implicated in ML resistance in 
several nematode species; these genes encode ATP-binding cassette (ABC) transporters. ABC 
transporters are found in the cell membrane and are responsible for the ATP-dependant efflux 
of xenobiotic compounds from the cell, they play an important role in protection against toxic 
environmental compounds (Dassa, 2003). ABC transporters are present in many organisms, 
including humans. Indeed, awareness of their role in drug resistance comes from the 
involvement of the ABCB transporter MDR-1, in multidrug resistance of cancer cells to 
chemotherapy (Dano, 1973). In mammals, through their expression at epithelial barriers such 
as the blood brain barrier and enterocytes, ABC transporters are important mediators of the 
pharmacokinetics of drugs such as MLs (Ballent et al., 2006; Kiki-Mvouaka et al., 2010; 
Laffont et al., 2002; Schinkel et al., 1994). Amongst the best characterised are the ABCB P-
glycoprotein (P-gp) sub-family; others include membrane resistance proteins (MPRs), the bile 




A relatively large number of ABC transporters have been shown to be expressed in nematodes, 
for example Caenorhabditis elegans has 15 P-gp and 8 MPR genes (Ardelli, 2013). In T. 
circumcinta P-gp genes are transcribed by all stages of the life cycle (Dicker et al., 2011b). In 
the free living stages of H. contortus they have been found to be expressed in the egg shell and 
larval cuticle (Riou et al., 2005). In adult worms they have been shown to predominate in the 
gastrointestinal (GI) tract, particularly the pharynx and anterior intestine (Smith and Prichard, 
2002). This has led to the theory that, as in mammals, ABC transporters may play an important 
role in drug metabolism. In support of this it has been demonstrated that MLs are good 
substrates for ABC transporters (Dupuy et al., 2010; Dupuy et al., 2006; Kiki-Mvouaka et al., 
2010; Lespine et al., 2009; Lespine et al., 2006; Lespine et al., 2007). In addition, gene 
knockout studies in C. elegans have shown that various MRP knockout combinations confer 
increased sensitivity to MLs (Ardelli and Prichard, 2008; Ardelli and Prichard, 2013). For 
example, knocking out MRPs 4 and 8, versus MRPs 6 and 8 in C. elegans confers increased 
sensitivity to IVM and MOX, respectively (Ardelli and Prichard, 2008). These data 
demonstrate the importance of ABC transporters in ML metabolism in nematodes, and supports 
the theory that they play a key role ML resistance. 
 
There is a growing body of evidence that ABC transporters, in particular P-gps, are involved 
in ML resistance. It has been shown that substances that interfere with the action of P-gps, can 
lead to an increased sensitivity of ML resistant parasitic nematodes to IVM in vitro (AlGusbi 
et al., 2014; Ardelli and Prichard, 2013; Bartley et al., 2009; Demeler et al., 2013; Raza et al., 
2015). Many drugs function as P-gp inhibitors, they do so either directly, or through 
competitive inhibition, by nature of the fact that they are also substrates. In support of these in 
vitro studies, there have been studies demonstrating that the efficacy of IVM against ML 
resistant nematodes in vivo can be improved, when given in combination with loperamide (an 
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opiod derivative that has been classified as a P-gp inhibitor) (Lifschitz et al., 2010a; Lifschitz 
et al., 2010b). This effect is thought to be due, in part, to increased bioavailability of IVM in 
the host due to modulation of host P-gps, but there may also be a direct effect on the parasite’s 
drug metabolism. Importantly these in vivo studies suggest that MLs in combination with P-gp 
inhibitors, are a potential novel control option in ML resistant nematode populations. There is 
also increasing evidence from genetic studies for the role of ABC transporters in ML resistance. 
For example, there is a reduction in P-gp gene heterozygosity after IVM exposure in O. 
volvulus and H. contortus, which indicates that certain P-gp genotypes confer an advantage for 
nematodes in the presence of IVM (Ardelli et al., 2005; Ardelli and Prichard, 2007; Blackhall 
et al., 2008).  In addition up-regulation in P-gp and MRP ribonucleic acid (RNA) transcription 
has been observed in ML resistant strains of C. elegans (MRP-1, MRP-6, pgp-1 and pgp-2), 
H. contortus (pgp-2, pgp-9) and T. circumcincta (pgp-9) (Ardelli and Prichard, 2008; Ardelli 
and Prichard, 2013; Dicker et al., 2011b; Williamson et al., 2011), which indicates that 
increased drug efflux by these channels plays a role in resistance.  
 
There is little data regarding ABC transporters in cyathostomin parasites, and identifying them 
in these worms is made complex by the number of species that infect equids (Bucknell et al., 
1995; Gawor, 1995; Love and Duncan, 1992; Ogbourne, 1976; Reinemeyer et al., 1984; 
Traversa et al., 2010). One publication reported the deoxyribonucleic acid (DNA) sequence of 
two P-gp nucleotide binding domains in adult cyathostomins (Drogemuller et al., 2004). P-gp 
gene sequence from Cyathostomum. radiatus, Cylicocyclus insigne, Cylicocyclus nassatus, 
Cylicocyclus elongatus, Cylicostephanus hybridus, Cylicostephanus goldi, and Cyathostomum 
coronatum grouped by nucleotide identity as one cluster, and a second cluster comprised 
Cylicostephanus hybridus, Cyathostomum pateratum, and Cyathostomum catinatum. This 
suggested the possibility of at least two P-gps in the study samples. Subsequently, the DNA 
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sequence of the pgp-9 gene in C. elongatus was published and the data showed that IVM acts 
as a substrate for this protein and can competitively inhibit other substrates (Kaschny et al., 
2015). These data demonstrate that P-gps are expressed in cyathostomins and interact directly 
with IVM, therefore given the evidence in other closely-related nematodes (Dicker et al., 
2011b; Lifschitz et al., 2010a; Williamson et al., 2011), it is reasonable to assume that P-gps 
will also play a role in MLs resistance in cyathostomins. 
 
The first aim of the work within this chapter was to identify whether upregulation of pgp-9 
plays a role in ML resistance in cyathostomins. This was determined by comparing the 
transcription profile of pgp-9 in response to IVM exposure for free living infective stages of 
cyathostomins from: a) a population of equids with a long history of ML use and reduced egg 
reappearance periods (ERPs) and b) a population which have never been exposed to 
anthelmintics. The second aim was to examine whether interference with P-gp function could 
potentially be used to improve ML efficacy against cyathostomins. To assess this, the effect of 
a range of P-gp inhibitors on IVM efficacy was compared in cyathostomin populations a) and 
b) above, using the larval development test (LDT) and the larval migration inhibition test 
(LMIT). 
 
6.2. Materials and Methods 
6.2.1. Parasite populations 
Cyathostomin samples were sourced from two equid populations to represent parasites of 
differing sensitivity to MLs, both of which were used for a number of specific applications 
throughout this Chapter. Population 1 (Pop 1, IVM-resistant), harbouring ‘resistant’ 
cyathostomins, were donkeys at the Donkey Sanctuary in Sidmouth, Devon, where there is a 
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history of resistance to MLs, as determined by faecal egg count reduction tests (FECRT) 
(Trawford  et al., 2005; Trawford, 2009).  Criteria for inclusion of animals in the study was a 
FEC of ≥ 500 eggs per gram (epg) within eight weeks of administration of IVM or moxidectin 
(MOX). Population 2 (Pop 2, IVM-naive), was deemed to harbour ‘sensitive’ cyathostomins, 
and was a herd of Konik horses used for conservation purposes by the National Trust at their 
site at Wicken Fen, East Anglia. Sensitivity to anthelmintics in Pop 2 was assumed on the basis 
that this was a closed herd within which animals had never been treated with an anthelmintic. 
It was not possible to perform a faecal egg count reduction test (FECRT) to confirm sensitivity 
in Pop 2 as treatment of these horses was prohibited. 
 
In addition an archive of adult cyathostomins collected from horses and donkeys post-mortem 
and held at the University of Liverpool in ethanol at -20 ºC, were used for isolation of pgp-9 
and design of a real time polymerase chain reaction (PCR) (Hodgkinson et al., 2008). 
 
6.2.2. Parasite sample collection 
Faecal samples were taken from animals in Pops 1 and 2, from which eggs and third stage 
larvae (L3) were collected and harvested as described in Section 2.2.1 and 2.2.2 respectively.  
 
6.2.3 Design of real time PCR for cyathostomins pgp-9, and measurement of its transcription 
in populations of differing ivermectin sensitivity 
6.2.3.1. Production of cDNA from adult cyathostomins for isolation of pgp-9 DNA sequence  
RNA was extracted from groups of 10 adult worms from a number of cyathostomin species 
within the archive of adult cyathostomins: Cylicocyclus nassatus, Cyathostomum pateratum, 
130 
 
Cyathostomum catinatum, and from a mixed adult cyathostomin sample taken from a donkey, 
W, at the Donkey Sanctuary (DSW). RNA was extracted using the QIAGEN RNeasy Mini kit 
according to the manufacturer’s protocol with the following adaptations. Each sample was 
homogenised in 600 µl of RNeasy lysis buffer using a bead beater at speed 48 for 2 x 1 min, 
and then placed on ice. The resultant lysate was pipetted into a fresh eppendorf, mixed with 
700 µl of ethanol and the protocol continued as per the manufacturer’s instructions.  In the final 
stage, RNA was eluted from the RNeasy spin column in 40 µl of RNase-free 
diethylpyrocarbonate (DEPC) treated dH2O (Sigma-Aldrich, UK). RNA was used immediately 
or stored neat at -80 ºC. As RNA concentrations were likely to be low, quantification was not 
performed at this stage, and the maximum volume of RNA (12 µl) was used for cDNA 
synthesis. cDNA synthesis was performed using the QIAGEN Quantitect Reverse 
Transcriptase kit according to the manufacturer’s instructions, including the genomic DNA 
wipeout step.  All cDNA samples were stored at -20 ºC. In order to assess integrity of cDNA, 
PCR for beta-tubulin was performed. using the following primer combinations: 200_F, 5’-
TCYGAYACHGTTGTGGAGCC-3’ and 200_RS, 5’-AAGATGATTYAVATCWCCRTA-3’ 
which amplified a 160 base pair (bp) fragment of beta-tubulin isotype-1 gene (Lake et al., 
2009), and CN23F, 5’-AAGTTCTCTACTGCAATAATGCGTG-3’ and CN31R 5’-
AACGCAATCAATGTGTATTTCGC-3’, which amplified a 1100 bp fragment of beta-tubulin 
isotype-1 gene (Pape et al., 2002; Pape et al., 1999). The PCR was performed using QIAGEN 
Taq PCR Master Mix Kit. To each reaction, 25 µl of Master Mix, 2.5 µl of forward and reverse 
primer (final concentration 0.5 µM), 18 µl of DNase free water, and 2 µl of template cDNA 
were added, to give a total volume of 50 µl. The PCR reaction was run on the Biometra T3 
Thermocycler. The reaction conditions were 3 min at 94 ºC, followed by 34 cycles of 1 min 
denaturation at 94 ºC, 1 min at annealing temperature and 1 min extension at 72 ºC, followed 
by a final extension phase of 10 min at 72 ºC. The annealing temperature was 50 ºC for the 
131 
 
primer pair, 200_F/200_RS, and 55 ºC for the primer pair, CN23F/CN31R. The PCR products 
were subjected to electrophoresis on 1 % agarose gels at 100 V for 30 min and the products 
stained for UV visualisation using the ‘SYBR safe’ stain (Life Technologies, UK), alongside 
a 100 bp or 1000 bp ladder (Invitrogen, UK) for size estimation.   
 
6.2.3.2. Primer design for identification of pgp-9 from cyathostomin cDNA samples 
Full-length pgp-9 DNA sequence from the cyathostomin C. elongatus (Accession number 
(AN): KJ701410.1) was kindly donated by Professor Georg von Samson-Himmelstjerna and 
Dr Jürgen Krücken of Freie Universität Berlin to aid in primer design. Partial pgp-9 translated 
amino acid sequence from T. circumcincta (AN:CBX21126.1) and H. contortus 
(AN:AFX93750.1), and full pgp-9 translated amino acid sequence from C. elegans 
(AN:CAB03973) and C. elongatus (AN: KJ701410NA .1) were aligned using Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/) to identify regions which are conserved in 
nematode pgp-9. A region was identified, which was analysed using NCBI protein blast 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) to ensure that it was specific to pgp-
9 and did not align with other nematode P-gp amino acid sequences.  NCBI primer design 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) was used to identify the forward primer site 
in the C. elongatus nucleotide sequence, which corresponded to this highly conserved region. 
The reverse primer, also designed using NCBI, was located in the highly conserved first 
nucleotide binding domain of the C. elongatus sequence, which is found between 5’ 1150-1740 
3’ bp (Kaschny et al., 2015). The primers with the best thermo-kinetic parameters were chosen 
and aligned, using Clustal Omega (as above), with C. elongatus and H. contortus (A.N. 
JX430937.1) nucleotide sequence to allow the design of degenerate primers which would 
amplify pgp-9 from both species, thus maximising the likelihood that the primers would 
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amplify pgp-9 from multiple different cyathostomins species. The primers were as follows: 
forward, PGP9F 5’-CKGCMACRATACAGGCAATR-3’ and reverse PGP9R 5’-
GTCCTCACGTCCMGAMARTTG-3, and they amplified a 1100 bp fragment of pgp-9 cDNA.  
 
6.2.3.3. Amplification and sequencing of the first transmembrane and nucleotide binding 
domain of pgp-9 from cyathostomin cDNA 
PCR (see section 6.2.3.1) was performed on cDNA synthesised from, C. nassatus, C. 
pateratum, C. catinatum and the sample of unknown species ‘DSW’ with primers PGP9F and 
PGP9R using an annealing temperature of 52 ºC. Only the DSW template gave a product but 
due to non-specific products it required gel purification of the product and re-PCR with the 
same primers (PGP9F and PGP9R) to give a product of the correct size (1100 bp) on the 
agarose gel. The product was purified using the QIAGEN QIAquick Gel extraction kit and 
quantified using the Invitrogen Qubit Assay, as per the manufacturer’s instructions. The PCR 
product was cloned for sequencing using the Pgem-T Easy Vector System (Promega) as per 
manufacturer’s instructions.  Following ligation and transformation, 10 white colonies were 
picked from plates and placed separately in 5 ml of LB broth with ampicillin (Section 2.1). 
Plasmid DNA was purified from the cells using the Promega Wizard Plus SV Minipreps DNA 
Purification System, as per manufacturer’s instructions. The plasmid DNA was quantified 
using the Qubit assay (Invitrogen) and 100 ng/µl sent for sequencing (Source Biosciences, UK) 
using forward and reverse Pgem-T plasmid primers M13F/M13R.  The ten resultant sequences 
(designated DSW A1-5 and B1-5) were entered into NCBI nucleotide BLAST 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch) to evaluate their 
similarity with other nematode nucleotide sequences and confirm that pgp-9 sequences had 
been amplified. Alignments between cDNA and amino acid sequences of all clones and C. 
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elongatus pgp-9 (A.N. KJ701410.1) were created using Clustal Omega, and the percentage 
identity between them calculated. In addition, a phylogenetic tree comparing the relationship 
between the nucleotide sequence of DW1 A1-5 and B1-5, C. elongatus pgp-9 (A.N. 
KJ701410.1), H. contortus pgp-9 (A.N. JX430937.1), T. circumcincta pgp-9 (A.N. 
FR691848.1), C. elegans pgp-9 (C47A10.1 wormbase i.d.) and Caenorhabditis briggsae pgp-
9 (XM_002638567.1) was created using MEGA version 6.06 software. Specifically, a 
maximum likelihood tree with 500 bootstraps using a kimura 2-parameter model, was 
constructed.  
 
6.2.3.4. Design of primers and standards for real time quantitative PCR for cyathostomin pgp-
9 transcription 
A SYBR® green (Life Technologies) real time quantitative PCR assay was designed to 
determine pgp-9 transcript levels, relative to a housekeeping 18S rRNA gene, in cyathostomin 
cDNA samples. The 18S assay was designed using a consensus sequence of 99 bp produced 
from the alignment of 63 bp fragments of the 18S rRNA from six species of cyathostomins, 
and from a range of other organisms as follows: C. labiatum (A.N. AJ223727); C. ashworthi 
(A.N. AJ223346); C. nassatus, (A.N. AJ223348); C. elegans, (A.N. X03680); Ascaris suum, 
(A.N. U9436); Toxoplasma gondii, (A.N. L37415); Schizosaccharomyces pombe, (A.N. 
AY251644); Dirofilaria immitis, (A.N. AF036638); Xenopus laevis, (A.N.  X02995); 
Drosophila melanogaster, (A.N. M21017); Strongyloides stercoralis, (A.N. M84229); and 
Enoplus brevis, (A.N. U88336). Primers were as follows; 18SRTf 5’ 
GATTGATTCTGTCAGCGCTATA 3’ and 18SRTr 5’ TAATGAGCCGTTCGCAGT 3’ and 
were confirmed to lack sequence identify with 18S rRNA of equids or bacteria using NCBI 
BLAST.  A standard synthetic 99 bp 18S template was manufactured by Sigma-Aldrich, UK. 
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For pgp-9, primers were designed using Primer 3 version 4.0.0 (http://primer3.ut.ee/) based on 
the sequence data from DSW A1. The primers with the best thermokinetic parameters were 
chosen and aligned with all 10 sequenced pgp-9 sequences and C. elongatus pgp-9 (A.N. 
KJ701410.1). Due to the presence of three nucleotide polymorphisms in the sequence aligning 
to these primers, degenerate primers were designed to maximise the amplification of pgp-9 
from multiple cyathostomin species. The degenerate primers for Pgp-9 were PGP9RTF 5’ 
AYATTGGGCTYGGTCTTGCT 3’ and PGP9RTR 5’ ACCGTTCCYCCTTTCATCGT 3’. 
The 112 bp sequence flanked by the two primers was synthesised by Sigma-Aldrich, UK, for 
use as a standard with the most commonly occurring base incorporated at each of the 12 sites 
of nucleotide variation.  
 
6.2.3.5. Optimisation of real time PCR assay for pgp-9: standard curve and optimisation of 
cDNA concentrations 
A 10-fold dilution series of the 18S and pgp-9 standard oligonucleotides was made in 100 
µg/ml yeast tRNA (Invitrogen, UK). The final theoretical copy numbers for each dilution were 
5x10-1, 5x100, 5x101, 5x102, 5x103, 5x104, 5x105, 5x106, 5x107, 5x108. The primers 18SRTf, 
18SRTr, PGP9RTF and PGP9RTR were diluted to 100 µM. A master mix was made up with 
10µl 2x SensiMix (dT) (Bioline, UK), 7 µl DNase/RNase free dH2O (Sigma-Aldrich, UK), 1 
µl of 4µM forward and reverse primer (either for 18S or pgp-9) per sample. To each well of a 
96-well plate, 19 µl of mastermix were added, followed by 1 µl of each standard concentration. 
Duplicates were run for each standard concentration and a non-template control (dH2O) was 
also included. The plate was run on DNA Engine Opticon 2 Continuous Fluorescence detector, 
with the following reaction conditions: 95º C for 10 min, followed by 35 cycles of 95 ºC for 15 
s, 53 ºC for 30 s and 72 ºC for 15 s. The standard curve was repeated as described above with 
135 
 
the addition of serial dilutions of cDNA from DSW, starting at 4.1 ng/µl of neat cDNA. 
Analysis of cDNA concentration, showed that pgp-9 could be detected optimally at the 
concentration of 4.1 ng/µl. 
 
6.2.3.6. Evaluation of pgp-9 transcription after ivermectin exposure in third stage larvae from 
mixed species cyathostomin populations of differing ivermectin sensitivity 
A total of ~800,000 and ~1.1 m L3 were cultured from the faeces of 10 animals from Pop 1 
and 2, respectively. These L3 were pooled for each population and suspended in 450 ml of 
distilled water, (dH2O) (Sigma-Aldrich). They were mixed and, for each population, divided 
into three aliquots of 50 ml (negative controls), and 6 aliquots of 48.5 ml (test samples) and 
placed into 50 ml centrifuge tubes. The L3 in each aliquot were ex-sheathed, as described for 
the LMIT in Section 2.4.1. To three of the 48.5 ml test samples, 1.5 ml of DMSO (Sigma-
Aldrich, UK) was added to serve as a control for the drug solvent. To the remaining three test 
samples, 1.5 ml of 5 µg/ml IVM (Sigma-Aldrich, UK) in DMSO were added, giving a final 
IVM concentration of 0.15 µg/ml. This concentration was chosen as a ‘sub-lethal’ dose (i.e. 
where percentage larval migration began to decrease, but the majority of the L3 were still alive 
and presumably still capable of transcribing RNA), based on data from the LMIT in preliminary 
experiments, see Appendix 1.9. All aliquots were incubated for 2 h at 26 ºC as for the LMIT. 
After incubation, all aliquots were centrifuged for 2 min at 200 g, the supernatant removed and 
the L3 re-suspended in 20 ml of dH2O. This was repeated three times. Finally, L3 from each 
aliquot were transferred to an eppendorf and centrifuged for 5 min at 11,000 g. The remaining 
supernatant was removed from each aliquot and they were air dried, re-suspended in 100 % 
ethanol (Sigma-Aldrich, UK) and stored at -20 ºC.  RNA extraction and cDNA synthesis was 
carried out on each L3 sample as described in Section 6.2.3.1. In the cDNA synthesis step, 
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reverse transcriptase-free negative controls were included for each aliquot. The cDNA 
concentration in each sample was quantified using the Picogreen DNA quantification kit 
(Promega), as per manufacturer’s instructions. The cDNA concentration in each aliquot was 
standardised to 2 ng/µl using RNase/DNase-free water (Sigma-Aldrich, UK). Real time PCR 
for 18S and pgp-9 was then performed alongside standard curves for all samples according to 
the method outlined in Section 6.2.3.5, except, in order to keep cDNA concentrations close to 
the optimum, 2 µl of cDNA were added to each reaction to give a total of 4 ng DNA. Duplicates 
were included for each sample, as well as reverse transcriptase-free negative controls and non-
template controls. For each incubation (i.e. dH2O, 3 % DMSO or 0.15 µg/ml IVM), there were 
two technical (within assay) repeats of each sample from the three biological repeats described 
above.  
 
6.2.3.7. Analysis of real time PCR data 
Raw data from the real time PCR was evaluated using Opticon Monitor 3 version 3.1.32.0 
software. Standard graph correlations were checked and melting curves examined for each 
sample; those which did not have a single peak at the expected temperature were excluded from 
further analysis. Figure 6.2.1. shows the pgp-9 melting curves for samples used in the analysis. 
Raw data from the qPCR reactions were entered into a Microsoft Excel spreadsheet. The 
percentage genomic contamination in each sample was calculated from the reverse 
transcriptase negative control for the raw 18S data, this was used to correct the raw data for 
18S and pgp-9 so that any genomic DNA was not counted. The average copy number between 
each technical repeat was taken for each sample for 18S and pgp-9, and the relative transcript 
level of pgp-9 gene compared to the 18S gene, calculated for each biological repeat. The data 
was entered into SPSS 21 to generate a box and whisker plot to represent the data graphically. 
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This data was analysed with two way analysis of variance (ANOVA), to compare pgp-9 
transcription between treatments and equid populations, using R statistical software (R Core 
Team, 2014).  
 
                                  
Figure 6.2.1. Pgp-9 real time PCR melting curves for all third stage larval (L3) cDNA samples from 
Populations 1 and 2. 
 
 
6.2.4. Evaluating the effect of P-glycoprotein inhibitors on ivermectin efficacy in the larval 
development test and larval migration inhibition test 
6.2.4.1. Pharmaceutical preparations for use in the larval development test and larval 
migration inhibition test 
IVM (Sigma-Aldrich, UK) was dissolved in DMSO (Sigma-Aldrich, UK) to give stock 
solutions of 5000 nM for the LDT and 3000 µg/ml for the LMIT.  These were serially diluted 
in DMSO as described in Sections 2.5.1. and 2.4.1. respectively to give working concentrations 
for use in the two tests. The concentration of three P-gp inhibitors was optimised, as described 
in Sections 2.5.2. and 2.4.3. (see Appendix 1.17., 1.12. and 1.13. for results of optimisation), 
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for use in both the LDT and LMIT, so that it was used at the optimal concentration for P-gp 
inhibitory activity, without having an effect on its own against cyathostomins. Ketoconazole 
(Sigma-Aldrich, UK) was used at 10 µM in all tests with the LDT and LMIT. For the LDT a 
stock solution of 2000 µM in DMSO was used and added in a 0.5:100 ratio to the test. For the 
LMIT a 1000 µM in DMSO was used and added in a 1:100 ratio at each stage of the test. 
Pluronic 85 (P85) (BASF, USA) was used at 22 µM in the LDT and LMIT. For the LDT a 
stock solution of 4400 µM in dH2O (Sigma-Aldrich, UK) was added in a 0.5:100 ratio to the 
test. For the LMIT a stock solution of 2200 µM in dH2O was used and added in a 1:100 ratio 
at each stage of the test. IVM-AG (synthesised at Toxalim, INRA, Toulouse, and kindly 
donated by Dr Anne Lespine) was used at 8 nM in the LDT and, for this, a stock solution of 
1600 nM was used and added in a 0.5:100 ratio to the test. In the LMIT IVM-AG was used at 
a concentration of 60 nM and, for this, a stock solution of 6000 nM was used, which was added 
in a 1:100 ratio at each stage of the test. 
 
6.2.4.2. The larval development and larval migration inhibition test with pluronic 85, 
ketoconazole and ivermectin aglycone 
The LDT and LMIT with IVM was performed with and without the addition of three P-gp 
inhibitors, ketoconazole, P85 and IVM-AG, in samples from Pop 1 and Pop 2. The LDT was 
performed with increasing concentrations of IVM as described in Section 2.5.1. However, for 
each parasite sample, the test was repeated with the addition of 10 µM ketoconazole, 22 µM 
P85 and 8 nM IVM-AG in all wells, including the negative control. The working concentrations 
of IVM were adjusted to keep the DMSO concentration constant at 0.5 %. The LDT, with the 
addition of each P-gp inhibitor, was repeated using two parasite samples from each Population. 
The LMIT was performed as described in Section 2.4.1. with increasing concentrations of IVM. 
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For each sample, the test was repeated with the addition of 10 µM ketoconazole, 22 µM P85 
or 60 nM IVM-AG in all wells, including the negative control. Again, the working 
concentrations of IVM were adjusted to keep the DMSO concentration constant at 3 %. The 
LMIT with the addition of each P-gp inhibitor was repeated using four parasite samples from 
each population.  
 
6.2.4.3. Analysis of dose response data from the larval development test and larval migration 
inhibition tests 
Dose response data was analysed using general linear mixed models (GLMM). Conventional 
PROBIT analysis was also performed on the data for comparison, see Appendix 3.1. It was not 
possible to analyse some of dose response data with the PROBIT model, and hence GLMM 
was chosen as the optimal method here. For the GLMM method, the data was grouped 
according to drug combination and test, including IVM alone in each group for comparison of 
P-gp inhibitor addition within each model, i.e. model 1 = IVM alone and IVM + P85 in Pops 
1 and 2 in the LDT, model 2 = IVM alone and IVM + keto in Pops 1 and 2 in the LDT and so 
on. The GLMM was constructed with concentration IVM, p-gp inhibitor (present or absent) 
and Population (Pop 1 or 2) as fixed factors and animal/repeat as random effects. An interaction 
term was introduced between all pairs of fixed factors. The GLMM was performed using R (R 
Core Team, 2014) with the Lme4 package (Bates et al., 2015) according to the following code:  
 





Where ndl3.r = undeveloped or non-migrated larvae, dl3r = developed or migrated larvae, conc 
= concentration IVM, pgpi = presence/absence of P-gp inhibitor, pop = population 1 or 2, 
animal = repeats between and within animal. 
 
The coefficients for each variable in the model output were used to calculate an odds ratio (OR) 
for the likelihood of larval death at each concentration, taking into account the Population and 
whether or not they had been exposed to P-gp inhibitor.  The ORs were calculated and plotted 
in Microsoft Excel, 2013. 
 
6.3. Results 
6.3.1 Design of real time PCR for cyathostomins pgp-9, and measurement of its transcription 
in populations of differing ivermectin sensitivity 
6.3.1.1. PCR for beta tubulin and Pgp-9 on cDNA from archived cyathostomins samples 
PCR for the small amplicon of beta-tubulin was positive for all cDNA samples tested, with the 
expected fragment size of 160 bp being observed (Figure 6.3.1a). However, for the larger 
amplicon, only DSW showed a positive result at the expected size of 1100 bp (Figure 6.3.1b). 
PCR for pgp-9 using primers designed from a consensus sequence of C. elongatus and H. 
contortus was negative in all samples except DSW (Figure 6.3.1.c). It was assumed that the 













Figure 6.3.1. Composite gel image showing the PCR product for the beta-tubulin 160bp (a), beta-
tubulin 1100bp (b) and pgp-9 (c) amplicons for cyathostomin cDNA from Cylicocyclus nassatus, (Nass) 
Cyathostomum pateratum (Pat), Cyathostomum catinatum (Cat) and mixed species, DSW1 and 2. 
 
6.3.1.2. Analysis of sequence data from PCR for pgp-9  
The sequence was found to have 92 % identity to the pgp-9 genes previously identified for C. 
elongatus across 100 % of the amplicon. BLAST analysis showed 77 % and 74 % identity to 
H. contortus and T. circumcincta pgp-9 respectively, and lower levels of identity to other 
nematode species (Appendix 3.2). A nucleotide sequence alignment of all 10 sequences (A1-5 
and B1-5) from the DSW PCR product showed the range of identity to be between 91.1 % 
(between C. elongatus and DSW sequence B4 and A4) and 99.8 % (between DSW sequence 
B2 and B3). The maximum likelihood phylogenetic tree for nucleotide sequence (Figure 6.3.2.) 
bootstrap values indicated that the model predicts with 100 % certainty that the sequences from 
DSW are closely related to C. elongatus in comparison to sequence from other nematodes. For 
the 10 sequences from DSW there was 80 % certainty that these separated into two clusters. 
Within the clusters there were few differences between sequences and the likelihood that these 
represented phylogenetically distinct sequences fell, as reflected by the lower bootstrap values 









seen in Figure 6.3.2. The alignment of a deduced consensus amino acid coding sequence for 
the 10 DSW sequences, and the corresponding gene region of C. elongatus, is shown in Figure 
6.3.3. The sequence reveals the typical domain arrangement of one half of a P-gp gene with an 
ABC transporter transmembrane domain containing transmembrane helices followed by the 
first part of the first nucleotide binding domain containing the highly conserved Walker A/P 
loop (CDD accession number cd03249), highlighted in Figure 6.3.3. Other highly conserved 
regions lie just outside of the sequenced region (Figure 6.3.3.). The sequence identity ranged 
between 91.1 % (between C. elongatus and DSW B4 and A4) and 99.8 % (between sequence 




Figure 6.3.2. Maximum likelihood phylogenetic tree demonstrating the relationship between nucleotide sequences for DSW (A1-5 and B1-5) (highlighted red) 
and published pgp-9 sequences from Cylicocylus elongatus pgp-9 (A.N. KJ701410.1), Haemonchus contortus pgp-9 (A.N. JX430937.1), Teladorsagia 
circumcincta pgp-9 (A.N. FR691848.1), Caenorhabditis elegans pgp-9 (C47A10.1 wormbase i.d.) and Caenorhabditis briggsae pgp-9 (XM_002638567.1). 
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Figure 6.3.3: Amino acid alignment of translated sequence from a consensus of all DSW sequences (DSW_C) and Cylicocyclus elongatus pgp-9 amino acid 
sequence (A.N. AJM87336.1) (C_elongatus_pgp9). Amino acid changes are indicated underneath the alignment, with * indicating conserved, : indicating 
strongly similar, . indicating weakly similar and blank indicating different.  The characteristic regions of ABC transporters are highlighted with text boxes in 
the two nucleotide binding domains. Colour coding is a follows: red = Walker A/P loop; black = Q loop; yellow = ABC transporter signature motif; green = 















6.3.1.3. Pgp-9 transcription in L3 from two mixed species populations of cyathostomins of 
differing ivermectin sensitivity 
Absolute and relative copy numbers of pgp-9 transcript in L3 samples from Pop 1 (IVM-
resistant) and Pop 2 (IVM-naive) after incubation with either dH2O, 3% DMSO or 0.15 µg/ml 
IVM for 2 h are shown in Table 6.3.1; these are represented in a box and whisker plot showing 
the transcript levels of pgp-9 mRNA relative to the housekeeping gene, 18S (Figure 6.3.4). 
After exposure to dH2O there was slightly higher transcript expression in Pop 1 than Pop 2, 
suggesting higher baseline levels of pgp-9 transcription in Pop 1, although the difference was 
not significant (p=0.159). After exposure to DMSO there was a statistically significant increase 
in pgp-9 transcription in Pop 1 compared to Pop 2 (p=0.03). Finally, after exposure to IVM 
there was a highly statistically significant increase in pgp-9 transcription in Pop 1 compared to 
Pop2 (p<0.001). Within each population there was a significant effect of the different 
treatments for Pop 1 (p=0.005), but not for Pop 2 (p=0.313). The fold increase in pgp-9 











Table 6.3.1. The results, in terms of absolute and relative copy numbers, of real time PCR for the house 
keeping gene 18S and pgp-9 in Populations 1 and 2, exposed to distilled water (dH2O), 3 % dimethyl 
sulfoxide (DMSO) or ivermectin at 0.15 µg/ml (IVM). 
Sample Treatment Biological 
repeat 












Population 1 DH2O 1 1.83E+08 156.14 8.52E-07 
  2 1.33E+09 891.79 6.68 E-07 
  3 8.65E+08 1657.53 19.17 E-07 
 DMSO 1 1.53E+09 2675.41 17.53 E-07 
  2 3.23E+08 301.65 9.34 E-07 
  3 2.43E+08 440.50 18.10 E-07 
 IVM 1 2.37E+08 737.13 31.13 E-07 
  2 1.32E+08 458.68 34.63 E-07 
  3 1.21E+08 532.03 44.02 E-07 
Population 2 DH2O 1 9.67E+08 340.79 3.53 E-07 
  2 1.64E+09 717.24 4.38 E-07 
  3 3.68E+09 2189.31 5.95 E-07 
 DMSO 1 5.55E+08 209.81 3.78 E-07 
  2 1.4E+09 411.78 2.94 E-07 
  3 9.17E+08 674.28 7.35 E-07 
 IVM 1 9.71E+08 699.05 7.20 E-07 
  2 9.26E+08 544.00 5.88 E-07 








                     
Figure 6.3.4. Box plot showing the transcript levels of pgp-9 mRNA relative to the housekeeping gene, 
18S, in third stage larvae from Populations 1 and 2, which had been incubated with distilled water 
(DH2O), dimethyl sulfoxide (DMSO) or ivermectin (IVM). 
 
6.3.2. Evaluating the effect of P-glycoprotein inhibitors on ivermectin efficacy in the larval 
development test and larval migration inhibition test 
The results of the GLMM for each P-gp inhibitor are shown in Table 6.3.2., with coefficients 
and P-values for each variable. For P85 in the LMIT a piecewise GLMM was performed to 
model the effect at low and high IVM concentrations. Concentration of IVM and the presence 
of P-gp inhibitor had a significant positive effect for all tests (p values between 0.002 and 
<0.001), except with IVM-AG in the LDT (p=0.561).  There was also a significant effect of 
Population in all LMIT tests (p<0.001), except in the piecewise model for P85. There was no 
effect of Population in the LDT (p=0.270 (with P85), p=0.907 (with ketoconazole), p=0.561 
(with IVM-AG)). There were significant interactions between concentration and P-gp inhibitor 
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addition for all models except IVM-AG in the LDT, which indicated that the effect of P-gp 
inhibitor altered depending on IVM concentration. There were significant interactions between 
concentration and Population in all models except P85 in the LMIT at concentrations lower 
than 0.6 µg/ml, which indicated that the effect of Population changed depending on IVM 
concentration. Finally there were significant interactions between Population and P-gp 
inhibitor in all models except P85, which indicated that the effect of the addition of P-gp 
inhibitor differed between Populations in most cases. The overall outcome of all of these effects 
and their interactions was represented by the OR for larval death at each concentration of IVM 
and are represented graphically for each Pgp-inhibitor in the LDT or LMIT in Figures 6.3.5., 
6.3.6. and 6.3.7. These graphs demonstrate that IVM-AG and ketoconazole increase the 
likelihood of larval death in the LMIT (Figure 6.3.5.). The effect is greater in Pop 1 for IVM-
AG and ketoconazole. The OR graphs for the piecewise model for P85 are presented in Figure 
6.3.6 and show that, concentrations less than 0.6 µg/ml (Figure 6.3.6.a), P85 increases the 
likelihood of larval death, whereas high concentration greater than 0.6 µg/ml (Figure 6.3.6.b) 
P85 reduces the likelihood of larval death. Figure 6.3.7. shows the effect of adding P-gp 
inhibitors in the LDT, on the likelihood of larval death. There was a clear increase in OR for 
larval death in both Pop1 and 2 with P85 and ketoconazole, there was no differential effect of 









Table 6.3.2. Results of a general linear mixed model for the dose response data in the LMIT and LDT 
with the addition of three p-glycoprotein inhibitors (PGPI); pluronic 85 (P85), ketoconazole (keto) and 
ivermectin aglycone (IVM-AG), in Populations 1 (Pop1) and Population 2 (Pop2). There is a separate 
model for each PGPI in each assay and within this, the coefficient, standard error and p-value are given 
for each fixed factor and interaction between factor (indicated by : ). 
 




LDT P85 Concentration 0.32 0.01 <0.001* 
  PGPI addition -0.47 0.15 0.002* 
  Pop 2 -0.70 0.63 0.27 
  Concentration: PGPI 1.29 0.06 <0.001* 
  Concentration: Pop 2 0.52 0.04 <0.001* 
  Pop 2: PGPI 2.98 0.20 <0.001* 
 Keto Concentration 0.36 0.01 <0.001* 
  PGPI addition  -0.76 0.16 <0.001* 
  Pop 2 -0.09 0.84 0.907 
  Concentration: PGPI 1.13 0.05 <0.001* 
  Concentration: Pop 2 0.40 0.03 <0.001* 
  Pop2: PGPI 2.56 0.19 <0.001* 
 IVM-AG Concentration 0.35 0.01 <0.001* 
  PGPI addition -0.08 0.14 0.561 
  Pop 2 -0.09 062 0.885 
  Concentration: PGPI -0.02 0.02 0.321 
  Concentration: Pop 2 0.35 0.02 <0.001* 
  Pop 2: PGPI 0.72 0.15 <0.001* 
LMIT P85 Concentration < 0.6 2.34 0.36 <0.001* 
  Concentration >= 0.6 0.10 0.00 <0.001* 
  PGPI addition 0.22 0.03 <0.001* 
  Pop 2 0.13 0.18 0.489 
  Concentration<0.6: PGPI 2.67 0.40 <0.001* 
  Concentration>=0.6: 
PGPI 
-0.08 0.00 <0.001* 
  Concentration<0.6: Pop 2 0.17 0.40 0.670 
  Concentration>=0.6: Pop 
2 
-0.03 0.00 <0.001* 
  Pop 2: PGPI 0.07 0.04 0.077 
 Keto Concentration 0.13 0.00 <0.001* 
  PGPI addition 0.53 0.03 <0.001* 
  Pop 2 0.46 0.09 <0.001* 
  Concentration: PGPI 0.04 0.00 <0.001* 
  Concentration: Pop 2 0.07 0.00 <0.001* 
  Pop 2: PGPI 0.66 0.04 <0.001* 
 IVM-AG Concentration 0.06 0.00 <0.001* 
  PGPI addition 0.40 0.04 <0.001* 
  Pop 2 0.66 0.09 <0.001* 
  Concentration: PGPI 0.01 0.00 <0.001* 
  Concentration: Pop 2 0.06 0.00 <0.001* 
  Pop 2: PGPI -0.49 0.06 <0.001* 










Figure 6.3.5. Graphical representation of the odds ratio for larval death (calculated from the output of 
the general linear mixed model) plotted against ivermectin concentration, for the larval migration 
inhibition test, with the addition of ketoconazole (keto) (a) and ivermectin aglycone (IVM-AG) (b). 
Each graph shows Populations 1 and 2, with and without the addition of the p-glycoprotein inhibitor 











Figure 6.3.6. Graphical representation of the odds ratio for larval death (calculated from the output of 
a piecewise general linear mixed model) plotted against ivermectin concentration, for the larval 
migration inhibition test (LMIT), with the addition of pluronic 85 (P85) at a concentration of less than 
0.6 µg/ml (a) and greater than 0.6 µg/ml (b). Each graph shows Populations 1 and 2, with and without 











Figure 6.3.7. Graphical representation of the odds ratio for larval death (calculated from the output of 
the general linear mixed model) plotted against ivermectin concentration, for the larval development 
test (LDT) with the addition of pluronic 85 (P85) (a) and ketoconazole (keto) (b) and ivermectin 
aglycone (c). Each graph shows Populations 1 and 2, with and without the addition of the p-glycoprotein 








This study has demonstrated higher levels of pgp-9 gene transcript after IVM exposure for 
cyathostomin L3 with a ‘resistant’ phenotype (defined as an increased ERP in vivo). In addition 
it has demonstrated that IVM efficacy in the same population can be increased by its 
combination with certain P-gp inhibitors in vitro. Together this evidence suggests a role for P-
gps in emerging IVM resistance in cyathostomins, and raises the possibility that the use of P-
gp inhibitors in equids in vivo may increase the susceptibility of IVM-resistant parasite 
populations, as has been shown for sheep and cattle (Lifschitz et al., 2010a; Lifschitz et al., 
2010b).  
 
6.4.1. Identification of pgp-9 sequence from a cyathostomin population of unknown species 
In order to design a real time PCR assay to measure transcription of pgp-9 in cyathostomins, 
DNA was amplified from a cDNA sample, produced from cyathostomin populations of 
unknown species. Pgp-9 was chosen specifically as increased transcription of this gene has 
been associated with ML resistance in closely related parasitic nematodes (Dicker et al., 2011b; 
Williamson et al., 2011).  The results of the BLAST and phylogenetic analysis supported that 
the cyathostomin pgp-9 gene had been successfully isolated.  Preliminary analysis of the 
sequence data showed that there were high levels of nucleotide identity (91.1-99.8 %) amongst 
DSW sequences and with the recently published, C. elongatus pgp-9 sequence (Kaschny et al., 
2015). Preliminary analysis of the data, in a maximum likelihood phylogenetic model, 
predicted with 100 % certainty that there was a true difference between DSW A1-5 and B1-5 
nucleotide sequence and C. elongatus sequence; this may reflect intra-specific variation but 
may also be due to inter-specific variation due to the presence of multiple different 
cyathostomins species in parasites present with the equid GI tract (Ogbourne, 1976). The fact 
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that analysis of nucleotide sequence showed they clustered into two groups, raises the 
possibility that pgp-9 from two species of cyathostomin was amplified here. Previous work on 
morphological identification of adult cyathostomins isolated from donkeys at the Donkey 
Sanctuary identified 80 % Cyathostomum tetracanthum, C. catinatum and C. pateratum 
with some Cylicostephanus longibursatus and Cylicocyclus nassatus (Cwiklinski et al., 
unpublished data). Further work is required to identify levels of intra- and inter-specific 
variation of pgp-9 in cyathostomins and which species we have represented here. 
 
6.4.2. Pgp-9 transcription in cyathostomin populations with differing ivermectin sensitivity 
Importantly, from the sequence data identified here, it was possible to design consensus primers 
for, and validate, a real time PCR assay which would measure transcript levels in pgp-9 
sequence from cyathostomin cDNA. Subsequently it was shown that pgp-9 transcription in 
cyathostomin L3 exposed to IVM was increased three fold in cDNA from Pop 1 (IVM 
‘resistant’), whilst no change was measured in that from Pop 2 (IVM ‘sensitive’). As noted 
above, in this study cyathostomin species composition was not known for the two L3 
populations. As the primers were designed from consensus sequence for all DSW sequences 
and C. elongatus, it is possible that the PCR would have measured transcription of pgp-9 from 
the range of cyathostomin species in each population. The real time PCR was also carried out 
on cDNA from C. nassatus, C. pateratum, C. catinatum as part of the validation process, with 
positive results and melting curves identical to the pgp-9 standard (data not shown here). 
However further work in identifying the exact species mix in the two populations, and 
validating the PCR on each of these species individually, is required to fully validate the real 
time PCR. Regardless of species differences, within the context of each population, it is clear 
that IVM induced higher levels of pgp-9 transcript in Pop 1 compared to the baseline with 
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dH2O, whereas it has no effect in Pop 2, indicating that this gene is upregulated in 
cyathostomins with a ‘resistant’ phenotype. This is in agreement with studies in two closely 
related species, T. circumcincta, and H. contortus, which also demonstrated increased 
transcription of this gene in drug resistant strains (Dicker et al., 2011b; Williamson et al., 2011). 
In Williamson et al (2011), transcription levels were measured in L3 cultured from multi-drug 
resistant versus susceptible parasites that had been passaged through goats, the fold change in 
pgp-9 was similar to that seen here, at 2.65. Dicker et al. (2011) measured transcription levels 
in all life cycle stages of T. circumcincta from a multidrug resistant versus susceptible strain, 
a much larger fold change of 17.49 was recorded in this study. The reason for the higher levels 
of transcription observed for T. circumcinta, in comparison to the findings here, may be that 
the data was generated using a homogenous multidrug resistant strain, with FECR values of 
only 60 % for MLs, whereas in this study a reduced ERP was used as a proxy for ML resistance. 
In addition the samples used here were mixed samples from multiple cyathostomin species, 
which may have introduced variation if those species had different transcription levels. 
Unfortunately in cyathostomins there are currently no established parasite populations with 
unequivocal ML resistance for performing this type of study.  
 
Different P-gps have been implicated in ML resistance in other parasitic nematodes; for 
example, pgp-11 in Cooperia oncophora and Parascaris equorum (De Graef et al., 2013; 
Janssen et al., 2013). De Graef et al (2013) demonstrated increased transcript levels of pgp-11 
in adult worms isolated from calves that had been treated with IVM or MOX. In addition they 
were able to induce increased transcript levels in L3 by exposing them to IVM in vitro in 
resistant, but not susceptible, isolates, which is identical to our findings here for pgp-9. Janssen 
et al (2013) demonstrated increased transcription of pgp-11 in pre-adult stages of ML resistant 
P. equorum, in addition to three SNPs causing missense mutations. Gene knockout studies in 
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C. elegans have also shown that different combinations of ABC transporter are associated with 
IVM and MOX sensitivity, indicating that the drug type affects which transporters are likely to 
be associated with resistance (Ardelli and Prichard, 2008). In summary, the variations in P-gp 
subtype associated with ML resistance probably reflect a difference in the functionality of 
corresponding genes, such that the specific P-gp involved for their efflux may differ among 
nematode species and ML subclass. 
 
6.4.3. The effect of P-glycoprotein inhibition on the effect of ivermectin against cyathostomins 
in vitro 
In the second part of this study in vitro bioassays were used to investigate the effect of a range 
of P-gp inhibitors on IVM efficacy in cyathostomins. Specifically the LDT and LMIT were 
chosen as they are established methods for evaluating IVM efficacy in parasitic nematodes 
(Demeler et al., 2010a; Demeler et al., 2010b). The LDT measures the ability of L1 to develop 
to L3 in the presence of increasing IVM concentrations, and the LMIT measures the motility 
of L3, through their ability to migrate across a mesh in the presence of increasing IVM 
concentrations. An interesting observation here was that overall there was no statistically 
significant difference between Pop 1 and 2 in the LDT, whereas the LMIT consistently 
differentiated between the two with respect to IVM efficacy. This is in agreement with previous 
studies in cyathostomins where the LDT has shown poor correlation with the in vivo phenotype 
(Lind et al., 2005; Tandon and Kaplan, 2004). In other parasitic nematodes such as H. 
contortus, the LDT is an established technique for detecting differences in drug sensitivity 
(Dolinska et al., 2013). This may indicate that cyathostomins differ in the specific mode of 
action of IVM and potential mechanisms of resistance. A recent study has validated the use of 
the LMIT to detect differences in in vivo sensitivity to IVM (McArthur et al., 2015). The data 
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herein confirm that, in cyathostomins, the LMIT is a better in vitro tool for identifying reduced 
IVM efficacy, and consequently for investigating resistance mechanisms in cyathostomins. 
 
This study demonstrated that the addition of P-gp inhibitors impacts the effect of IVM on the 
larval stages of cyathostomins, as measured in the LMIT and LDT. This finding is consistent 
with studies in other parasitic nematodes (AlGusbi et al., 2014; Ardelli and Prichard, 2013; 
Bartley et al., 2009; Demeler et al., 2013; Raza et al., 2015). Overall the effect was dependent 
on the parasite isolate, the test (and hence the life cycle stage of the parasite) and the P-gp 
inhibitor used. P-gp inhibitors have been shown to have different modes of action and levels 
of affinity for different ABC transporters. Ketoconazole, an antifungal imidazole used in 
veterinary medicine, is a potent inhibitor of cytochrome p450 in humans (Maurice et al., 1992) 
and it has been shown to alter the pharmacokinetics of several P-gp substrate drugs by 
competitive inhibition at P-gp channels (Bartley et al., 2009; Bartley et al., 2012; Hugnet et al., 
2007; Kageyama et al., 2005; Ward et al., 2004). Specifically it has been shown to compete 
with IVM at the cyathostomin pgp-9 channel (Kaschny et al., 2015). IVM-AG is an avermectin 
derivative that is a substrate for P-gp, and therefore also acts by competitive inhibition. It has 
been shown to be as potent as verapamil, one of the best P-gp inhibitors, and importantly it has 
greater affinity for nematode versus mammalian P-gp (Lespine et al., 2013). P85 has a 
multimodal action, it belongs to a group of compounds called polaxomers, which are used as 
nanocarriers in drug delivery systems. They incorporate into cell membranes changing their 
microviscosity, this has the effect of inhibiting ATPase activity, thus reducing the activity of 
ABC transporters (Batrakova and Kabanov, 2008). They have been shown to be potent 





In this study, in the LMIT IVM-AG and ketoconazole increased the effect of IVM to a greater 
extent in Pop 1 than Pop 2. In other words, substrate inhibitors of P-gp increased the effect of 
IVM on L3 with a ‘resistant’ phenotype, but had less effect on L3 with a ‘sensitive’ phenotype. 
This suggests that P-gp activity is upregulated in the ‘resistant’ phenotype, which supports the 
earlier finding of increased pgp-9 transcription in L3 from the same population.  A study by 
Demeler et al (2013), tested different P-gp inhibitors against C. oncophora in the LDT and 
LMIT, and reported similar results to those found here; i.e. in the LMIT only there was an 
increased effect on the resistant population versus a susceptible one. In this study, the LMIT 
P85 had a bi-modal effect, whereby it increased the effect of IVM in both populations at low 
IVM concentrations, and at IVM concentrations above 0.6µg/ml the effect was reversed. One 
study in C. elegans has also shown that the effect of different P-gp inhibitors can be dependent 
on IVM concentration, although there was not a clear reversal of the effect as seen here (Ardelli 
and Prichard, 2013). Another study using P85 as a P-gp inhibitor with IVM in a larval feeding 
assay in H. contortus and T. circumcinta, did not note this bimodal effect (Bartley et al., 2009), 
and in addition it was not seen here in the LDT for P85. One point to note is that much higher 
concentrations are used in the LMIT than in assays on earlier larval stages, and hence the effect 
seen may be an interaction specific to these high concentrations. Relating the mode of action 
of P85 to the effects seen here is clearly not straightforward, and further work is needed to 
elucidate them.  
 
In the LDT, ketoconazole and P85 increased the effect of IVM in both populations to a similar 
extent. As mentioned above, the LDT did not differentiate between the ‘resistant’ and 
‘sensitive’ population, and therefore it follows logically that it also did not differentiate 
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between the effects of P-gp inhibitors on IVM efficacy in these populations. Demeler et al. 
(2013), found a similar effect in C. onchophora and Bartley et al. reported little differential 
effect of P-gp inhibitors between resistant and sensitive in a larval feeding assay, which is also 
carried out on the early larval stages. What can be concluded from the LDT here, is that P-gp 
inhibitors markedly increase the effect of IVM on early larval stages of cyathostomins, which 
suggests that they do express P-gps and that they are involved in the metabolism of IVM. In 
contrast to ketoconazole and P85, it was found that IVM-AG did not have an effect in the LDT. 
This was surprising given its effect in the LMIT, however it was used at a much lower 
concentration in the LDT than LMIT, as during optimisation it was found that it had an 
independent effect at higher concentrations. IVM-AG is known to exert some paralytic effect 
on early larval stages of GI nematodes, although it is significantly less potent than IVM, and 
has no effect on adults (Sheriff et al., 2002). It is probable that it was not at a high enough 
concentration to cause significant competitive P-gp inhibition here. Further work here might 
include increasing concentrations in the LDT to investigate any possible synergistic effect. 
 
There have been a number of other studies reporting the effects of different P-gp inhibitors on 
the in vitro effect of IVM in parasitic nematodes (AlGusbi et al., 2014; Ardelli and Prichard, 
2013; Bartley et al., 2009; Demeler et al., 2013; Raza et al., 2015). As with this study there are 
reports of differing effects dependent on parasite population, test and P-gp inhibitor used. For 
example Raza et al. (2015) tested some P-gp inhibitors, tariquidar, zosuquidar, elacridar, 
verapamil and valspodar, against H. contortus larvae of differing drug sensitivity, in the LDT 
and LMIT. They found that several of these increased sensitivity of drug resistant and 
susceptible isolates, for example, tariquidar with IVM in the LMIT and zosuquidar with IVM 
in the LDT, whereas others had a significant effect on the resistant isolate only, for example, 
zosuquidar with IVM in the LMIT and verapamil with IVM in the LDT. There is also in vitro 
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evidence that there are differences between nematode species, for example a recent study 
investigating the effect of verapamil on IVM in the LMIT showed there to be a positive effect 
in both resistant and sensitive isolates from Ostertagia ostertagi but only in the resistant isolate 
of C. oncophora (AlGusbi et al., 2014). In summary these studies, combined with the data 
collected here, suggest that some inhibitors interact with P-gps representing intrinsic pathways 
present across nematode populations with different drug sensitivities, and others interact with 
P-gps of significance only to resistant nematodes, and represent an acquired resistant 
mechanism. These interactions also appear to alter depending on test (and therefore life cycle 
stage) and nematode species.  
 
6.4.4. The potential use of P-glycoprotein inhibitors in combination with ivermectin in vivo to 
increase ivermectin efficacy 
Due to the evidence from in vitro studies, there is increasing interest in the potential use of P-
gp inhibitors to provide more effective control of GI nematodes in vivo. The proposed 
mechanisms of such combinations in vivo are: (i) reducing the efﬂux of drug from nematodes, 
and hence increasing the amount of drug reaching its target site within the nematode, and (ii) 
reducing the excretion of drugs by host animals, and hence increasing their bioavailability. 
Based on the results here, IVM-AG and ketoconazole are possible options for taking forward 
to in vivo trials in equids as they have both increased the effect of IVM in the ‘resistant’ 
population. Even though the effects of P85 were not specific to the ‘resistant’ population, it is 
also worth considering, as its effects were potent in the LDT, and at lower concentrations of 
IVM in the LMIT. The concentrations that the worm is exposed to in vivo are likely to be 
significantly lower than 0.6 µg/ml, where a reversal of the effect of P85 was seen in the LMIT 
(Lloberas et al., 2012; Perez et al., 1999; Perez et al., 2002). To date, the results of in vivo trials 
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in other species have been equivocal. For example, a study in sheep showed that, although the 
plasma concentration of IVM was significantly increased by its co-administration with 
ketoconazole, there was no effect on efficacy against H. contortus as measured by the FECRT 
(Bartley et al., 2012). The same study did show a moderate effect of P85 on IVM efficacy, even 
though the plasma concentration was similar to that seen with ketoconazole, which might 
indicate that P85 had a direct effect on parasite P-gp function. P85 may have an advantage over 
other drugs such as ketoconazole, in that it is an excellent drug delivery agent, and therefore is 
more likely to be delivered to the parasite with IVM (Batrakova and Kabanov, 2008). 
 
The study which has shown the most convincing effect of an IVM/P-gp combination has used 
loperamide in combination with IVM in sheep against resistant GI nematodes, and shown a 
markedly improved efficacy (Lifschitz et al., 2010a). Loperamide has been shown to increase 
plasma concentrations of MLs (Lifschitz et al., 2002); it also reduces faecal transit time and 
therefore may increase exposure time of parasites to MLs in the gut. Despite the lack of clarity 
of the evidence, given that no new anthelmintics are likely to be licenced in equids in the short 
to medium term, there is certainly cause to investigate the use of P-gp inhibitors in combination 
with MLs for treatment of cyathostomin infections in future. Some of the P-gp inhibitors tested 
here have already been used systemically in equids, which may facilitate future in vivo trials, 
for example ketoconazole for the treatment of fungal infections (Nappert et al., 1996), and 
loperamide for diarrhoea (Sanchez, 2014). It is also important to be aware of the potential side 
effects of drug interactions, for example increased toxicity of IVM due to increased 
bioavailability and plasma levels, however, reassuringly toxicity has not been noted in the in 




6.4.5. The use of a general linear mixed model to analyse dose response data 
In this study two different approaches were initially taken to analyse dose response data from 
in vitro tests. The first is the conventional PROBIT analysis, which gives an EC-50 value for 
comparison between tests, see Appendix 3.1. The potential issue with using this method is that, 
especially in tests subject to variability, the results do not always fit a PROBIT model, a good 
example in this study is the case of P85 in the LMIT. If the results were analysed using PROBIT 
then the EC-50 values would not truly represent the bimodal relationship between IVM 
concentration and larval migration in the presence of P85. Other methods are also described in 
the literature, such as the four parameter model, which offer greater flexibility in model fitting 
(AlGusbi et al., 2014; Demeler et al., 2013). Here, the use of a GLMM was explored to allow 
statistical comparison of the effect of each PGPI on the two populations in each test. A 
piecewise break down of this model allowed successful modelling of the data from the LMIT 
with P85. The results correlated with what was seen from the EC-50 ratios (Appendix 3.1., 
Table A.3.1) thus validating the methodology. The GLMM can therefore be considered in 
future to be a flexible and statistically powerful method for analysing this type of data. 
 
6.5. Conclusion 
The results strongly implicate a role for P-gps in reduced sensitivity to IVM in cyathostomins. 
Specifically, increased pgp-9 transcription in response to IVM in mixed species L3 populations 
was identified.  The in vitro data confirm that IVM interacts with P-gps in cyathostomins, as 
the effect of IVM was increased by three different P-gp inhibitors in the LMIT and LDT. 
Specifically ketoconazole and IVM-AG increased the effect of IVM in the ‘resistant’ 
cyathostomin isolate to a greater extent than in the ‘sensitive’ population, implicating 
interference with an acquired resistance mechanism. These data support the possibility that P-
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gp inhibitors could be used in combination with IVM in vivo, as a novel approach to improving 
control of IVM resistant cyathostomins. The expression of various P-gps at different lifecycle 
stages in multiple cyathostomin species represents a highly complex system and it is clear that 
further work is needed to identify specific resistance mechanisms that can be targeted in future 





























































Multidrug resistance is emerging in cyathostomins, and a lack of novel therapeutics on the 
horizon is putting the control of these important gastrointestinal (GI) nematodes under threat.  
This thesis examined the potential of novel control options for cyathostomins, with a focus on 
bioactive plants and combinations of ivermectin (IVM) and P-glycoprotein (P-gp) inhibitors. 
It was found that a number of crude plant extracts from plants sourced both in the UK, and 
Ethiopia, showed good anthelmintic activity in vitro (Chapters 4 and 5). It was also found that, 
not only was pgp-9 transcription increased in cyathostomins with a ‘resistant’ phenotype, but 
P-gp inhibitors significantly increased IVM activity against cyathostomins in vitro (Chapter 6). 
This thesis provides vital preliminary in vitro data in order to take some of these novel 
therapeutic options forward into in vivo trials.   
 
7.2. Do bioactive plant extracts represent a realistic option for the control of 
cyathostomins? 
Here via a participatory rural appraisal (PRA) for Ethiopia and a literature review for the UK, 
several plant species were chosen for in vitro evaluation of any anthelmintic effects against 
cyathostomins. These are established techniques for gathering information on the potential 
anthelmintic activity of plants (Hussain et al., 2008; Lans et al., 2000; Nabukenya et al., 2014a; 
Tolossa et al., 2013). During this work several issues arose which highlighted potential 
problems with the uptake of plant-based treatments for cyathostomins in equids. For Ethiopia 
the PRA data suggested that people do not treat donkeys and horses as they do other livestock, 
see Section 3.3.1., and hence there may be a fundamental lack of awareness of the need to 
administer treatment, even if a plant was to be recommended. As discussed in Section 3.4.4., 
it may be of use to identify proxies to indicate that treatment is needed in equids such as has 
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been done for parasitic disease in livestock (Nabukenya et al., 2014a; Vilela et al., 2012), or 
alternatively recommend regular treatment at certain times of year when transmission intensity 
is known to be at its highest (Getachew et al., 2008). It may be necessary to implement 
education programs imparting this information, before recommending any plant based 
treatments.  In addition, in a thematic analysis of opinions from the PRA, it was found that 
there was a move away from traditional plant treatments in favour of chemical anthelmintic 
preparations available at government clinics, due to concerns regarding efficacy and side 
effects (Scantlebury et al., 2013).  This has also been noted in other recent ethnobotanical 
studies (d'Avigdor et al., 2014). It seems that peoples’ opinions regarding ethnoveterinary 
medicines are changing, and this may make it difficult to implement plant-based treatment 
recommendations in future. The PRA also called into question the ethics of recommending 
plant based treatments to poor rural communities in developing countries. There was wide 
variability in the preparation and dosing of plants and the side effects reported, in addition 
some of the methods of dosing were potentially dangerous, see Table 3.3.4.a and b. Any future 
in vivo trial would need to address these factors, and ensure that the proposed treatment was 
not dangerous in any form.  
 
In developed countries, such as the UK, such issues are largely obsolete as people regularly 
treat equids with anthelmintics and there is access to better diagnostics. However there are 
similar safety considerations surrounding dosing and administration of bioactive plants. There 
are also issues surrounding the development of any plant based product for use in the UK as a 
novel pharmaceutical product. For example, to develop new an anthelmintic preparation with 
efficacy greater than 95 %, it would be necessary to identify the active component/s in each 
extract, perform toxicity tests and in vivo efficacy tests using a refined preparation (Shi et al., 
2009; Wang et al., 2011). Research arising from this study could include such techniques, 
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however large scale production and testing in equids would be costly and better suited to a 
pharmaceutical company. It has already been highlighted in the introduction to this thesis, that 
the novel synthetic anthelmintics, emodepside and monepantel, do not appear to be being 
developed by pharmaceutical companies for use in equids (Section 1.3.4) (Epe and Kaminsky, 
2013), hence it seems unlikely that there would be uptake from this industry for developing 
plant extracts.  
 
An alternative approach would be to evaluate the merit of supplementing equine feed with 
crude dried extract, or allow equids to graze forage with anthelmintic component, such as has 
been done for bioactive forages in ruminants (Heckendorn et al., 2007; Hoste et al., 2015). This 
approach would also eliminate some of the safety considerations surrounding methods of 
administration which apply in both the UK and Ethiopia, making it potentially the most feasible 
option for improving control of cyathostomins in equids using bioactive plants. 
 
7.3. Which of the bioactive plants tested here should be considered for in vivo trials in 
equids? 
As discussed above, the most feasible option in the short term, for developing a plant based 
anthelmintic treatment for use in equids in both the UK and Ethiopia, would be 
supplementation of the diet with a forage or crude extract with some anthelmintic activity. The 
aim would be similar to that of many of the novel approaches that were discussed in the 
introduction to this thesis, i.e. to reduce reliance on the currently available synthetic 
anthelmintics, and thus reduce selection pressure for further development of drug resistance 
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(Matthews, 2014). The choice of plant for future in vivo trials, will depend on which species is 
best suited to this therapeutic goal, whilst taking into account safety considerations. 
 
The in vitro findings here showed that one of the most efficacious extracts from Ethiopia was 
Acacia nilotica fruit pods, whose anthelmintic effect was found to be due to the action of 
condensed tannins. In support of the use of A. nilotica for in vivo trials in equids, there is also 
evidence that it is efficacious against GI nematodes in vivo in sheep (Bachaya et al., 2009). In 
addition, in tropical and sub-tropical regions other tannin rich legume forages, such as 
Desmodium intortum (Mill.) Urb. and Sesbania sesban (L.) have been found to have 
anthelmintic activity in vivo (Debela et al., 2012). Acacia nilotica pods are seasonal, but in 
theory could be harvested for use in equids throughout the year and provided as forage, as 
described for other livestock species in Djibuti (Audru et al., 1993). Major advantages of 
forages with anthelmintic activity, are that they also have some nutritional value, and can be 
fed as part of a balanced diet (Hoste et al., 2015) and, in addition, they are usually consumed 
by choice, thus alleviating issues over methods of administration. This approach could be an 
extremely useful addition to cyathostomin control in equids in Ethiopia. In temperate regions 
such as the UK, forages containing high levels of tannins have also been found to be effective 
in reducing parasite burdens in small ruminants (Heckendorn et al., 2007; Lange et al., 2006). 
Examples of these are Onobrychis viciifolia Scop., Lotus corniculatis L. and Lespedeza cuneate 
G. Don., some of which were highlighted in the literature review for the UK in Chapter 3, see 
Appendix 2.2.. The bioactive forages were originally rejected for testing on donkey 
cyathostomins in the UK, due to concerns over their high nutritional value and the tendency of 
donkeys to obesity (Burden, 2012). However considering the evidence of the effect of tannins 
on cyathostomins, they deserve further consideration in future studies with horses and donkeys.  
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Other plants which were identified here as having an anthelmintic effect in vitro, included R. 
abyssinicus and C. prophetarum from Ethiopia, and Allium sativum, Zingiber officinale and 
Chenopodium album from the UK. These could also be considered for future in vivo trials given 
as a crude dried extract, as equids are unlikely to eat them in significant quantities voluntarily. 
Toxicity studies and detailed consideration of dosing and method of administration would be 
needed before embarking upon this work. The advantage of the A. sativum and Z. officinale for 
use in developing countries, is that they are already manufactured as dietary supplements in 
equids (Williams and Lamprecht, 2008), which would facilitate in vivo trials. Although these 
extracts are commonly given to equids, no study has reported their effects on GI nematode 
burdens in equids. This is an obvious area for further investigation that has been highlighted 
by this study.  
 
If the aim were to develop a novel therapeutic with high efficacy for use in developed countries, 
the best candidate for taking forward to in vivo trials based on the results of this thesis, would 
be papaya latex supernatant (PLS), which contains high levels of cysteine proteinases (CPs). 
PLS was found to be effective against multiple stages of cyathostomins at low concentrations, 
thus, of all of the plant extracts tested, it showed the most potent effect against cyathostomins 
(Chapter 5). In addition there is a great deal of supporting evidence for its anthelmintic efficacy 
from in vivo studies in other veterinary species, and significant adverse side effects are not 
reported (Buttle et al., 2011; Levecke et al., 2014; Mansur et al., 2014a; Satrija et al., 1994; 
Stepek et al., 2006, 2007b, c). In the event of multidrug resistance becoming widespread in 
cyathostomins, PLS represents an excellent candidate for consideration as a novel therapeutic 
for cyathostomins in equids. Unfortunately a major factor preventing the development of 
extracts containing CPs as novel anthelmintics in other veterinary species, is that they may not 
be patentable, due to the fact they have been widely used for decades in traditional medicine. 
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This may make it unlikely that a pharmaceutical company would develop PLS as a product for 
treatment of cyathostomins in equids, even if there were a dire need.  
 
7.4. The challenge of defining anthelmintic efficacy 
This study has highlighted some general issues surrounding testing plants for anthelmintic 
activity. It was noted in Chapter 4, that the effect of extracts differed depending on the in vitro 
test and solvent used. Similarly there are reports of such variations in the literature (Marie-
Magdeleine et al., 2009; Marie-Magdeleine et al., 2010a; Marie-Magdeleine et al., 2010b). 
There are also many other variables when testing plant extracts in vitro. The efficacy of extracts 
has been shown to depend on the part of the plant that is used: for example, an in vitro study 
assessing the anthelmintic activity of Peltophorum africanum found the root to be five times 
more efficacious than the leaf (Bizimenyera et al., 2006). The preparation of the plant material 
and method of extraction of plant compounds also varies between studies. For example there 
is a large variation in the time in which the plant compounds are extracted for: from as little as 
15 minutes to 120 hours (Githiori et al., 2003a; Hordegen et al., 2003). In addition a wide 
variety of solvents are used for extraction including water, ethanol, methanol, acetone, ethyl 
acetate, hexane, DMSO, dichloromethane and acetic acid. Commonly aqueous and hydro-
alcoholic solvents such as methanol and ethanol have been compared, with the latter usually 
proving more efficacious (Iqbal et al., 2006c; Marie-Magdeleine et al., 2010b). These 
differences probably account for the variation in results of studies in the literature for both in 
vitro and in vivo data. For example Hordegan et al. (2003) performed an in vivo study looking 
at the potential effects of 5 plant extracts, which had shown good efficacy in previous studies 
and only one plant, F. parviflora, showed significant efficacy. In addition the efficacy of 
Albizia anthelmintica in vivo has been assessed in different studies and found to be 34 % and 
171 
 
90 % depending on the study design (Gathuma et al., 2004; Githiori et al., 2003a). It is therefore 
important that initial plant screening should include testing on multiple life-cycle stages of 
parasites, with extracts from different extraction techniques, in vitro and in vivo. Future work 
here could include repeating extractions with different solvents and in more in vitro tests, but 
ultimately randomised controlled trials in vivo are needed to confirm anthelmintic efficacy. 
 
Another area for future consideration is the use of high throughput screening techniques to look 
at the effect of plant extracts. Here the number of plants that could be screened was limited by 
the optimisation and repeated screening of extracts in tests that take up to three days to 
complete. Recently, specialist laboratories have validated high throughput automated systems 
for some nematode species (Marcellino et al., 2012; Smout et al., 2010).  These techniques 
were designed to aid the screening of large libraries of synthetic compounds for anthelmintic 
activity, but would also be applicable to screening plant extracts. Microfluidic techniques are 
also under development for analysing the effect of drugs on nematodes, and could be of use in 
future for immature stages cyathostomins (San-Miguel and Lu, 2013).  At present none of these 
techniques have been evaluated for use in cyathostomins and this is an important area of future 
research for the development of novel therapeutics.  
 
7.5. Should P-glycoprotein inhibitors in combination with ivermectin be taken forward 
to in vivo trials in equids?  
As described in Chapter 6, in vitro tests were used to test a different hypothesis; that P-gps are 
involved in IVM metabolism in cyathostomins, and the use of inhibitors of these protein 
channels can potentially be used to improve the effect of IVM against cyathostomins as a novel 
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control option. Initially the transcription of pgp-9 was measured in ‘resistant’ versus ‘sensitive’ 
cyathostomin third stage larvae (L3), and found to be significantly increased in the ‘resistant’ 
population after exposure to IVM. This is in agreement with studies from other closely related 
GI nematodes (Dicker et al., 2011b; Williamson et al., 2011) and indicates that pgp-9 
expression is associated with ivermectin resistance in cyathostomins.  In support of this data, 
in vitro tests described in Chapter 6 showed that the P-gp inhibitors pluronic 85 (P85), 
ketoconazole and ivermectin aglycone (IVM-AG) increased the effect of IVM in the larval 
migration inhibition test (LMIT) and/or larval development test (LDT), and that this effect was 
specific to ‘resistant’ cyathostomins in the LMIT with ketoconazole and IVM-AG. Based on 
this evidence, in vivo trials in equids should be considered as a direct progression of this work.  
 
The important question with respect to novel options for controlling cyathostomins, is whether 
modulating P-gp activity in vivo will improve IVM efficacy. The evidence from in vivo studies 
in other host species is not fully supportive, as discussed in Chapter 6, Section 6.4.4. (Bartley 
et al., 2012). There are several possible reasons for this. Firstly the ML resistance trait is 
thought to be multigenic and may differ between field isolates of resistant nematodes, and 
therefore P-gps, although genuinely upregulated in some examples of resistance, may not 
represent the major mechanism of resistance in others. For example a study evaluating the 
transcriptome of ML resistant Teladorsagia circumcincta reported that there was no increase 
in transcription of P-gps after IVM exposure in vitro (Dicker et al., 2011a), whereas another 
study found a marked increase in transcription of pgp-9 in the same species (Dicker et al., 
2011b). Similarly one study in Haemonchus contortus showed no changes in transcription of 
P-gp genes in an ML resistant isolate (Williamson and Wolstenholme, 2012), whereas another 
study showed that both pgp-2 and pgp-9 expression were increased (Williamson et al., 2011). 
There is also the possibility that the P-gp inhibitors that have not worked in vivo, have not been 
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given at the right dose, or by the best route of administration. For example, there is evidence 
from drug combinations with anthelmintics that certain routes of administration result in an 
improved synergistic effect (Lanusse et al., 2015). In addition the choice of P-gp inhibitor used 
appears to affect efficacy in vivo; studies to date indicate that loperamide has a better effect 
than ketoconazole and P85 (Bartley et al., 2012; Lifschitz et al., 2010a; Lifschitz et al., 2010b). 
Based on these observations future in vivo trials in equids should aim to evaluate a range of P-
gp inhibitors at different doses, administered by different routes. 
 
Should it be proven that P-gp inhibitors improve efficacy of IVM in vivo in equids, careful 
consideration must also be given to the consequences of such treatments. One theory is that, 
by effectively increasing the anthelmintic dose that parasites are exposed to in vivo, selection 
pressure for multidrug resistance might be increased (Lespine et al., 2012). This hypothesis 
could be tested in vitro but this would be difficult in cyathostomins as currently, there are no 
in vitro models of resistance. This may mean that drug combinations with MLs and P-gps 
would not be suitable for use as a commercial preparation for widespread use, however they 
could still offer a vital treatment alternative in cases of clinical disease due to multi resistant 
cyathostomins.  
 
7.6. Final conclusions 
This thesis has highlighted several avenues for further investigation that hold promise for 
improving control of cyathostomins infections in equids. After consideration of the data here 
in combination with supporting evidence it can be recommended that PLS, P-gp/IVM 
combinations and tannin rich forages, should be seriously considered for in vivo trials in equids 
174 
 
in developed countries, where anthelmintic resistance is a major threat to control. Plants such 
as A. nilotica and bioactive legume forages, which contain high levels of condensed tannins 
are good options for taking forward to in vivo trials for use in developing countries, where 
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1.1. Optimisation of egg storage method 
Three different methods of nematode egg storage have been described; anaerobic storage at 
room temperature, or 4 ºC and aerobic storage at 4 ºC (Coles et al., 1992; Ihler and Bjorn, 
1996). The optimal method for cyathostomins has not been established, and hence was tested 
here. Figure A.1.1. shows the mean percentage egg hatch in cyathostomins egg samples after 
seven days under these different conditions. One way analysis of variance (ANOVA), 
performed in SPSS version 21 (SPSS Inc., Chicago IL), on the data demonstrated that there 
was no significant difference in percentage egg hatch between different storage methods after 
7 days of storage, p = 0.067, all samples had  >80 % egg hatch. It was noted at microscopy that 
the majority of eggs that were stored aerobically and anaerobically at 4 °C were showing signs 
of development, and thus for all future experiments eggs were stored anaerobically at room 
temperature. 
 
Figure A.1.1. The effect of different storage methods (fresh hatch, anaerobic, anaerobic 4 ºC, aerobic 
4 ºC) on egg samples at seven days, on mean percentage egg hatch (taken from an average of a sample 




































1.2. Comparison of percentage egg hatch in tap water and distilled water 
The chemical composition of the tap water (H2O) can have an inhibitory effect on egg hatch. 
It was therefore necessary to assess whether the tap H2O available in the laboratory at the 
University of Liverpool altered percentage egg hatch. A student T test, performed in SPSS 
version 21, demonstrated that a significantly greater percentage of eggs hatched when using 
distilled H2O (dH2O) rather than tap H2O, p = 0.016. The data are represented in a bar chart in 
Figure A.1.2. Thus dH2O was considered optimal for use in all further tests. 











































1.3. Evaluation of the effect of dimethyl sulfoxide in the egg hatch test 
Dimethyl sulfoxide (DMSO) is the most commonly used solvent to dissolve anthelmintic 
compounds in pharmacological studies using the egg hatch test (EHT), hence as part of the 
validation process the effect of DMSO on egg hatch was evaluated. The ability of eggs to hatch 
in increasing concentrations of DMSO (between 0-10 % v/v) was evaluated, the results are 
shown in Figure A.1.3. This was repeated throughout the thesis in each new parasite population 
used, in case of any differential effect amongst populations. There was a significant reduction 
in egg hatch at DMSO concentrations of > 5% (p<0.001), measured by repeated measures 
analysis of variance (ANOVA), performed in SPSS version 21.  
                           
Figure A.1.3. Graphical representation of the effect of increasing dimethyl sulfoxide (DMSO) 






























1.4. Preliminary examples of the egg hatch test with thiabendazole 
Dose response curves for the EHT with thiabendazole (TBZ) for cyathostomins eggs from 
horse and donkey samples are shown in Figures A.1.4.a and b respectively. The results clearly 
demonstrate that percentage egg hatch in cyathostomins can be reduced in a dose dependent 
fashion by TBZ, and thus the EHT can be used with confidence to assess whether other 
compounds, such as plant extracts, have any effect on cyathostomin egg hatch. EC-50 values 
were calculated for each test using PROBIT analysis (SPSS 21), and were 0.052 µg/ml 
(confidence interval (CI): 0.049-0.055) and 0.043 µg/ml (CI: 0.033-0.050) for the horse and 
donkey samples respectively. 
 
                       
 
                       
Figure A.1.4. Logarithmic dose response curves showing the effect of an increasing concentration of 




















































1.5. Preliminary examples of the egg hatch test with papaya latex supernatant  
Figure A.1.5. shows dose response curves for preliminary EHTs with papaya latex supernatant 
(PLS). EC-50 values (calculated in GraphPad Prism version 6.00 for Windows (GraphPad 
Software, La Jolla California USA, www.graphpad.com)) were 0.09 (CI:0.08-0.08) and 0.09 
(CI:0.08-0.10) µM, for the two repeats. There was no significant difference between repeats 





             
Figure A.1.5. Graphical representation of the dose response relationship between mean percentage 
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1.6. Assessment of suitability of mesh pore size by heat treatment of sheathed and ex-sheathed 
third stage larvae  
To ensure that the mesh size used in the larval migration inhibition test (LMIT) protocol was 
appropriate for the cyathostomin populations used in this thesis, a heat treatment assay was 
performed. Sheathed and ex-sheathed third stage larvae (L3) were killed by exposure to 70 ºC 
heat for 20 min. Their ability to migrate across a 25 µm nylon mesh (HPC gears), was then 
compared to live L3. Figure A.1.6., demonstrates that for both sheathed and ex-sheathed L3 
the pore size of 25 µm prevents dead or immotile L3 from crossing the nylon mesh, whilst 
allowing the majority of live L3 to migrate. 
                   
Figure A.1.6. The mean percentage larval migration in sheathed and unsheathed third stage larvae (L3) 








































1.7. Comparison of sheathed versus ex-sheathed third stage larvae in the larval migration 
inhibition test 
The LMIT was repeated with and without ex-sheathment of L3. There was no significant 
difference in percentage migration in controls (p=0.344), as identified by the students T test 
(SPSS 21) of sheathed and ex-sheathed L3 through the nylon mesh. However there was a 
significant difference in the total number of migrators and non-migrators that were counted at 
the end of the tests, p<0.001. A mean of 82 ± 10 sheathed and 207 ± 14 ex-sheathed L3 were 
counted. This indicated that there had been a loss of sheathed L3 during the experiment due to 
the sheathed L3 becoming trapped in the nylon mesh.  A comparison of sheathed and ex-
sheathed L3 in the LMIT with IVM is shown in Figure A.1.7.  
                      
Figure A.1.7. The effect of ivermectin (IVM) concentration on sheathed and ex-sheathed cyathostomin 





































1.8. Evaluation of the effect of dimethyl sulfoxide on larval migration in the larval migration 
inhibition test 
The LMIT was repeated with DMSO (1-10 %) in order to establish the effect of the solvent on 
migration, and hence determine limits of DMSO concentration for further experiments. This 
was repeated throughout the thesis in each new parasite population used, in case of any 
differential effect between populations. The results of this titration are shown in Figure A.1.8. 
There was a significant effect on larval migration at DMSO concentrations higher than 5 % 
(p=0.02), measured by repeated measures ANOVA (SPSS version 21) thus 5 % was the 
maximum used in all further tests. 
 
                   
Figure A.1.8. The effect of increasing concentrations of dimethyl sulfoxide (DMSO) on larval 































Concentration DMSO (% vol)
239 
 
1.9. Preliminary examples of the larval migration inhibition test with ivermectin  
Figure A.1.9. shows dose response curves for preliminary repeats of the LMIT with increasing 
concentrations of ivermectin (IVM) in horses and donkeys. The EC-50 values calculated by 
PROBIT analysis (SPSS 21 version 21) were 1.928 µg/ml (CI: 0.365-4.595), 8.391 µg/ml (CI: 
1.374-19.834), 0.472 µg/ml (CI: 0-8.859) and 1.684 (CI: 0.150-7.923) for donkey 1, donkey 2, 
horse 1 and horse 2 respectively. 
 
                    
                          
                    
Figure A.1.9. The effect of an increasing concentration of ivermectin (IVM) on the mean percentage 
































































1.10. Optimisation of incubation time with papaya latex supernatant in the larval migration 
inhibition test 
The LMIT was repeated for PLS with four different incubation times (2, 6, 16 and 24 h), to 
establish the optimal time for demonstration of a good effect. The results are shown in Figure 








Figure A.1.10. The effect of increasing incubation times with papaya latex supernatant (PLS) in the 
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1.11. Preliminary examples of the larval migration inhibition test with increasing 
concentrations of papaya latex supernatant and stem bromelain 
Preliminary repeats of the LMIT were performed for PLS, with incubation time 16 h. The dose 
response curves are shown in Figure A.1.11. EC-50 values (calculated using Graphpad Prism 
6) were 18.69 (CI:12.58-27.76) and 15.42 (CI:10.35-22.91) µM for PLS repeats 1 and 2. There 
was no significant difference between repeats for PLS, calculated using the sum of squares F 







                                                                             
 
 
Figure A.1.11. Graphical representation of the dose response relationship between mean percentage 
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1.12. Dose titration of pluronic 85 and ketoconazole in the larval migration inhibition test 
For optimisation of concentration in the LMIT, pluronic 85 (P85) and ketoconazole were 
diluted in dH2O or DMSO respectively and used in the LMIT in a 1:100 ratio to give final 
concentrations of 500.0, 250.0, 125.0, 62.5, 31.3, 15.6, 7.8, 3.9 and 2.0 µM in the test. The 
DMSO concentration was kept constant at 3 %, at all drug concentrations. Figure A.1.12. shows 
the results of these dose titrations. No significant effect was seen at any concentration tested 
for either P85 or ketoconazole except 500 µM. 
 











1.13. Dose titration and establishing optimal concentration for ivermectin aglycone in the 
larval migration inhibition test 
For ivermectin aglycone (IVM-AG) a dilution was made in DMSO to give working 
concentrations which were added to the LMIT in a ratio of 0.5:100 to give the final 
concentrations, 200, 180, 160, 140, 120, 100, 80, 60, 40 and 20 nM. The concentration of 
DMSO was kept constant at 3 %. As the optimal concentration has not been previously 
reported, an additional test was run where increasing concentrations of IVM-AG were 
compared with increasing concentrations of IVM-AG plus 1 µM IVM. This was done to 
determine the concentration at which the addition of IVM-AG optimally improved inhibition 
of larval migration compared to IVM alone. The effect of co-incubation with IVM-AG and 
IVM, peaked at 60 nM and 120 nM IVM-AG. The lower of these concentrations, 60 nM, was 
chosen for further tests. 
                       
Figure A.1.13. Graph showing the effect of increasing concentrations of ivermectin aglycone (IVM-
AG) on mean percentage third stage larvae (L3) migration, with and without, the addition of 1 µM 


































1.14. Optimisation of growth medium and amphotericin B concentration in the larval 
development test for cyathostomins 
Two growth mediums were used in preliminary experiments. The first (growth medium A 
(GMA)) consisted of  10 x Earles salt solution (Sigma-Aldrich, UK) and yeast solution (1g 
yeast (Sigma-Aldrich, UK) autoclaved in 90 ml 0.9 % sodium chloride (NaCl) (Sigma-Aldrich, 
UK)) in a 1:9 ratio. This was combined with 1.5 mg/ml autoclaved lyophilised Escherichia coli 
K12 (Sigma-Adlrich, UK) in a 2:1 ratio. The second (growth medium B (GMB)) consisted of 
10 x Earles salt solution and yeast solution (1g yeast autoclaved in 90 ml 0.9 % NaCl) in a 1:9 
ratio. This solution was diluted 2.5 times with dH2O and combined with autoclaved 1.5 mg/ml 
lyophilised Escheria coli K12 in a 2:1 ratio. A larval development test (LDT) was set up to 
compare growth mediums and dose titration of amphotericin B (Sigma-Aldrich, UK) (final 
concentrations 0-58 µg/ml). Figure A.1.14. shows the effect of increasing concentrations of 
amphotericin B on percentage larval development in GMA and GMB. Amphotericin B had no 
effect up to 33 µg/ml. Percentage larval development was consistently higher with GMA 
compared to GMB. It was also observed that the motility of larvae was greater in GMA and 
the medium was less cloudy, suggesting less bacterial growth. Hence GMA was used in all 
LDTs. 
                       
Figure A.1.4. Graph showing mean percentage larval development in growth medium A (GMA) and 


































1.15. Evaluation the effect of dimethyl sulfoxide in the larval development test 
The LDT was performed with a dose titration of drug solvent DMSO (between 0-1% v/v) to 
establish the threshold for the concentration of DMSO in each well. The results are shown in 
Figure A.1.5. There was a significant effect on larval migration at DMSO concentrations higher 
than 0.5 % (p=0.001), measured by repeated measures ANOVA (SPSS version 21). Therefore 
a concentration of 0.5 %, in accordance with that described in Demeler et al (2010), was used 
in all further tests.  
                      
Figure A.1.15. Graph showing the effect of increasing concentrations of dimethyl sulfoxide (DMSO) 
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1.16. Preliminary examples of the larval development test with ivermectin 
Examples of the results of preliminary LDTs in cyathostomins samples from horses and 
donkeys are shown in Figure A.1.16. EC-50 values calculated with PROBIT analysis (SPSS 
version 21) for the IVM LDT in four separate samples were: donkey 1 = 6.823 nM (CI: 5.407-
8.310), donkey 2 = 11.396 nM (CI: 10.106-12.842), horse 1 = 3.727 nM (CI: 2.842-4.875), 
horse 2 = 4.240 nM (CI: 3.808-4.706).  
 
                     
Figure A.1.16. The effect of increasing concentrations of ivermectin (IVM) on larval development in 













































1.17. Dose titration of pluronic 85, ketoconazole and ivermectin aglycone in the larval 
development test 
For optimisation of concentration in the LDT, P85 and ketoconazole were diluted in dH2O or 
DMSO respectively to give working solutions which were added in a 0.5:100 ratio in the LDT 
to give final concentrations of 250.0, 125.0, 62.5, 31.3, 15.6, 7.8, 3.9, 2.0, and 1.0 µM. For 
optimisation of concentration in the LDT IVM-AG was dissolved in DMSO to give working 
solutions which were added to the LDT in a 0.5:100 ratio to give the final concentrations 
100.00, 50.0, 25.00, 12.50, 6.25, 3.13, 1.56, 0.78, 0.39 and 0.20 nM.  Figure A.1.17. shows the 
results of these dose titrations. For ketoconazole there was a marked effect of larval 
development at concentrations above 15.6 µM, and for IVM-AG there was an effect on larval 
development at concentrations greater than 12.5 nM. 
            
Figure A.1.17. Dose titrations of pluronic 85 (P85), ketoconazole and ivermectin aglycone (IVM-AG) 
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2.2. Summary of the results of the PubMed literature review for identification of UK plant candidates  
Table A.2.1. Summary of the results of the PubMed literature review for identification of UK plant candidates for in vitro testing, including 138 references 
reporting anthelmintic effects of plants against nematodes 
Efficacy Moderate/low 
Efficacy 
No Efficacy Animal Nematode 
spp 
Extract with Reference 
- Annona squamosa  
- Eclipta prostrate 
- Solanum torvum  
- Terminalia chebula 
- Catharanthus roseus 
In vitro 
   Haemonchus contortus Ethyl acetate, 
acetone, methanol 




- Anisomeles malabarica 
- Datura metel 
- Solanum torvum  
- Annona squamosa 
In vitro 
   Haemonchus contortus Ethyl acetate, 
acetone, methanol 
(Kamaraj et al., 2011)  
  Artemisia spp.  
In vivo 
Gerbil Haemonchus contortus Ethanol,  
Aqueous 
(Squires et al., 2011)  
- Anogeissus leiocarpus  
- Khaya senegalensis  
- Euphorba hirta 
- Annona senegalensis 
nigrescens 
In vitro 
   Caenorhabditis elegans  Ethanol (Ndjonka et al., 2011)  
- Trichosanthes dioica 
Roxb. 
In vitro 
   Ascaridia galli Dichoromethane’ 
Methanol, 
Aqueous 
(Bhattacharya et al., 
2010)  
- Manihot esculenta     Haemonchus contortus Dichoromethane, 
Methanol, 
Aqueous 
(Marie-Magdeleine et al., 
2010b)  
- Eucalyptus staigeriana  
In vivo 
  Goats 
(toxicity in 
rats) 
Haemonchus contortus Essential oil (Macedo et al., 2010)  
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  - Lysiloma latisiliquum 
In vivo  
Sheep Haemonchus contortus Fodder (Martinez-Ortiz-de-
Montellano et al., 2010)  
 - Zanthoxyylum 
rhoifolium  
In vivo 
 Sheep Haemonchus contortus Leaf extract (Peneluc et al., 2009)  
Orange oil emulsion 
In vivo 
`  Sheep 
Gerbil 
Haemonchus contortus  (Squires et al., 2010) 
- Lotus pedunculatus 
- Lotus corniculatus  
- Dorycnium 
pentaphyllum 
- Dorycnium rectum 
- Rumex obtusifolius 
In vitro 
   Teledorsagia 
circumcincta 
Extracts (Molan and Faraj, 2010) 
- Anacardium humile 
In vitro 




(Nery et al., 2010) 
-  Balanites aegyptiaca  
In vivo 
  Rats Trichinella spiralis Methanol (Shalaby et al., 2010)  
 - Rubus niveus  
In vitro 
  Meloidogne incognita 
(root knot nematode) 
Alcohol 
Petroleum 
(Sultana et al., 2010) 
- Melia azedarach 
In vitro 
 
   Haemonchus contortus Aqueous, 
Hydroalcholic, 
Leaves and seed 
(Kamaraj et al., 2010) 
- Lysimachia ramosa 
In vitro 
   Fasciolopsis buski 
Ascaris suum  
Raillietina 
echinobothrida  




   Haemonchus contortus Dichloromethane. 
aqueous, 
methanol 
(Marie-Magdeleine et al., 
2010a) 
- Combretum molle  
In vitro 






(Ademola and Eloff, 
2010) 
 - Morinda citrifolia 
In vivo 
 Chickens Ascarida galli Aqueous, 
Ethanol 
(Brito et al., 2009)  
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- Zingiber officinale 
extracts 
In vitro 




(Lin et al., 2010) 
 - Azadirachta indica  
In vitro 





(Iqbal et al., 2006a) 
- Acacia polyacantha 
- Anogeissus leiocarpus  
- Bridelia micratha 
- Cassia seiberiana  
- Combretum nigricans 
- Grewia bicolour 
- Strychnos spinosa 
- Ziziphus mucronata  
In vitro 
   Caenorhabditis elegans  Aqueous 
Organic 
(Waterman et al., 2010) 
- Quercus coccifera  
- Ceratonia siliqua  
In vitro/in vivo 




- Olea europaea 
- Ceratonia siliqua 
In vitro/in vivo  
 Sheep Haemonchus contortus  (Manolaraki et al., 2010)  
- Canthium manni 
In vitro/in vivo 
 
  Mice Heligosomoides 
polygyrus 
 (Wabo Pone et al., 2010; 
Wabo Pone et al., 2009)  
 - Carica papaya 
(latex) 
In vivo 
 Chickens Mixed gastrointestinal 
nematodes 
 (Chota et al., 2010) 
- Khaya senegalensis 
In vitro  
 
   Haemonchus contortus Ethanol 
(Separation of 
fractions) 
(Ademola et al., 2009)  
 - Prosopis laevigata 
In vivo 
 Gerbils Haemonchus contortus Hexane  (De Jesus-Gabino et al., 
2010) 
- Cocos nucifera 
In vivo 
 
  Mice Gastrointestinal 
nematodes 
Butanol  (Costa et al., 2010)  
- Sericea lespedeza  
In vivo 
  Goats Gastrointestinal 
nematodes 
Fed hay (Terrill et al., 2009)  
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- Acacia nilotica 
- Ziziphus mummularia  
In vitro/in vivo 
  Sheep Gastrointestinal 
nematodes in vivo 
Haemonchus contortus 
in vitro 
Methanol (Bachaya et al., 2009) 






  Haemonchus contortus Aqueous, 
Hydroalcoholic 
(Tadesse et al., 2009)  
 -Cleistopholis patens   Rhabditis 
pseudoelongata 
 (Akendengue et al., 
2009)  
 - Coreopsis 
lanceolata 
  Caenorhabditis elegans  Spectroscopic 
methods 
(Kimura et al., 2008)  
- Cucurbita moschata 
In vitro 
 
   Haemonchus contortus Dichloromethane  
Methanol 
Aqueous 
(Marie-Magdeleine et al., 
2009)  
- Artemisia absinthium 
In vivo 




(Tariq et al., 2009)  




Chopped leaves (Litherland et al., 2008) 
- Cocos nucifera  
In vitro 




Ethyl acetate (Oliveira et al., 2009)  
  - Allium sativum 





Papaya seed in 
water 
(Burke et al., 2009)  
 - Lantana camara   Meloidogyne incognita Extracted 
compounds 
(Begum et al., 2008) 




(Grade et al., 2008)  
- Allium sativum    Mice Aspiculuris tetraptera Crushed garlic (Ayaz et al., 2008)  
 - Coriander  
orientalis 
- Valeriana wallichi 
In vitro 
  Bursaphelenchus 
xylophilus (pine wood 
nematode) 
Essential oils (Kim et al., 2008)  
- Annona squamosa  
In vitro 
   Haemonchus contortus Ethyl acetate (Souza et al., 2008)  
 - Sericea lespedeza   Goats Gastrointestinal 
nematodes 
Hay (Moore et al., 2008) 
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 - Lippia sidoides 
In vivo 




Essential oil (Camurca-Vasconcelos 
et al., 2008) 
- Achillea millifolium  
In vivo 
  Sheep Gastrointestinal 
nematodes Haemonchus 
contortus in vitro 
Aqueous 
Ethanol 
(Tariq et al., 2008a)  
 - Camellia sinensis 
In vitro 
  Caenorhabditis elegans  Extraction of 
polyphenols 
(Mukai et al., 2008) 
- Acacia pennatula 








 (Alonso-Diaz et al., 
2008)  
- Iris hookeriana 
In vivo 





(Tariq et al., 2008b)  
 - Prosopis laevigata 
In vitro 




(Lopez-Aroche et al., 
2008)  




Dried leaves (Chagas et al., 2008)  







Aquous bark extract (Nwosu et al., 2008) 
- Caesalpina crista 
- Chenpodium album 
In vitro/in vivo 






(Jabbar et al., 2007)  
- Cysteine protease 
extracts 
In vitro 
   Meloidogyne 
Globodera (plant 
nematode) 
 (Stepek et al., 2007a)  
 - Lippia sidoides 
- Croton zehntneri 
In vitro/vivo 
 Mice Haemonchus contortus 
in vitro 
Mice Gastrointestinal 
nematodes in vivo 
 (Camurca-Vasconcelos 
et al., 2007) 




Fed grass (Seng et al., 2007) 
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- Pectis oligocephala 
- Pectis apodocephala 
In vitro 
   Meloidogyne incognita 
Aedes aegypti 
Essential oils (Albuquerque et al., 
2007) 
- Carica papaya latex 
In vivo 
  Rodents Heligmosomoides 
polygyrus 
 (Stepek et al., 2007c) 
 - Hedera helix 
In vivo 




(Eguale et al., 2007a)  
 -Onobrychis viciifolia 
In vitro/in vivo 




 (Brunet et al., 2008) 
- Chicorium intybus 
In vivo 




 Sheep Haemonchus contortus 
Cooperia spp. 
Fed plant (Heckendorn et al., 2007)  
- Myristica fatua 
In vitro 
   Caenorhabditis elegans  Almond extract (Desrivot et al., 2007)  
 - Cissampelos  
capensis 
In vitro/in vivo 
 Mice Gastrointestinal 
nematodes 
Extracted 
compounds of  
(Ayers et al., 2007)  
 - Spigelia anthelmia  
In vivo 
 Sheep Gastrointestinal 
nematodes 
Ethanol (Ademola et al., 2007) 
- Coriandrum sativum 
In vitro 
 - Coriandrum sativum 
In vivo 
Sheep Haemonchus contortus Aqueous 
hydroalcoholic 
(Eguale et al., 2007b)  
 - Acacia negra 
In vivo 
 Sheep Gastrointestinal 
nematodes 
 (Cenci et al., 2007) 
 Azadirachta indica  
In vivo 
 Sheep Gastrointestinal 
nematodes 
Fresh leaves (Chandrawathani et al., 
2006)  
 - Chicorium intybus  
In vivo 
 
 Sheep Gastrointestinal 
nematodes 
Pasture (Athanasiadou et al., 
2007) 
  -Melia azadarach 
In vitro 
    (Szewczuk et al., 2006)  
 - Spigelia anthelma  
In vivo 
 rats Nippostrongylus 
brazilienses 
Aqueous (Jegede et al., 2006)  
- Sericea lespedeza 
In vivo 
  Sheep Haemonchus contortus Hay (Lange et al., 2006)  
255 
 
- Swertia chirata 
In vivo 





(Iqbal et al., 2006e)  
- Jasminum fruticans 
-Mentha longifolia 
- Pinus nigra 
- Zea mays 
- Citrillus lanatus 
- Juniperus drupacea 
- Juniperus oxycedrus 
- Plantago lanceeolata 
In vitro 
  Mice Pinworm Ethanol 
Aqueous 
(Kozan et al., 2006) 
-Ananas comosus 
- Azdarachta indica  
- Caesalpinia crista 
- Vernonia 
anthelmintica 
- Fumaria parviflora 
- Embelia ribes 
In vitro 
   Haemonchus contortus  (Hördegen et al., 2006)  
- Momordica charantia    Caenorhabditis elegans Crude extract (Das et al., 2006)  
- Melia azedarach     Haemonchus contortus Hexane 
Ethanol 
(Maciel et al., 2006)  
 - Leucaena 
leucocephala 
(Ademola and Idowu, 
2006)  
In vitro 
  Haemonchus contortus  (Ademola and Idowu, 
2006) 
- Sericea lespedeza 
In vivo 
  Goats Gastrointestinal 
nematodes 
Hay (Shaik et al., 2006)  




Dried leaves (Costa et al., 2006)  
- Carica papaya latex 
In vivo  
  Mice Trichuris muris  (Stepek et al., 2006)  
- Zingiber officinale 
In vivo 




(Iqbal et al., 2006a)  
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- Nicotiana tabacum 
In vivo 




(Iqbal et al., 2006c) 
- Butea monosperma  
In vivo 
  Sheep Gastrointestinal 
nematodes 




   Trichostrongylus 
colubriformis 
Aqueous  (Bizimenyera et al., 
2006)   
- Onobrychis viciifolia 
In vitro 
   Haemonchus contortus Fractionation of 
extracts 




   Strongyloides stercoralis Aqeous 
Alcohol 
(Boonmars et al., 2005)  
- Calotropis procera 
In vivo 




(Iqbal et al., 2005) 
 - Nigella sativa 
- Allium cepa 
In vivo 
 Rats Trichinella spiralis oil (Abu El Ezz, 2005)  
 - Lantana camara 
In vitro 
  Meloidogyne incognita 
(root knot nematode) 
Bioassay 
fractionation 
(Qamar et al., 2005) 
- Zanthoxylum 
xanthoxyloides 
- Newbouldia leavis 
- Morinda lucida 
- Carica papaya 
In vitro 
   Haemonchus contortus  (Hounzangbe-Adote et 
al., 2005)  




(Ademola et al., 2005)  
 - Zanthoxylum fagara 
In vivo 




  Mouse Heligmosomoides 
polygyrus 
Extracts from 
papaya, fig, etc 
(Stepek et al., 2005) 
 - Onobrychis 
viciifolia 
In vivo 
 Goats Gastrointestinal 
nematodes 
Hay (Paolini et al., 2005)  
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  - Lotus pedunculatus 
- Hedysarium 
coronarium  
- Onobrychis viciifolia  




Grazed on forage 
rich pasture 
(Athanasiadou et al., 
2005)  
  - Hagenia abyssinica 
- Olea europaea  
- Annona squamosa 
- Ananas comosus 
- Dodonea angustifolia 
- Hildebrandtia 
sepalosa 
- Azadirachta indica 
In vivo 
Lambs Haemonchus contortus Aqueous Fresh (Githiori et al., 2004)  
- Artemesia brevifolia 
In vivo 
  Sheep Haemonchus contortus Crude Aqueous 
Methanol 
(Iqbal et al., 2004) 
- Khaya senegalensis 
In vivo 




(Ademola et al., 2009) 
- Myrsine africana 
- Albizia anthelmintica 
- Hildebrandtia sepalosa 
In vivo 
  Sheep Gastrointestinal 
nematodes 
Traditional methods (Gathuma et al., 2004) 
 - Myrsine africana 








(Githiori et al., 2003b) 
 - Mangifera indica 
In vivo 
 Mice Trichinella spiralis Aqueous (Garcia et al., 2003)  
- Fumaria parviflora 
In vivo 
 
 - Vermonia 
anthelmintica 
- Embelia ribes 





Ethanol (Hordegen et al., 2003)  
- Spigelia anthelmia 
In vitro 
   Haemonchus contortus Hexane 
Chlorophorm 
Ethyl acetate 









Haemonchus contortus  
Heligmosomoides 
polygyrus 
Aqueous (Githiori et al., 2003a)  
- Quebracho extracts 
In vivo 
  Goats Haemonchus contortus  
 
Fed 5% dry matter (Paolini et al., 2003)  
- Annona senegalensis 
In vitro 
 - Vernonia amygdalina 
In vitro 
 Haemonchus contortus  
 
Whole ground plant 
in faecal culture 
(Alawa et al., 2003) 
 - Lotus corniculatus 
- Cichorium intybus 
In vivo 
  Gastrointestinal 
nematodes 
Grazing (Marley et al., 2003) 
- Artemesia santonica 
In vitro 
 
- Albizzia lebbek 
- Inula helenium 
In vitro 
  Ascaris lumbricoides Aqueous  (El Garhy and 
Mahmoud, 2002) 
 - Ocimum 
gratissimum 
In vitro 




(Pessoa et al., 2002) 




Sheep Haemonchus contortus  
 
Aqueous (Githiori et al., 2002) 
 - Occimum sanctum 
In vitro 
  Caenorhabditis elegans Essential oil (Asha et al., 2001) 
- Quebracho 
In vivo 
  Sheep Gastrointestinal 
nematodes  
Aqueous (Athanasiadou et al., 
2001) 
 - Carica papaya 
In vitro 
  Caenorhabditis elegans Aqueous  (Kermanshai et al., 2001) 
- Berlina grandiflora 
In vitro 
   Caenorhabditis elegans Ethyl acetate 
MethanolHexane 
(Enwerem et al., 2001)  




Grazing  (Bernes et al., 2000) 
 - Calotropis procera  
In vivo 
 Sheep Haemonchus contortus  
 
 (Al-Qarawi et al., 2001) 
- Nauclea latifolia 
In vivo 
  Sheep Gastrointestinal 
nematodes 
Aqueous (Onyeyili et al., 2001)  
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Ascorbic acid  
(Molan et al., 2000a) 
 
 - Hedysarum 
coronarium 
- Lotus corniculatus 
In vivo 
 Deer Gastrointestinal 
nematodes Lungworm 
Fresh (Hoskin et al., 2000) 
 - Lantana camara 
In vitro 
  Meloidognyne incognita 




(Begum et al., 2000) 
 
 
CT containing forages 
In vitro 
     (Molan et al., 2000b)  
Lit rev Italy: 
-Ruta graveolens 
-Cucurbita maxima 
- Artemesia absinthium 
- Allium sativum 
     (Guarrera, 1999)  
  - Ficus carica 
- Ficus insipid 
In vivo 
Mice   (de Amorin et al., 1999) 




 Sheep Ascaris suum  (Navarrete and Hong, 
1996) 
 - Carica papaya latex 
In vivo 
 Mice Heligmosomoides 
polygyrus 




  Caenorhabditis elegans  (Stadler et al., 1994)  
 - Curcuma comosa 
In vitro  
  Caenorhabditis elegans  (Jurgens et al., 1994)  
- Caesalpina crista 
In vivo 
  Chickens Ascaridia galli  (Javed et al., 1994) 
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- Annona muricata 
- Annona cherimolia 
In vitro 
   Molinema dessetae  (Bories et al., 1991)  
- Saussurea lappa 
In vivo 
  Human Gastrointestinal 
nematodes 
Methanolic extract (Akhtar and Riffat, 1991)  
- Ficus glabrata 
In vivo 
  Humans Ascaris 
Ancyclostoma 
Trichuris 
Fresh (Hansson et al., 1986)  
  - Embelia ribes 
- Hagenia abyssinica 
(toxic) 
In vivo 
Chicks   (Low et al., 1985)  
  - Chenopodium 
ambrosoides 
In vivo 
Humans Ascarids Powdered dry plant (Kliks, 1985)  
 - Stemona japonica 
- Sophora flavescens 
In vitro 
 






(Terada et al., 1982)  
 - Artemisia herba-
alba 
In vivo 
 Goats Haemonchus contortus  Powdered roots (Idris et al., 1982)  
- Carica papaya 
- Butea frondosa 
- Momordica charantia 
In vivo 
  Chickens Ascardia galli  (Lal et al., 1976) 
- Curcubita maxima 
 
     (Bose et al., 1961; 
Srivastava and Singh, 
1967)  




3.1. PROBIT analysis method and results for comparison with general linear model outcome 
in Section 6.2.4.3 and 6.3.2. 
Data were grouped according to drug combination and test, i.e. ivermectin (IVM) alone in the 
larval development test (LDT), IVM +  pluronic 85 (P85) in the LDT etc. Data from each group 
were analysed using PROBIT regression analysis with correction for natural mortality based 
on the data, to enable calculation of an effective median concentration (EC-50) of IVM. The 
independent covariate, concentration, was transformed by the natural logarithm to enable best 
fit of the model. This analysis was performed using SPSS version 21 (SPSS Inc., Chicago IL). 
EC-50 ratios were calculated for comparison of IVM alone with IVM plus P-gp inhibitor, 
defined as the synergy ratios (SR). EC-50 ratios were also calculated for comparison between 
parasite populations in each assay, defined as resistance ratios (RRs). Table A.3.1. shows the 
EC-50 values and the ratio of EC-50 values IVM alone: IVM + PGPI, defined as the synergy 
ratio (SR). From these results it can be seen that, in the LDT, P85 and ketoconazole increased 
the effect of IVM in both Pops 1 and 2, but to a lesser extent in Pop 1 than in Pop 2. In the 
LDT, IVM-AG has no positive effect on IVM efficacy. In the LMIT, IVM-AG and 
ketoconazole both increased the effect of IVM in Pop 1, but had little effect in Pop 2. In the 
LMIT, P85 increased the effect of IVM at lower anthelmintic concentrations but decreased the 
effect at high concentrations; hence it was not possible to model the data meaningfully using 
PROBIT regression. The resistance ratio (RR), i.e. the ratio of Pop 1: Pop 2, was 1.1 in the 
LDT and between 3.0-18.3 in the LMIT. There was a range of RRs for the LMIT because each 





Table A.3.1. EC-50 values calculated for each Population in the larval development test (LDT) and 
larval migration inhibition test (LMIT), with ivermectin (IVM) and IVM plus Pluronic 85 (P85) (22 
µM), ketoconazole (keto) (10 µM) and ivermectin aglycone (IVM-AG) (8 and 60 nM for the LDT and 
LMIT, respectively). For each p-glycoprotein (P-gp) inhibitor a ratio of the EC-50 with IVM alone and 
the EC-50 with P-gp inhibitor is shown, defined as the synergy ratio (SR) 
 
































 LMIT P85* - - - 



























LMIT P85* - - - 











*For P85 in the LMIT, an atypical dose response relationship was observed and the data did not fit a 







3.2. Results of BLAST analysis of sequence data for cyathostomin pgp-9 
 
Table A.3.2. The top 11 results of a NCBI nucleotide BLAST search using sequence data from the PCR 














mRNA, complete cds 




mRNA partial cds 






domain 1 (pgp-9 gene) 





XM_013451424.1 333 586 79% 3e-88 80% 
Caenorhabditis 
briggsae C CBR-PGP-
9 protein (Cbr-pgp-9) 
mRNA complete cds 




mRNA, complete cds 




mRNA, complete cds 






LL376643.1 262 392 41% 4e-67 74% 





LL362081.1 255 1051 88% 6e-65 75% 
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